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Discovery of miRNA-regulated processes in mammalian 
development 
by 
 
Amanda Garfinkel Young 
Abstract 
The genomes of plants and animals encode hundreds of non-coding ~22nt RNAs termed 
“microRNAs” (miRNAs). These RNAs guide the sequence-specific inhibition of translation and 
destabilization of mRNA targets through short (6-7 nucleotide) stretches of complementarity 
between the 5’ end of the miRNA (seed region) and the 3’ untranslated region (UTR) of the 
targeted mRNA. Computational estimates based on prediction of conserved seed matches in 
3’UTRs suggest that over half of genes in mammalian genomes are miRNA-regulated. Many 
miRNAs are also ubiquitously expressed in a variety of embryonic and adult tissues. Given these 
observations, we have sought to address the challenge of determining which cellular and 
biological processes that miRNAs might regulate in different cell types and tissues.  
First, we have developed methods to isolate candidate miRNA-targeted mRNAs by 
immunoprecipitation of Ago2 in the miRNA effector complex (miRNP). In one purification 
method, the Ago2-bound mRNAs are identified by microarray. The second purification method 
adds crosslinking, RNase digestion, and cloning and deep-sequencing (CLIP-seq) to improve the 
specificity. These experiments were performed in mouse embryonic stem cells (mESCs) and a 
miRNA-deficient derivative cell line, lacking miRNA-processing enzyme, Dicer, to enrich for 
targets of miR-290~295, a miRNA cluster highly-expressed in mESCs. By these methods, we 
have identified a set of candidate mRNAs that bear a motif in their 3’UTRs that matches the seed 
of miR-290~295 and exhibit a miRNA-dependent gene expression signature. Gene ontology 
analysis of these candidate mRNAs shows they are involved in regulating the cell cycle, 
apoptosis, and the TGF-ß pathway. We further show that mESCs lacking miR-290~295 are 
unable to differentiate into endoderm, a TGF-ß regulated process.  
We present additional evidence that RNAs crosslinked to Ago2 are significantly enriched 
in a G-rich motif in a miRNA-independent manner, as it is present in Ago2-CLIP libraries from 
Dicer wild-type and Dicer null mESCs. This G-rich motif exhibits higher conservation than the 
general 3’UTR background and appears to modulate the activity of miR-290~295 binding sites 
from the 3’UTRs of two genes. This G-rich motif may confer additional specificity to the Ago-
miRNP and increase its affinity for miRNA-targeted mRNAs. 
We have also investigated the function of a family of miRNA clusters in mouse 
embryonic development by targeted deletion of miR-17~92, and its paralogs, miR-106b~25 and 
miR-106a~363. miR-106b~25 and miR-106a~363 null mice are viable and fertile, however, miR-
17~92-null mice die short after birth with lung hypoplasia and ventral septal defect. miR-17~92 
null embryos also lack mature B cells, due to a block in the pro- to pre-B cell transition. Pre-B 
cells from the fetal livers of miR-17~92 null embryos have higher rate of apoptosis compared to 
wild-type embryos and upregulation of pro-apoptotic gene, Bim, a miR-17~92 target. 
Our findings demonstrate roles for two different clusters of miRNAs in regulating 
cellular processes of cell cycle, cell death, and cell signaling, that are important for differentiation 
of several different tissue types. Biochemical target identification and targeted deletion of 
miRNA clusters in the mouse are both useful tools for uncovering miRNA functions. 
Thesis supervisor: Phillip Sharp 
Title: Institute Professor of Biology 
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Introduction 
One of the fundamental processes of biology is how our genetic information is 
turned into functional molecules in the cell. Work over the last five decades has shown 
that this process begins with DNA being transcribed in the nucleus and spliced into 
messenger RNA (mRNA), which is then exported into the cytoplasm where it is 
translated into protein, or stored, or degraded. Perhaps the most surprising discovery of 
the past decades is that RNA is not just a messenger, but can actually regulate gene 
expression post-transcriptional manner. This phenomenon is broadly defined as RNA 
interference (RNAi) and involves a short RNA reducing target gene expression in a 
sequence specific manner. One class of these RNAs are microRNAs (miRNAs), which 
are short ~22nt non-coding RNA genes. This gene class appears to have evolved 
independently in plants and animals and animal genomes encode hundreds of miRNA 
genes, many of which are conserved from C. elegans to humans. miRNAs control their 
target mRNAs through sequence-specific interactions that result in the destabilization 
and subsequent degradation and inhibition of translation of the target mRNAs. miRNAs 
play critical roles in diverse cellular processes such as apoptosis, proliferation, 
differentiation: in organismal contexts such as embryonic development and cardiac 
electrophysiology; and in diseases such as cancer and Alzheimer's disease (reviewed in 
Singh et al. 2008). In Chapter 1, miRNA biogenesis, activity, and cellular functions are 
described, focusing mostly on mammalian miRNAs. Lastly, a brief description of the role 
of miRNAs in mouse embryonic stem cell biology is discussed, as it is the focus of 
research in this thesis. 
miRNA biogenesis 
pri-miRNA transcription and processing 
Most mammalian primary miRNA precursors (pri-miRNAs) are transcribed by 
Chapter 1: Introduction 
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RNA Polymerase II (Fig. 1), but a few are transcribed by Polymerase III (Cai et al. 2004; 
Lee et al. 2004; Monteys et al. 2010). Those generated by Pol II are capped and poly-
adenylated and come from independent transcriptional units either in intergenic regions 
or in introns. By computational estimates, roughly 50% of miRNAs are found within other 
transcriptional units, either in the exon or intron of host non-coding RNAs or in the intron 
of host protein coding genes (Cai et al. 2004; Lee et al. 2004; Baskerville et al. 2005; 
Rodriguez et al. 2007; Saini et al. 2007; Griffiths-Jones et al. 2008). The miRNA resides 
in a hairpin structure, termed the pre-miRNA, with a ~33nt stem region that can be either 
mostly or completely paired, and a loop region. 36-47% of pre-miRNA hairpins in 
vertebrates are also present in clusters of pre-miRNAs in the same primary transcript 
(Saini et al. 2007; Thatcher et al. 2008).  
The pre-miRNA hairpin is processed from the primary transcript in the nucleus by 
the Microprocessor complex containing the RNase III-class enzyme Drosha, and its co-
factor DGCR8 (Fig. 1)(Lee et al. 2003; Denli et al. 2004; Gregory et al. 2004; Han et al. 
2004; Landthaler et al. 2004; Zeng et al. 2005b). The Microprocessor complex 
recognizes the stem and the unpaired flanking regions of the hairpin. DGCR8 acts as a 
molecular ruler to guide Drosha's cleavage of the two strands at the base of the hairpin 
by its two RNase III domains acting as an intramolecular dimer (Zeng et al. 2003; Zeng 
et al. 2005a). This leaves the stem with a 5' phosphate and a 3'OH on a 2-nt overhang. 
The Microprocessor complex tracks with Pol II and its activity can precede splicing of the 
intron where the pre-miRNA resides (Kim et al. 2007b; Morlando et al. 2008). There also 
exists a class of miRNAs, termed mirtrons, that do not require Drosha for their 
processing as the two ends of the pre-miRNA lie at the splice sites of introns (Okamura 
et al. 2007; Ruby et al. 2007).  
Chapter 1: Introduction 
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Pre-miRNA processing 
Following liberation from the primary transcript, the pre-miRNA is bound by Ran-
GTP/Exportin-5 and exported to the cytoplasm (Fig. 1)(Yi et al. 2003). Once in the 
cytoplasm, the pre-miRNA is recognized by the RISC Loading complex (RLC). The RNAi 
silencing complex (RISC) is the effector complex of short RNA function that mediates 
targeting and regulation of the cognate mRNAs (Hammond et al. 2001; Hutvagner et al. 
2002; Martinez et al. 2002; Martinez et al. 2004). This complex contains a member of the 
conserved Argonaute (Ago) protein family (Carmell et al. 2002; Caudy et al. 2002). The 
RLC contains Dicer, an RNase III-class enzyme, TRBP, Tar-RNA binding protein, PACT, 
protein activator of PKR, and Ago (Chendrimada et al. 2005; Gregory et al. 2005; Haase 
et al. 2005; Maniataki et al. 2005; Lee et al. 2006). Dicer is a highly conserved protein 
present in all species that have RNAi (Bernstein et al. 2001; Grishok et al. 2001; 
Hutvagner et al. 2001). Dicer's PAZ domain binds the 2nt overhang on the pre-miRNA 
(or long dsRNA) and its two RNase III domains, acting as an intramolecular dimer, 
cleave ("dice") the two strands of the stem 21-22nt away, removing the loop and leaving 
a 5' phosphate and 3'OH on a 2nt 3' overhang (Fig. 1)(Song et al. 2003; Yan et al. 2003; 
Lingel et al. 2004; Ma et al. 2004; Zhang et al. 2004; MacRae et al. 2007). TRBP and 
PACT, while not required for processing, appear to increase dicing efficiency and TRBP 
stabilizes Dicer protein (Chendrimada et al. 2005; Lee et al. 2006). Dicer, TRBP, and 
Ago2 make up a minimal complex that is sufficient for processing of the pre-miRNA and 
loading the mature miRNA into RISC (Gregory et al. 2005; Maniataki et al. 2005; Wang 
et al. 2009b).  
Several groups have shown that Drosha and Dicer processing of pri- and pre-
miRNAs, respectively, can be regulated by other RNA binding proteins (Guil et al. 2007; 
Davis et al. 2008; Heo et al. 2008; Michlewski et al. 2008; Newman et al. 2008; 
Chapter 1: Introduction 
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Piskounova et al. 2008; Rybak et al. 2008; Viswanathan et al. 2008; Trabucchi et al. 
2009). Generally these proteins act by binding to pri-/pre-miRNA species and either 
facilitating or inhibiting cleavage by Drosha or Dicer. For example, TGF-ß and BMP 
activation of SMAD proteins stimulates their binding to pri-miR-21 along with p68 
helicase, and consequently enhances its Drosha-mediated processing (Davis et al. 
2008). Both Dicer and Drosha processing of the let-7 family of miRNAs can be inhibited 
by Lin-28, and this seems to be an important mechanism for regulating the proliferation 
of embryonic stem cells and their differentiated derivatives (Heo et al. 2008; Newman et 
al. 2008; Piskounova et al. 2008; Rybak et al. 2008; Viswanathan et al. 2008; Melton et 
al. 2010).  
miRNA duplex unwinding and loading 
After Dicer processing, the remaining species is the miRNA duplex, which must 
be subsequently unwound (Fig. 1). One strand, the miRNA or guide strand, is loaded 
into the RISC-Ago complex and the other strand, the miR* or passenger strand, is 
discarded and degraded. Strand selection is, in part, based on asymmetry between the 
thermodynamic stabilities of the two ends of the duplex. The strand whose 5' end resides 
in the more unstable end of the duplex is more likely to be incorporated into RISC 
(Khvorova et al. 2003; Schwarz et al. 2003). While protein "sensors" of this asymmetry, 
R2D2 and Loquacious, have been identified in Drosophila (Forstemann et al. 2005; 
Jiang et al. 2005; Saito et al. 2005); no such sensor has been found in mammalian 
systems and maybe the Ago protein itself (Tomari et al. 2004; Wang et al. 2009a; Yoda 
et al. 2010).  
Additionally, Ago2, an RNase-H-like endonuclease in RISC, can cleave the 
passenger strand of a perfectly complementary RNA duplex (siRNA) this rendering it 
incapable of being the guide strand in RISC (Matranga et al. 2005; Miyoshi et al. 2005; 
Chapter 1: Introduction 
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Rand et al. 2005; Leuschner et al. 2006; Diederichs et al. 2007; Kim et al. 2007a). Ago2 
can also cleave the miR* strand of the miRNA duplex and 3' arm of the pre-miRNA 
hairpin, however, this activity requires extensive base-pairing in the miRNA duplex or 
stem of the pre-miRNA, which is uncommon. In the absence of perfect base-pairing in 
the stem, Ago proteins in vitro can unwind miRNA duplexes and load the miRNA strand. 
The efficiency is increased if there are mismatches in the duplex between positions 2-10 
and/or positions 12-15 (Wang et al. 2009a; Yoda et al. 2010). Ago proteins enhance the 
stability of overexpressed miRNAs in cultured cells (Diederichs et al. 2007). Ago2, in 
particular, is also required for stability of miRNAs in vivo, as loss of Ago2 in B cells 
results in the decrease of expression of some miRNAs. This appears to be independent 
of its endonuclease activity, as a cleavage-defective mutant of Ago2 can rescue the 
phenotype (O'Carroll et al. 2007).  
RISC/miRNP 
Minimal active RISC contains a single stranded RNA bound to an Ago protein. 
There are 8 members of the Ago super-family present in mammalian genomes 
(reviewed in Hock et al. 2008). In the Ago subfamily, there are 4 genes in human, 
hAgo1-4, and 5 genes in mouse, mAgo1-5; they are all expressed ubiquitously in many 
tissues types and cell lines (Sasaki et al. 2003). In the Piwi sub-family, there is human 
Hiwi, Hiwi2, Hiwi3 and Hili, and mouse Miwi, Miwi2, Mili; they are expressed specifically 
in the germline and appear to regulate meiosis and spermatogenesis, at least in part, by 
the piRNA pathway. The Ago sub-family will be discussed here exclusively as it is most 
relevant to miRNA function, but for further discussion of piRNAs see Thomson and Lin 
(2009). The members of the Ago sub-family are highly related to one another both within 
and across species. Crystallographic studies of Ago proteins found in Archaea and 
corresponding biochemical analysis of metazoan Ago proteins have yielded important 
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insights into the structure and function of these proteins. Ago proteins consist of 3 
domains: PAZ, Mid, and PIWI domains. The Ago PAZ domain, which is structurally 
similar to the Dicer PAZ domain, binds the 3'OH of the guide strand RNA (Song et al. 
2003; Yan et al. 2003; Lingel et al. 2004; Ma et al. 2004). The Mid domain contains a 
basic pocket for binding the 5' phosphate of the short RNA, an important component the 
RNA binding specificity of Ago (Parker et al. 2004; Yuan et al. 2005). The PIWI domain 
is homologous to RNase-H catalytic domain, though only Ago2 possesses 
endonucleolytic (slicer) activity. The catalytic triad for hAgo2 consists of Asp597, Asp669 
and His807. Ago1 and Ago4 lack these residues, explaining why they lack slicer activity. 
However, Ago3 also has these residues, but has no slicing activity in vitro (Liu et al. 
2004; Meister et al. 2004b; Parker et al. 2004; Song et al. 2004; Ma et al. 2005; Parker 
et al. 2005; Rivas et al. 2005; Yuan et al. 2005; Wang et al. 2008c; Wang et al. 2008d; 
Wang et al. 2009c). Surprisingly, Ago1 in vitro is able to cleave a perfectly 
complementary RNA duplex with the sequence of miR-21, but is unable to catalyze 
cleavage of a perfectly complementary target RNA (Wang et al. 2009a). However, in 
vivo, this activity does not seem to be robust enough to allow for appreciable recruitment 
of mRNA targets to the Ago1-miRNP (Wang et al. 2009a).  
Regulation of target mRNAs by miRNAs requires additional factors associated 
with RISC in a complex termed the miRNA ribonucleoprotein particle (miRNP) 
(Mourelatos et al. 2002). Several studies of Ago-associated proteins have identified 
other components of the miRNP, including GEMIN3, GEMIN4, VIG, TSN, FMRP family 
members, MOV10, HSP90, HNRNP family members, RCK/p54, and others (Tahbaz et 
al. 2001; Caudy et al. 2002; Mourelatos et al. 2002; Caudy et al. 2003; Tahbaz et al. 
2004; Meister et al. 2005; Chu et al. 2006; Hock et al. 2007). Some of these associated 
co-factors can modulate the function of the miRNP. For example, FMRP is required in 
the mouse brain for regulation of NR2A 3'UTR by miR-125b complexed with Ago1 in the 
Chapter 1: Introduction 
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miRNP (Edbauer et al. 2010). Another Ago-associated protein, Importin 8, in involved in 
regulating the subcellular localization of Ago proteins, as well as loading of miRNA target 
mRNAs into the miRNP complex (Weinmann et al. 2009). 
The active RISC/miRNP identifies target mRNAs through base-pairing 
interactions between the guide RNA and the target RNA. The base-pairing between the 
guide and target in an A-form helix is initiated at the 5' end of the guide RNA, although 
the first nucleotide is unpaired (Ma et al. 2005; Parker et al. 2005; Yuan et al. 2005). 
Pairing between the central region of the guide and the target aligns the duplex in the 
active site of Ago2 and results in cleavage of the target mRNA at the scissile phosphate 
group opposite the phosphate group between the tenth and eleventh nucleotides of the 
guide RNA strand, as measured from the 5' end of the guide strand (Elbashir et al. 
2001a; Elbashir et al. 2001b; Liu et al. 2004; Ma et al. 2005; Parker et al. 2005; Yuan et 
al. 2005; Wang et al. 2008c; Wang et al. 2008d; Parker et al. 2009; Wang et al. 2009b; 
Wang et al. 2009c). 
Few mammalian miRNAs have extensive pairing to their mRNA targets. Only 
mouse miR-196 has been shown to cause endonucleolytic cleavage of a target mRNA, 
HoxB8 (Yekta et al. 2004) (Fig. 1). Instead, most mammalian miRNAs base pair with 
their targets between nucleotides 2-8, as measured from the 5' end of the miRNA, have 
no pairing in the central region, and have variable amounts of pairing between nt 12-17 
(Grimson et al. 2007). The region of pairing in the 5' end of the miRNA, termed the seed 
region, is usually critical for this recognition of the target mRNA and its regulation 
(Doench et al. 2003; Lewis et al. 2003; Doench et al. 2004; Brennecke et al. 2005). The 
topic of miRNA targeting is discussed in more detail in a later section. 
Modes of miRNA-mediated silencing 
In the absence of mRNA cleavage, the miRNP affects the expression of the 
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target mRNAs through two modes of regulation: inhibition of translation and 
destabilization and degradation of the transcript (Fig. 1). 
Translational Repression 
Initial work focused on the former mechanism as the first identified animal 
miRNA, C. elegans lin-4, caused a large decrease in the protein from the lin-14 
transcript with little accompanying decrease in transcript levels (Lee et al. 1993; 
Wightman et al. 1993). Although, a later study indicates that lin-14 transcript is also 
destabilized by lin-4 (Bagga et al. 2005). Olsen et al. (1999) showed that lin-4 and lin-14 
both associate with polyribosomes, and speculated that lin-4 causes an inhibition of 
translation after the initiation step. This mode of regulation was further supported by 
studies of both endogenous and artificial miRNA targets in mammalian cells that showed 
that target mRNAs associate with poly-ribosomes, miRNA repression leads to decreased 
readthrough at a stop-codon, and miRNAs repress internal ribosome entry site (IRES)-
containing mRNAs whose initiation does not depend on canonical initiation factors 
(Maroney et al. 2006; Nottrott et al. 2006; Petersen et al. 2006).  
However, several other groups showed that miRNAs inhibit translation of their 
target mRNAs by blocking initiation. These groups observed that miRNA target mRNAs 
are not associated with polyribosomes and fail to be repressed when they contain a cap-
analog or IRES (Humphreys et al. 2005; Pillai et al. 2005). Additional experiments 
performed in intact cells and cell-free extracts also showed that an intact cap and a 
polyA tail are required for repression (Wang et al. 2006; Wakiyama et al. 2007; Beilharz 
et al. 2009) and that miRNAs either inhibit 60S joining the loaded 40S complex (Wang et 
al. 2008a) or 80S initiation complex formation (Mathonnet et al. 2007). Addition of eIF4F 
to the extract could relieve the repression, suggesting miRNA-mediated repression 
impinges on the recognition of the cap structure (Mathonnet et al. 2007). Indeed, Ago2 
Chapter 1: Introduction 
 18 
has been shown to bind the mRNA 7-methylguanosine cap, and may inhibit translation 
initiation by this activity (Kiriakidou et al. 2007; Djuranovic et al. 2010). It has also been 
shown that the miRNP can recruit eIF6 to the targeted mRNA and prevent association of 
the large ribosomal subunits (Chendrimada et al. 2007). Translational repression also 
requires RNA helicase RCK/p54 (Chu et al. 2006). At this point, it remains possible that 
miRNAs regulate the translation of their targets both at the step of initiation and at a step 
after initiation, potentially by enhancing ribosome drop-off. 
mRNA destabilization 
The importance of the second mode of miRNA-mediated regulation was later 
recognized with the observation that addition of exogenous miRNAs to human cells can 
cause downregulation of a large set of mRNAs (Lim et al. 2005). Additionally, several 
groups reported the localization of Ago2 to mRNA-processing bodies (P-bodies) (Liu et 
al. 2005b; Pillai et al. 2005). These cytoplasmic foci are thought to be sites of mRNA 
degradation and storage as they are enriched in many mRNA-degrading enzymes, 
including XRN1 and DCP1/2 (reviewed in Anderson et al. 2009). In human cells, about 
10% of cytoplasmic Ago protein localizes to P-bodies, while the remaining protein is in 
the diffuse cytoplasm, and the protein shuttles rapidly between these two sites (Leung et 
al. 2006). However, this localization is not required for miRNA target degradation (Chu et 
al. 2006; Eulalio et al. 2007).  
Ago also interacts with the GW182 protein and this interaction is critical for 
destabilization of targeted mRNAs (Liu et al. 2005a; Rehwinkel et al. 2005; Ikeda et al. 
2006; Eulalio et al. 2008). GW182 recruits CCR4-NOT deadenylase complex to the 
target mRNA; deadenylation is followed by decapping and 5' to 3' exonucleolytic 
degradation by XRN1 (Behm-Ansmant et al. 2006; Chen et al. 2009; Zekri et al. 2009). 
Ago2 interaction with GW182 is mediated through the C-terminal half on Ago2, and in 
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particular by two phenylalanines, F594 and F629 (Chen et al. 2009). These residues in 
Ago2 are required for repression of a target that is artificially tethered to Ago2 through 
the LambdaN-BoxB association (Eulalio et al. 2008). However, it has also been shown 
that these phenylalanines are required for Ago mRNA cap binding activity (Kiriakidou et 
al. 2007), and thus may effect miRNA-mediated repression through inhibition of 
translation initiation as well. mRNA deadenylation is not required for miRNA-mediated 
translational inhibition of the mRNA and some miRNA targets have been shown to have 
a decrease in protein output with little to no change in mRNA levels (Pillai et al. 2005; 
Wu et al. 2006; Baek et al. 2008; Eulalio et al. 2008; Selbach et al. 2008; Eulalio et al. 
2009). Taken together, these observations suggest that the two modes of miRNA-
mediated silencing occur independently and the contribution of each to the overall level 
of target repression depends on unknown factors or sequence contexts (Wu et al. 2006; 
Baek et al. 2008).  
Translational Activation 
miRNAs may also cause translational activation of their target mRNAs. This has 
been shown to occur for an endogenous mRNA, TNF-alpha, under conditions of cell 
cycle arrest (Vasudevan et al. 2007a). Vasudevan and colleagues (2007b) also 
demonstrated that artificial miRNA targets are translationally repressed in cycling cells, 
but are translationally activated in G0/G1 quiescent cell state. Additionally, miR-10a 
upregulates the translation of TOP-motif (terminal oligopyrimidine tract) containing 
mRNAs by binding sites in the 5'UTR near the TOP motif, although these sites do not 
contain canonical seed matches to miR-10a (Orom et al. 2008). It is still unclear whether 
translational activation by miRNAs is a general phenomenon or a specialized activity of 
certain miRNA:mRNA target pairs under certain conditions. 
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miRNA binding sites in 5’UTRs and coding sequences 
In addition to the report from Orom et al. (2008), several other groups have 
investigated miRNA binding sites in 5'UTRs. A proteomic analysis of neutrophils lacking 
miR-223 expression found no miRNA-dependent effects on protein abundance for 
mRNAs containing miR-223 seed matches in their 5'UTRs (Baek et al. 2008). However, 
an investigation of miRNA binding sites in the 5'UTR of luciferase reporter mRNAs found 
that they can confer miRNA-dependent translational inhibition (Lytle et al. 2007). In 
these experiments, initiation of translation of the reporter mRNAs was mediated by IRES 
elements, rather than the canonical mRNA cap, which could account of the differences 
observed. 
miRNAs can also target sites in the coding sequence (CDS) of transcripts 
(Duursma et al. 2008; Tay et al. 2008). Tay et al. (2008) observed that several miRNAs 
in ES cells can post-transcriptionally regulate Oct4, Sox2, and Nanog, and thus affect 
the pluripotency of these cells. This phenomenon has also been observed on a genome-
wide scale for miRNA-dependent expression changes (Grimson et al. 2007; Baek et al. 
2008). The degree of mRNA change is significantly less for transcripts with miRNA sites 
in CDS as compared to those with sites in the 3'UTR. Consistent with this, translation of 
3'UTRs sequences bearing miRNA binding sites fused to the CDS of a transgene 
abolishes their ability to confer miRNA-dependent downregulation (Gu et al. 2009). At 
this point, it remains unclear whether the regulatory mechanisms are the same for 
miRNA binding sites in the CDS and 3'UTRs of transcripts. Also, it is possible that the 
interaction of miRNAs with sites in CDS differs from the interaction with sites in the 
3'UTR, as only 1 out of 5 of the sites identified by Tay et al. (2008) has a canonical 
miRNA seed match.  
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Interface of the miRNA pathway with other post-transcriptional regulatory 
pathways 
miRNA-regulated sites in 3'UTRs are only one kind of a larger category of 3'UTR 
sequence elements that are regulated by RNA-binding proteins (RBPs). Several groups 
have shown that miRNA-mediated effects can be abrogated by binding of other RBPs to 
sites near miRNA binding sites (Bhattacharyya et al. 2006b; Kedde et al. 2007; 
Vasudevan et al. 2007a). For example, HuR binding to the CAT-1 transcript under stress 
conditions in liver cells relieves miR-122-mediated repression of this mRNA 
(Bhattacharyya et al. 2006a). Given that miRNP complexes are quite stable in the cell 
(Lee et al. 2006; van Rooij et al. 2007; Gatfield et al. 2009), this is probably an important 
general mechanism for regulating miRNA-dependent effects on transcripts. 
Discovery of miRNA biological functions 
The discovery of miRNAs as an entirely new gene class led many groups to 
explore the biological function(s) of these RNAs on both the cellular and organismal 
levels. This question has been addressed in three main ways: 1) computational miRNA 
target prediction 2) biochemical miRNA target identification and 3) miRNA loss-of-
function, by both use of specific miRNA inhibitors and classic reverse genetic 
approaches. 
Computational miRNA target prediction 
Seminal work on one of the first identified miRNAs (lin-4) in C. elegans 
demonstrated that the phenotype of lin-4 null animals, reiteration of the L1 stage in later 
larval stages, is due to the upregulation of LIN-14 protein (Lee et al. 1993; Wightman et 
al. 1993). They further showed that the lin-14 mRNA has complementary sites in its 
3'UTR that can base-pair with the lin-4 miRNA, and that the region containing these sites 
is required for repression of LIN-14 protein synthesis. After both experimental and 
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computational methods identified many miRNAs present in the genomes of C. elegans, 
Drosophila, mouse and human (Lagos-Quintana et al. 2001; Lau et al. 2001; Lagos-
Quintana et al. 2002; Lim et al. 2003), it became clear, based on lin-4:lin-14 paradigm, 
that identification of miRNA-targeted mRNAs would provide many insights into the 
biological functions of miRNAs.  
Given the large number of miRNAs, as well as mRNAs, present in animal 
genomes, computational approaches are necessary for prediction of miRNA-targeted 
mRNAs. Most target prediction algorithms were based on two features of the first 
validated miRNA:mRNA target pairs. First, there is at most 8-10 nt of continuous base-
pairing between seed region in the 5' end of the miRNA and the target site in the 3'UTR 
of the mRNA, including G:U wobble base-pairs (Lee et al. 1993; Wightman et al. 1993; 
Brennecke et al. 2003).There was also variable amounts of complementarity between 
the 3' end of the miRNA and the mRNA, ranging from no complementarity to several 
nucleotides of complementarity. Second, the seed match region in the target mRNA is 
often conserved between related species. Employing these criteria, multiple groups used 
a thermodynamic approach that modeled the interaction between the miRNA seed and 
all the annotated 3'UTRs in the genome of interest. Some algorithms assessed further 
base-pairing interactions between the 3' end of the miRNA and mRNA or allowed G:U 
wobble pairs or mismatches in the seed. Furthermore, the conservation of these sites 
was determined between related genomes. Generally, these initial studies estimated that 
between 10-30% of human genes are targets of miRNAs (Lewis et al. 2003; John et al. 
2004; Krek et al. 2005; Lewis et al. 2005; Miranda et al. 2006; Kertesz et al. 2007; 
Griffiths-Jones et al. 2008) and the overlap between predicted sets varied from 15%-
40% (Kertesz et al. 2007). This could be due to the use of different 3'UTR annotations or 
genomic alignments, or the various permutations and weighting of the criteria. 
Target prediction was further improved following the observation that transfection 
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of miRNAs into cells where they are not normally expressed could cause downregulation 
of hundreds of transcripts containing seed matches to the miRNA in their 3'UTRs (Lim et 
al. 2005). When this set of targets identified by miRNA overexpression was compared to 
the set of computationally predicted targets, it became clear that those with longer seed 
matches (7 rather than 6 nt of base-pairing), an 'A' in the first position of the target site, 
and those sites that had a higher degree of conservation caused a greater 
downregulation (Grimson et al. 2007; Nielsen et al. 2007). The preference for an ‘A’ in 
the first position of the target site, both at the level of conservation and degree of mRNA 
downregulation, could be due to the geometry of the miRNA:mRNA target duplex in the 
Ago protein (Lewis et al. 2005; Grimson et al. 2007). Crystallographic studies show that 
this nucleotide is unpaired, and since the first nucleotide of many miRNAs is ‘U’, 
disrupting this pairing would be energetically more favorable (Lim et al. 2003; Lewis et 
al. 2005; Ma et al. 2005; Parker et al. 2005; Yuan et al. 2005).  
Additionally, this method allowed for the investigation of other criteria for miRNA 
targeting, including location of the miRNA binding site with respect to the stop codon and 
polyA tail, AU content around the site, proximity to other miRNA binding sites, and 
contribution of pairing between the 3'end of the miRNA and the target site (Doench et al. 
2003; Grimson et al. 2007; Nielsen et al. 2007). miRNA binding sites appear to be more 
active if they are at least 14nt from the stop codon. This could be because the translation 
termination machinery inhibits miRNP from accessing the binding site. miRNA binding 
sites also appear to be more active if they are towards to ends of long 3'UTRs and in a 
region of high AU content. This likely is due to the miRNP having greater access to the 
miRNA binding site if it is not part of an RNA secondary structure. miRNA binding sites 
can also act cooperatively if they are within 40nt of each, potentially by increasing the 
likelihood the miRNP encounters the transcript. It has been experimentally determined 
that pairing between the 3'end of the miRNA and the target site confers additional 
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miRNA-dependent repression (Doench et al. 2004; Brennecke et al. 2005; Grimson et al. 
2007). This appears to be particularly consequential for pairing of 4 nt starting at position 
13 of the miRNA. Supporting this, there is also a detectable signal for conservation in the 
target for pairing to the 3' end of the miRNA (Grimson et al. 2007). These criteria have 
been incorporated into the newest version of the target prediction program, TargetScan 
5.1, as a composite score (context score). Additionally, analysis of conservation of 
miRNA binding sites in 23 non-fish vertebrate genomes, predicts over 45,000 miRNA 
binding sites in ~50% of mammalian genes for hundreds of miRNAs (Friedman et al. 
2009).   
Several target prediction programs either do not use conservation as a criterion 
or separately allow the investigation of non-conserved sites (RNA22, PITA, TargetScan) 
by focusing on seed matching and site context (Miranda et al. 2006; Grimson et al. 2007; 
Kertesz et al. 2007; Friedman et al. 2009). Given that many non-conserved miRNA-
binding sites have been shown to be functional, particularly if they have favorable 
sequence context, this is a useful aspect to target prediction programs (Krutzfeldt et al. 
2005; Lim et al. 2005; Giraldez et al. 2006; Grimson et al. 2007; Rodriguez et al. 2007; 
Baek et al. 2008). 
Given the potential for miRNAs to regulate sites in the 5'UTRs and CDS of 
transcripts, there have been efforts to also predict miRNA binding sites in these genic 
regions. This type of analysis relies on observing excess sequence conservation over 
the background sequence composition, since CDS sequences are already highly 
conserved, confidently predicting miRNA binding sites in this region is challenging 
(Lewis et al. 2005; Stark et al. 2007). Despite this, mRNAs bearing predicted seeds sites 
in the CDS do undergo miRNA-dependent changes in gene expression, although the 
degree of repression is less than those mRNAs bearing sites in the 3'UTR (Farh et al. 
2005; Lim et al. 2005; Grimson et al. 2007; Baek et al. 2008). Searching for miRNA 
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binding sites in the 5' UTRs of mRNAs, Lee et al. (2009) found conserved sequences 
that were complementary to the 3' ends of miRNAs, rather than the seed region, similar 
to previous observations of miRNA sites in 5'UTRs (Orom et al. 2008). One 5'UTR 
sequence, when placed upstream of Luciferase coding sequence, was sufficient to 
confer downregulation on luciferase gene expression. 
The sets of computationally predicted miRNA targets have provided the basis for 
validation of many miRNA:mRNA target interactions and investigation of the role of 
these interactions in a variety of cellular contexts. For example, identification of targeting 
of the oncogene E2F1 by miR-17-5p and miR-20 in human cells implicated these 
miRNAs the control of the cell cycle and cell growth (O'Donnell et al. 2005). However, 
the utility of these predictions for determining the function of a given miRNA in a given 
cell type/tissue or a specific cellular process is limited by the fact that there are hundreds 
of targets predicted for each miRNA, that each prediction program may predict a unique 
set of targets, and that the likelihood that an mRNA is targeted by that miRNA depends 
on the expression level of the miRNA and mRNA in its native context. The degree of 
conservation of the miRNA binding site and the favorability of the sequence context 
around the site can be used as reliable indicators of the likelihood a miRNA binding site 
is functional (Grimson et al. 2007; Nielsen et al. 2007; Friedman et al. 2009). However, it 
is possible that many functional miRNA binding sites are overlooked because it is not 
feasible to analyze all predicted miRNA binding sites. These sets of computationally 
predictions of targets have been validated by complementary approaches to 
biochemically identify miRNA targets. 
Biochemical miRNA target identification 
One such technique, as was previously mentioned, is to use microarray analysis 
to detect gene expression changes induced by miRNA overexpression or specific 
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miRNA loss, either by targeted deletion of the miRNA or miRNA inhibition by specific 
antisense oligo inhibitors (Lim et al. 2005; Rodriguez et al. 2007). Since miRNAs cause 
a decrease in the expression of their target mRNAs, the set of genes that possess 
miRNA seed-match sites and exhibit a change in expression are likely to be miRNA 
targets. This type of analysis has allowed for detection of a set of miRNA-regulated 
mRNAs under a give cellular context, and has verified many computational predicted 
targets. There are also several limitations this approach. First, the miRNA 
overexpression approach is most effective under the conditions where the miRNA is 
introduced to a cell type where it is normally not expressed, such as expressing miR-1, a 
heart specific miRNA, in Hela cells, a cervical cancer cell line. However, miR-1 may 
regulate heart-specific transcripts that are not expressed in Hela cells, and thus would 
not be identified by this assay. Inhibition of miRNAs with specific inhibitors can get 
around this problem, although the signal tends to be weaker. Second, some miRNA 
target mRNAs exhibit translational repression with little to no miRNA-dependent change 
on the mRNA level, and thus would not be detected by this assay (Baek et al. 2008; 
Selbach et al. 2008).  
A complementary approach to address this caveat is to analyze global miRNA-
dependent protein changes by quantitative mass spectrometry using SILAC (stable 
isotope labeling with amino acids in cell culture) (Baek et al. 2008). This technique has 
been used to identify targets of miR-124, a brain specific miRNA, in Hela cells as well as 
targets of miR-223 in neutrophils, using cells that have a targeted deletion of miR-223. 
This yielded several important insights into miRNA-dependent regulation and the 
performance of computational target prediction algorithms. First, some mRNAs exhibited 
a small change in protein expression without a change mRNA expression, however all 
genes that showed a greater than 30% repression had some mRNA destabilization 
component. This suggests that the most dramatic gene expression changes employ both 
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mechanisms of miRNA-dependent gene regulation.  
Second, when comparing the set of observed targets in this assay with those 
predicted by several computational algorithms (miRANDA, miRbase, Pictar, PITA, 
TargetScan and RNA22), the two programs whose predicted targets had the greatest 
degree of expression change (Pictar and TargetScan) considered both exact 7mer and 
8mer seed-match sites and conservation of those sites (John et al. 2004; Krek et al. 
2005; Miranda et al. 2006; Kertesz et al. 2007; Griffiths-Jones et al. 2008; Friedman et 
al. 2009). Those that allowed for mismatches or wobble base pairs in the seed region, or 
did not consider conservation did no better than the expression change for all genes 
containing seed match sites. However, two thirds of the targets predicted by the 
TargetScan and Pictar programs were not responsive to miRNA regulation in this assay, 
suggesting that there are additional unknown factors that govern miRNA-dependent 
regulation. One limitation of this approach is that quantitative mass spectrometry could 
only identify proteins whose abundance and solubility was such that they could be 
detected in this assay.  
Expression based approaches have identified the seed match site as the only 
distinguishable common feature among genes that show miRNA-dependent mRNA and 
protein changes. There are some reports of miRNA-targeted mRNAs bearing seed 
matches with mismatches or pairing between positions 3-8, not the canonical 2-7 (Wu et 
al. 2005; Didiano et al. 2006; Didiano et al. 2008; Tay et al. 2008; Friedman et al. 2009). 
Furthermore, there are many genes whose expression levels have been observed to be 
responsive to miRNA effects but do not contain canonical seed matches. While some of 
these changes maybe secondary effects from miRNA overexpression or inhibition, other 
of these may associate with the miRNP through non-seed based interactions. These 
types of interactions between the miRNP and the mRNA target maybe common in a 
subset of targets, and may not have been observed by the expression-based 
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approaches. 
Several groups have addressed this question by developing methods to 
biochemically purify miRNA target mRNAs (Beitzinger et al. 2007; Karginov et al. 2007; 
Orom et al. 2007; Hendrickson et al. 2008; Landthaler et al. 2008; Orom et al. 2008; Chi 
et al. 2009; Hong et al. 2009; Zisoulis et al. 2010). These methods employ 
immunoprecipitation techniques to either isolate mRNAs bound to a biotin-tagged 
miRNA or mRNAs bound to the Ago protein in the miRNP and then detection of the 
mRNAs by microarray analysis or deep sequencing. Isolation of mRNAs bound to a 
biotinylated oligo has the advantage of identifying targets of a specific miRNA, however 
there could be other, spurious interactions of mRNAs with the labeled RNA. By this 
technique, an unusual class of RNA targets containing miRNA binding sites in their 
5'UTRs was identified (Orom et al. 2008).  
Immunoprecipitation of the Ago protein in cultured cells has also identified many 
potential target mRNAs, however it is a challenge to match up the mRNAs with the 
miRNAs that are targeting them to the miRNP (Beitzinger et al. 2007; Karginov et al. 
2007; Hendrickson et al. 2008; Landthaler et al. 2008; Hong et al. 2009). Ultimately, 
bioinformatic analysis is necessary to look for seed matches in the 3'UTRs of the 
immunoprecipitated mRNAs. This approach is explored in Chapter 2 of this thesis, 
including an alternative experimental design to address this issue. A variation of the Ago 
immunoprecipitation technique termed CLIP uses cross-linking and RNase digestion to 
isolate short RNA tags that are in close physical association with the Ago protein. This 
has the advantage of improving the specificity of the isolation as well as identifying the 
sites in the mRNA were Ago is binding (Chi et al. 2009; Zisoulis et al. 2010). This 
method is described in Chapter 3 of this thesis to identify Ago-associated mRNAs in 
mouse embryonic stem cells. 
 Computational prediction and biochemical identification has yielded many 
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candidate miRNA-regulated mRNAs that must be tested for direct miRNA-dependent 
regulation. The canonical approach for validation is to use a reporter-based system to 
determine if the prospective miRNA-regulated sequence can confer repression on a 
GFP or luciferase reporter mRNA (Zeng et al. 2002; Brennecke et al. 2003; Doench et 
al. 2003). Typically, the sequence of interest is fused to the 3'UTR of a reporter 
luciferase gene and this construct is introduced into cultured cells along with a different 
untargeted luciferase expression construct as an internal transfection control. The 
degree of repression conferred by the miRNA-regulated sequence is determined by 
comparing its expression in the presence and absence of the miRNA species. 
Additionally, miRNA-dependent repression can be attributed to that sequence by 
mutating the seed-match site where the miRNA putatively binds. These mutations 
should inhibit miRNA binding and thus abrogate repression of luciferase. 
miRNA loss-of-function 
The traditional approach to understanding a gene's function is to inhibit the 
activity of that gene, either by adding a small molecule that inhibits the activity of the 
gene product or by blocking the synthesis of the gene product. The former has been 
developed for miRNAs in the form of sequence-specific inhibitors, which are short 
nucleotide-analog oligos that are antisense to the miRNA sequence and can effectively 
act as competitive inhibitors. These anti-sense oligos (ASOs) stably bind the miRNA in 
the miRNP complex and block the complex from binding target mRNAs (Hutvagner et al. 
2004; Meister et al. 2004a; Orom et al. 2006). ASOs have modifications on the ribose, 
such as 2' O-methyl groups or an extra bridge between the 2' oxygen and 4' carbon 
(locked nucleic acid-LNA) that increase their intracellular stability and inhibit them from 
being cleaved by RISC. Depending on the ASO modification used, the interaction 
between the miRNA and the ASO seems to enhance the turnover of the miRNA, and 
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thus decreases the expression of the miRNA (Krutzfeldt et al. 2005; Davis et al. 2006; 
Davis et al. 2009). These ASOs have been widely used to probe miRNA function in 
mammalian cells. For example, ASOs against miR-1 and miR-133 transfected into a 
muscle progenitor cell line, C2C12, inhibit myoblast proliferation and differentiation 
(Chen et al. 2006). These ASOs can be further modified to increase their stability in 
serum and tissue of whole animals and are called antagomirs. Antagomirs against miR-
122 administered to mice caused an upregulation of miR-122 target mRNAs, resulting in 
a decrease of plasma cholesterol levels (Krutzfeldt et al. 2005). 
Another method to inhibit miRNA function is to express a high-copy reporter 
mRNA with multiple miRNA binding sites for a given miRNA, which outcompetes the 
endogenous miRNA targets for available miRNPs (Ebert et al. 2007). These RNAs, 
termed “miRNA sponges”, can be stably expressed from integrated transgenes and have 
been used to investigate the function of a variety of miRNAs, including demonstrating a 
role for miR-31 in breast cancer metastasis (Valastyan et al. 2009). 
The advantages of miRNA sponges and ASOs is that they are relatively easy to 
make, are customizable to any miRNA sequence of interest, and work well in cell types 
that are easily transfected with oligos or infected with a virus expressing a sponge RNA. 
However, cell types that are not easily transfected or infected, such as primary neuron 
cultures or some immune cell types, are not amenable to this technology. Antagomirs 
are designed to work better in whole animal studies, but the current delivery methods 
only appreciably target the liver. 
Classic reverse genetic approaches using gene knockout technology in mice 
have also been employed to study miRNA function. Analysis of targeted deletion of Dicer 
in the mouse revealed the effects of global miRNA loss on embryonic development. 
Dicer-null embryos fail to survive past embryonic day 8.5. Those that survive to this time 
point do not express markers of differentiation nor markers of pluripotent cell populations 
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(Bernstein et al. 2003). These observations showed that miRNAs are required for 
embryonic development. Ago2 is also required for embryonic development, although 
conflicting reports suggest that Ago2 loss arrests embryos either just after implantation 
or during gastrulation (Liu et al. 2004; Alisch et al. 2007; Morita et al. 2007). Since Ago2-
null mouse embryonic fibroblasts and stem cells are still competent for miRNA-
dependent repression (Liu et al. 2004; Su et al. 2009), presumably through the other 
Ago family members, the mechanism underlying the Ago2 null embryonic phenotype 
remains unclear. It could be related to a decrease in miRNA expression, as has been 
observed for Ago2-deficient B-cells (O'Carroll et al. 2007).  
Several groups have made targeted deletions in the mouse of specific miRNAs. 
Notably, Zhao and colleagues (2007) knocked out miR-1-2, a muscle-specific miRNA. 
They found that approximately 50% of miR-1-2 null mice die between E15.5 and 
postnatally around the time of weaning. This was due to large ventricular septal defects 
in the heart, as well as embryonic pericardial edema. Those individuals that survived to 
adulthood had cardiac electrophysiological defects. The penetrance of these phenotypes 
was quite surprising given that the mouse genome encodes a paralogous miRNA, miR-
1-1, with identical sequence and pattern of expression as miR-1-2. Additionally, another 
miRNA, miR-206, has a similar expression pattern as miR-1-2 and has the same seed 
sequence, and thus probably regulates the same targets. This highlights the difficulty in 
applying these approaches to studying miRNA function, as many miRNAs exist as part 
of a group of miRNAs that have the same seed and same expression pattern. In light of 
this, Ventura and colleagues (2008) made targeted deletions of three miRNA clusters 
present at three different genomic loci and that share the same seeds; miR-17~92, miR-
106a~363, and miR-106b~25. This work is described in Chapter 4 of this thesis. 
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Introduction to miRNAs in murine Embryonic Stem cells 
ES cell biology 
Chapter 2 and Chapter 3 of this thesis focus on the function of miRNAs in murine 
Embryonic Stem cells (mESCs). mESCs are a cultured cell type derived from the pre-
implantation inner cell mass (ICM) of the developing mouse embryo. The ICM is made 
up of undifferentiated progenitor cells in an epigenetically plastic state that will give rise 
to the fully developed embryo (Niwa 2007). mESCs retain many properties of the ICM, 
including their pluripotency and ability to self-renew. These properties can be maintained 
indefinitely under defined culture conditions, but mESCs can also be instructed to 
differentiate both in vitro and in vivo into a variety of cell types of all three germ layers 
(Beddington et al. 1989). These characteristics make ESCs a useful model for studying 
embryonic development in vitro, and are also a potential source for transplantable cells 
and tissues for therapeutic purposes (Keller 2005). Understanding the miRNA-regulated 
gene expression networks in ESCs will aid in these endeavors. 
Dicer loss in ES cells 
Intriguingly, mESCs are the only reported cultured cell type that can survive loss 
of mature miRNAs by removal of Dicer, the miRNA-processing enzyme. Dicer loss in 
mESCs results in a temporary cell cycle arrest, following recovery, these cells continue 
to express markers of pluripotency, including Oct4 and Nanog, and cycle continuously, 
albeit at a slightly slower rate than wild-type mESCs (Kanellopoulou et al. 2005; 
Murchison et al. 2005). However, these cells fail to differentiate into any cell types from 
the 3 different germ layers, cannot form teratomas in nude mice, and cannot contribute 
to chimeras (Kanellopoulou et al. 2005; Murchison et al. 2005). Dgcr8-null mESCs, also 
lacking mature miRNA expression, have similar phenotypes (Wang et al. 2007; Wang et 
al. 2008b). Ablation of all Ago protein expression, and thus miRNP function, in mESCs 
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results in apoptosis of these cells (Su et al. 2009). Taken together, these results suggest 
that miRNAs are necessary for the survival and pluripotency of mESCs. Additionally, 
Dicer null mESCs provide a useful miRNA negative background for investigating the 
effects of miRNA loss and add-back of single miRNA species. 
miRNA population in ES cells 
Multiple studies have characterized the mature miRNA population in mESCs 
(Houbaviy et al. 2003; Calabrese et al. 2007; Babiarz et al. 2008). Houbaviy et al (2003) 
first described the expression of the miR-290-295 miRNA cluster specifically in mESCs 
and early embryos and not in adult tissues. This miRNA cluster is the most highly 
expressed miRNA cluster in mESCs. miR-290-295 contains miRNAs with multiple 
distinct hexamer and 7mer seed sequences, however ~80% of the miRNA expression 
from this cluster has the seed “AAGUGC” (Fig. 2). Two related miRNA clusters in 
human, miR-302 cluster and miR-371 cluster have significant expression in human 
ESCs. Addition of members of the miR-290~295 cluster to Dgcr8-null mESCs rescues its 
reduced rate of proliferation compared to wild-type cells (Wang et al. 2008b). This 
appears to be through regulation of the G1/S transition of the cell cycle by repression of 
p21. Additionally, these miRNAs regulate de novo DNA methylation in mESCs through 
repression of RBL2, a transcriptional repressor of the de novo demethylase DNMT3 
(Benetti et al. 2008; Sinkkonen et al. 2008). Despite the prominence of the miR-290~295 
cluster in the ES cell gene expression profile, there are still very few validated targets of 
this miRNA cluster. Thus the extent of miRNA-mediated regulation in mESCs remains 
relatively unexplored. For these reasons, much of the work in this thesis has focused on 
identification of bona fide miRNA targets in mESCs and their role in ESC biology. 
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Figure 1: microRNA pathway 
The typical miRNA is transcribed in the nucleus by RNA Pol II. The mature miRNA resides in a 
hairpin structure in the primary transcript (pri-miRNA). The miRNA hairpin is excised from the 
pri-miRNA by the Microprocessor, composed of RNase III-like enzyme Drosha and co-factor 
DGCR8. The miRNA hairpin (pre-miRNA) is exported to the cytoplasm by Ran-GTP/Exportin-5. 
There the loop of the hairpin is excised by the RLC, composed of RNase III-like enzyme Dicer, 
and co-factors TRBP and PACT. The miRNA duplex is loaded into an Ago protein and 
subsequently unwound, so the mature miRNA strand is the RNA guide in the complex. If the 
RNA guide has extensive complementarity to its target mRNA, the mRNA is endonucleolytically 
cleaved by RNase-H-like enzyme, Ago2, no other Ago family members possess this activity. 
Most miRNAs only have partial complementarity to their targets, in the 5’ region of the miRNA, 
termed the seed. This results in inhibition of translation of the mRNA, as well as deadenylation, 
decapping, and exonucleolytic degradation of the transcript from the 5’ and 3’ ends. 
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  Mature miRNA sequence 
mmu-miR-290-3p AAAGUGCCGCCUAGUUUUAAGCCC  
mmu-miR-290-5p ACUCAAACUAUGGGGGCACUUU 
mmu-miR-291a-3p AAAGUGCUUCCACUUUGUGUGC 
mmu-miR-291a-5p CAUCAAAGUGGAGGCCCUCUCU 
mmu-miR-291b-3p AAAGUGCAUCCAUUUUGUUUGU 
mmu-miR-291b-5p GAUCAAAGUGGAGGCCCUCUCC 
mmu-miR-292-3p AAAGUGCCGCCAGGUUUUGAGUGU 
mmu-miR-292-5p ACUCAAACUGGGGGCUCUUUUG 
mmu-miR-293 AGUGCCGCAGAGUUUGUAGUGU 
mmu-miR-293* ACUCAAACUGUGUGACAUUUUG 
mmu-miR-294 AAAGUGCUUCCCUUUUGUGUGU 
mmu-miR-294* ACUCAAAAUGGAGGCCCUAUCU 
mmu-miR-295 AAAGUGCUACUACUUUUGAGUCU 
mmu-miR-295* ACUCAAAUGUGGGGCACACUUC 
  
Figure 2A: miR-290~295 miRNA sequences 
miR-290~295 miRNA sequences. Mirbase naming conventions are presented (Griffiths-Jones et 
al. 2008). 3p and 5p indicate the arm of the pre-miRNA hairpin from which the miRNA is 
derived. * indicates the strand that is less likely to be incorporated into the miRNP. The hexamer 
seed is indicated in dark green. The additional nucleotide for the 7mer seed is indicated in light 
green. 
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Figure 2B, C: Seed distribution from miR-290~295 
B) miR-290~295 gives rise to miRNAs with 4 different hexamer seeds. Shown is fraction of total 
miRNA reads cloned from miR-290~295 that contain each hexamer seed (Chapter 3). C) miR-
290~295 gives rise to miRNAs with 8 different 7mer seeds (color-coded by hexamer). Shown is 
fraction of total miRNA reads cloned from miR-290~295 that contain each 7mer seed (Chapter 
3).
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All experiments conducted equally with Anthony Leung. Bioinformatic contributions from 
Cydney Nielsen, formerly of the laboratory of Christopher Burge, MIT Department of 
Biology. 
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Abstract 
MicroRNAs (miRNAs) are a large family of genes encoding 19-22nt non-coding 
RNAs that post-transcriptionally regulate their mRNA targets through short regions of 
complementarity in their 5'ends (termed seed region). Computational predictions of 
miRNA targets based on conservation of seed matches suggest that more than half of all 
mRNAs are regulated by miRNAs, yet few have been experimentally identified. To 
directly identify potential miRNA target mRNAs, we performed microarray analysis of 
mRNAs in Ago2 immunoprecipitated and whole cell extracts from mouse embryonic 
stem cells (mESCs) in the absence of miRNAs and in the presence of a single miRNA 
species, miR-295. This method identified a set of mRNAs that had seed matches to miR-
295 and were significantly down regulated in the whole cell extract in the presence of 
miR-295. Additionally, several mRNAs were found to be significantly enriched in the 
Ago2 immunoprecipitates, including Lefty1, a Nodal pathway inhibitor. mESCs that lack 
the miR-290~295 cluster have reduced induction of endodermal markers upon 
differentiation, which may be due to upregulation of LEFTY protein, an inhibitor of 
differentiation down this lineage.
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Introduction 
miRNAs are increasingly being recognized as important regulators of many 
cellular processes including proliferation, death, fate choice (reviewed in Singh et al. 
2008). These short 21-22nt non-coding RNAs are processed from hairpin precursors by 
RNase III enzymes, Drosha and Dicer (Kim et al. 2009). Mature miRNAs are 
incorporated into a ribonucleoprotein particle (miRNP) containing a member of the 
conserved Argonaute protein family (Ago) that binds to the target mRNA through a short 
region of complementarity in the 5' region of the miRNA termed the "seed region" 
(nucleotides 2-8) (Mourelatos et al. 2002; Lewis et al. 2003; Hock et al. 2008). This 
results in the inhibition of translation of the target mRNAs, and causes their destruction 
via deadenylation and decapping and subsequent degradation by 5' and 3' 
exonucleases (Bartel 2009; Carthew et al. 2009).  
Seed based pairing between the miRNA and the mRNA target has formed the 
basis for computational predictions of many miRNA targets. These predictions rely 
primarily on matches to the miRNA seed in the 3’ UTR of targets and conservation of 
these target sites across species (Lewis et al. 2003; Farh et al. 2005; Lewis et al. 2005; 
Grimson et al. 2007; Nielsen et al. 2007). Analysis of preferentially conserved pairing to 
the seed suggests that up to 50% of human genes could be regulated by miRNAs 
(Friedman et al. 2009). However, the scope of miRNA regulation in any given cell 
depends on the expression level of the miRNAs and mRNA targets and likely on other 
unidentified factors. A function-based experimental method for identification of miRNA 
targets would be useful for exploring this question.  
We, along with others, have developed a method to identify miRNA-regulated 
mRNAs that takes advantage of the association of these two species with Ago2 in the 
miRNP (Hock et al. 2007; Karginov et al. 2007; Hendrickson et al. 2008; Landthaler et al. 
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2008; Hong et al. 2009). Immunoprecipitates of Argonaute proteins are expected to be 
enriched in miRNA-regulated transcripts, which can then be identified by microarray 
analysis.  
We have also taken advantage of Dicer null mouse embryonic stem cells 
(mESCs) as a miRNA-deficient background in which to examine the targets of one 
miRNA, miR-295, that we transfected into this cell line. Dicer null mESCs lack 
expression of all mature miRNAs, but can still utilize a miRNA introduced as a duplex 
short interfering RNA (siRNA) in the miRNA pathway. The Dicer null mESCs exhibit 
many of the same properties of wild-type mESCs in terms of self-renewal, however they 
are unable to differentiate into different cell types (Kanellopoulou et al. 2005; Murchison 
et al. 2005). Pluripotent mESCs and murine early embryos express one particular cluster 
of miRNAs, miR-290~295, very highly and this cluster is downregulated upon 
differentiation of mESCs (Houbaviy et al. 2003). One hexamer seed sequence is 
predominantly expressed from this miRNA cluster (Chapter 1, Figure 2B, C), and thus 
these miRNAs may regulate a common set of target mRNAs. Taken together, these 
observations suggest that the phenotypes of Dicer-null mESCs could be attributed to 
loss of miR-290~295 and this cluster could control much of the miRNA-mediated 
regulation in this cell type.  
By immunoprecipitating Ago2 in Dicer-null mESCs in the presence and absence 
of miR-295 from the miR-290~295 cluster, we have identified many candidate target 
mRNAs whose association with Ago2 depends on the expression of miR-295. We have 
confirmed the regulation of one such target, Lefty1, and explored its role in the 
differentiation of mESCs down the endodermal linage. We believe this approach could 
also be more broadly applied to other cell types to uncover new targets of miRNAs and 
validate computationally predicted targets. 
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Results 
Analysis of Ago2-associated mRNAs in mESCs 
To identify candidate miRNA-regulated mRNAs in ESCs, we transfected Dicer-
null mESCs with FLAG/HA-tagged human Ago2 in the presence or absence of miR-295 
miRNA mimic siRNA according to the experimental outline in Figure 1A. After 
transfection, cells lysates were divided between processing for total RNA extraction and 
anti-HA Ago2 immunoprecipitation and RNA extraction. RNA expression profiles from 
total RNA preparation and immunoprecipitation were determined by Affymetrix 
microarray.  
miRNAs are known to cause degradation of their mRNA targets, thus significant 
miRNA-dependent changes in gene expression have been observed for mRNAs that 
contain miRNA seed matches in their 3'UTRs (Lim et al. 2005). The degree of mRNA 
downregulation has been shown to be dependent on the number of base-pairing 
nucleotides, having an adenine in the "1" position of the target seed match, as well as 
conservation of the seed and context around the seed (Figure 1B)(Farh et al. 2005; 
Grimson et al. 2007; Nielsen et al. 2007; Friedman et al. 2009). To examine miR-295-
dependent downregulation of candidate target mRNAs, the total RNA profile from Dicer-
null mESCs + miR-295 (TR+295) was compared to the total RNA profile from Dicer-null 
mESCs lacking miR-295 (TR-295) (Figure 1B). As previously reported, miR-295 seed 
match mRNAs showed a miR-295 dependent downregulation as compared to control 
mRNAs lacking miR-295 seed and matched for 3'UTR length and dinucleotide 
composition. The degree of downregulation was strongest for those mRNAs bearing a 
miR-295 8mer seed match, than m8-7mer/A1-7mer, and 6mer. These data show that 
transfection of miR-295 into Dicer-null mESCs imparts miRNA dependent regulation to 
seed-match bearing mRNAs and provides a set of candidate miR-295 target mRNAs in 
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this cell type. 
Next, we compared the gene expression profile of Ago2 immunoprecipitated 
RNA in the presence of miR-295 in Dicer null mESCs with the profile of Ago2 
immunoprecipitated RNA in the absence of miR-295. If miR-295 recruits seed-match 
bearing mRNAs to associate with the Ago2-miRNP, we would expect an enrichment or 
upregulation in expression of these mRNAs in the immunoprecipitates from cells 
transfected with miR-295 mimic as compared to those lacking miR-295. Surprisingly, 
there was no enrichment of seed-match mRNAs in the Ago2 immunoprecipitates with 
miR-295 as compared to the control set of mRNAs (Figure 1C). This type of global 
analysis of all mRNAs containing seed matches to miR-295 could obscure enrichment of 
only a small subset of mRNAs containing a match to the miR-295 seed in Ago2 
immunoprecipitates. To further explore this possibility, we plotted for each gene the total 
RNA expression change between Dicer null cells transfected with and without miR-295 
against change in expression in the Ago2 immunoprecipitates with or without miR-295 
(Figure 1D). Focusing on mRNAs that contain 8mer seed matches to miR-295, there are 
several mRNAs that were significantly enriched in Ago2 immunoprecipitates from Dicer 
null cells with miR-295 that showed little to no change on the mRNA level. We were 
particularly interested in these potential miRNA targets as they would not have been 
identified by the total RNA analysis alone. 
Leftys are targets of miR-290~295 cluster of miRNAs 
One such enriched mRNA was Lefty1, a known antagonist of the Nodal signaling 
pathway (Schier 2003). Lefty1 has been implicated in both the formation of the left/right 
axis during development as well as mesendoderm differentiation in multiple vertebrate 
systems, including fish, frog, and mouse. miR-295 has an 8mer binding site in the 3'UTR 
of Lefty1 and its homolog Lefty2 and this binding site is conserved across several 
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vertebrates (Figure 2A). In fact, a zebrafish miRNA with the same seed as miR-295, 
miR-430, has been shown to regulate both Lefty and Nodal and this regulation is 
required for proper mesendoderm development in the zebrafish (Choi et al. 2007). 
To determine whether Lefty protein expression is miRNA regulated in mESCs, 
we examined Lefty expression in wild-type mESCs and mESCs that bear a homozygous 
deletion for the miR-290~295 cluster of miRNAs (cluster KO) and thus do not express 
this cluster of miRNAs. We found that Lefty pro-protein, but not mature protein is 
upregulated in the cluster KO mESCs as compared to the wild-type mESCs (Figure 2B). 
Lefty protein is a secreted factor and we have only measured the cytosolic pool of this 
protein. It is possible that we were only able to observe a miRNA-dependent decrease in 
the precursor form, but not the mature form of the protein, because the cytoplasmic 
levels of the mature form are regulated at a step after protein processing.  
To establish that the miR-295 sites in the 3'UTRs of Lefty1 and Lefty2 are directly 
regulated by this miRNA, we fused the Lefty1 and Lefty2 3'UTRs to a Renilla luciferase 
reporter gene. We also created versions of these 3'UTRs constructs with 3 point 
mutations in the miR-295 seed match that would disrupt pairing of miR-295 to this site. 
All of these constructs were transfected into Dicer null mESCs with miR-295 mimic and 
normalized to the same value in Dicer null mESCs. Both Lefty1 and Lefty2 wild-type 
3'UTRs conferred repression on Renilla luciferase, while the corresponding seed 
mutated constructs did not (Figure 2B). Additionally, we analyzed the expression of the 
Lefty 3'UTR constructs in wild-type and miR-290~295-deficient mESCs, that bear a 
germline targeted deletion of this cluster. Since we determined that the seed mutant 
constructs are not miRNA-regulated, we normalized the wild-type construct expression 
to the seed mutant construct in these cell lines. The ratio of the expression of the Lefty1 
and Lefty2 wild-type to seed mutant version was lower in the wild-type mESCs as 
compared to the miR-290~295 null mESCs, again suggesting that this miRNA binding 
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site in the Lefty1 and Lefty2 3'UTR is regulated by miR-290~295 (Figure 2D).  
miR-290~295 controls endoderm differentiation of mESCs 
We next examined the effect that misregulation of Lefty proteins might have on 
differentiation of mESCs. Since Lefty is known in both mouse and zebrafish to inhibit 
mesendoderm formation by antagonizing Nodal signaling, we examined the RNA 
expression of a marker of the endoderm lineage, HNF4alpha, after a 4 day time course 
of withdrawal of LIF to induce differentiation in both wild-type and miR-290~295-deficient 
mESCs. We found that both miR-290~295 null mESC lines had significantly reduced 
induction of HNF4alpha marker as compared to the two wild-type mESC lines (Figure 
3A). Since LIF withdrawal allows for spontaneous differentiation of mESCs into all three 
germ layers, we also took a more directed approach to specifically differentiate mESCs 
into endoderm. This was accomplished by adding Activin, a Nodal agonist, to the media 
of wild-type and miR-290~295 null KO mESCs. After 7 days of differentiation, miR-
290~295 null mESCs had significantly lower induction of two markers of endoderm, 
HNFalpha and Sox17, as compared to the wild-type cells (Figure 3B). These data 
suggest that miR-290~295 regulates the ability of mESCs to differentiate into endoderm. 
Discussion 
Analysis of total RNA and Ago2-bound mRNA populations in Dicer null mESCs in 
the presence or absence of miR-295 identified a set of candidate miRNA target mRNAs. 
In the total RNA analysis, a set of candidate targets containing the miR-295 seed was 
downregulated in Dicer null mESCs in the presence of miR-295. The amount of 
downregulation was correlated with the extent of the pairing and type of seed match. In 
the Ago2-immunoprecipitate analysis, multiple mRNAs appeared to have enriched 
binding to Ago2 in the presence of miR-295. One such mRNA, Lefty1, contains an 8mer 
seed match to miR-295 and was enriched in the Ago2 immunoprecipitates by addition of 
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miR-295, but was not downregulated at the mRNA level. This site in the Lefty1 3'UTR, 
along with the site in its homolog, Lefty2, are conserved in multiple vertebrate species, 
and both can confer miR-295 dependent repression on a reporter transgene. miR-
290~295 also appears to play a role in differentiation of mESCs down the endoderm 
lineage, as mESCs lacking these miRNAs fail to induce markers of this lineage after 
differentiation by LIF withdrawal and Activin stimulation. Zovoilis et al. (2009) also 
observed that miR-290~295 inhibits differentiation of mouse mESCs into mesodermal 
cell types. 
As modeled in Figure 4, we propose that miR-290~295 represses Lefty proteins 
to allow for proper levels of Nodal signaling through the TGF-beta class of receptors, 
phosphorylation of SMAD2 and induction of endoderm differentiation. When miR-
290~295 expression is lost, there could be an upregulation of Lefty pro-protein and thus 
an inhibition of signaling through this pathway and a failure to induce markers of the 
endoderm lineage.  
We have only demonstrated a correlation between upregulation of Lefty protein 
and a decreased induction of endodermal markers in miR-290~295-deficient mESCs. It 
remains possible that another target of this cluster is responsible for the differentiation 
phenotype. To demonstrate that there is a direct connection between the deregulation of 
Lefty and the phenotypes of miR-290~295-deficient mESCs, siRNA-mediated 
knockdown of Lefty1 protein in miR-290~295-deficient mESCs should rescue this 
phenotype as should overexpression of the miRNA cluster. Furthermore, overexpression 
of the Lefty1 ORF, but not the Lefty1 ORF and 3'UTR sequence, should recapitulate the 
endoderm defect in wild-type mESCs.  
Interestingly, this site for miR-290~295 in Lefty1 and Lefty2 3'UTR is conserved 
from fish, to frogs, to mouse, to humans (Choi et al. 2007). However, in fish, miR-430 is 
responsible for repression of Lefty and Nodal to set-up proper mesendoderm 
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differentiation. A miRNA with the same seed as miR-430 in Xenopus, miR-427, also 
represses the expression of the two Xenopus Lefty homologs, but not Nodal, and 
inhibition of miR-427 also leads to a loss of mesoendodermal cell types (Rosa et al. 
2009). This suggests that only the Lefty arm of this regulatory pathway has been 
conserved. Additionally, another cluster of miRNAs, miR-302 cluster, is expressed in 
human mESCs and also regulates the differentiation of these cells into mesendoderm 
through repression of human Lefty A and B (Rosa et al. 2009).  
Human and mouse mESC differentiation are in vitro models of early embryonic 
development of mammals. Control of mesendoderm and left/right axis formation by miR-
290~295/miR-302 in vivo is certainly more complex due to spatial and temporal 
regulation of Nodals and Leftys. The earliest known role for Nodal expression in the 
mouse embryo is to specify the visceral endoderm and then distal visceral endoderm 
between E4-E5.5 (Mesnard et al. 2006). This study also showed that there is a transient 
downregulation of Lefty mRNA between E5 and E5.25, which could be mediated by miR-
290~295. A detailed examination of the expression pattern of this cluster of miRNAs in 
the developing mouse embryo is still lacking. Quantitative PCR and sequencing studies 
have shown that miR-290~295 is expressed from the 1-8 cell stage of the embryo, as 
well as at E9.5-E11 (Mineno et al. 2006; Tang et al. 2007). Genetic manipulation of miR-
290~295 expression in the early mouse embryo will be necessary to determine the role 
of these miRNAs in controlling mesendoderm formation in vivo. 
Finally, immunoprecipitation of Ago2 bound mRNA in the context of miRNA 
deficient mESCs in the presence of absence of a single miRNA allowed for the 
identification of candidate miRNA targets. Of these targets, we demonstrated that at 
least one is a valid miRNA target in mESCs. However, even in the absence of 
endogenous miRNAs, Ago2 bound a significant amount of mRNA, making the detection 
of enriched mRNAs in the presence of added miR-295 difficult. This could be due to 
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Ago2 having a high affinity for mRNA in the concentrated solution of cell lysate, such 
that there is spurious mRNA binding during the immunoprecipitation protocol. 
Alternatively, Ago2 may have some non-miRNA function in the cell that we observed in 
the isolation of mRNAs bound to Ago2 in the absence of miRNAs. In fact, Ago2 (eIF2C2) 
was first biochemically purified as a translation initiation factor, Co-eIF-2A, that could 
activate translation by stabilization of the ternary complex (Chakravarty et al. 1985; Roy 
et al. 1988). To further understand this, other immunoprecipitation techniques that allow 
for greater specificity of purification, like crosslinking immunoprecipitation (CLIP), may be 
necessary for higher-confidence identification of potential miRNA targets bound to Ago2 
(Ule et al. 2003; Ule et al. 2005; Chi et al. 2009; Zisoulis et al. 2010). 
Methods 
Cell culture 
mESCs were cultured in DME/HEPES supplemented with 2mM L-glutamine, 100 
Units Penicillin, 100 µg Streptomycin, 1X Non-essential amino-acids (Invitrogen), 15% 
Defined FBS (Hyclone-ES screened), 1000U/ml ESGRO Leukemia Inhibitory Factor 
(LIF) (Chemicon) on gelatinized flasks in the absence of a feeder layer. Dicer null mESC 
line were derived as described in Calabrese et al. (2007). miR-290~295 wild-type (WT) 
and knockout (KO) cell lines were a gift from Dr. Rudolf Jaenisch and were derived as 
previously described (Markoulaki et al. 2008). Each cell line was generated from an 
individual blastocyst, but the littermate associations are unknown. These cells were 
passaged on irradiated mouse embryonic fibroblast feeder layer purchased from the 
Koch Institute-Rippel Transgenic facility. 
Immunoprecipitation 
Cells were washed in plate on ice 2 times with 5 ml of cold PBS. Cells were lysed 
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by incubation for 10min in 500µl Cell lysis buffer (110 mM Potassium acetate, 2 mM 
magnesium acetate, 10mM HEPES pH 7.4, 200 mM KCl, .5% NP-40, 1X Mini-complete 
protease inhibitor (Roche), 1.25 µl Supernasin (Ambion)) Cell lysates from 2 10-cm 
dishes were scraped into 1.5 ml eppendorf tube and then homogenized seven times with 
a 26.5 gauge needle and 1 ml syringe. Cell lysates were then centrifuged for 10 min at 
4200 rpm. Cell lysates were then added to 20 µl of washed, and packed Protein A beads 
(Sigma) and incubated for 1 hour at 4 degrees with rotation for pre-clearing. After 
incubation, Protein A beads were pelleted by centrifugation and supernatant was 
removed. 10% of this supernatant was added to 1 ml of Trizol for Total RNA extraction 
following manufacturer's protocol, the remaining supernatant was added to 20 µl packed, 
washed EZ-view anti-HA beads (Sigma) along with enough lysis buffer to bring total 
volume to 1 ml and incubated for 2 hours at 4 degrees with rotation. After incubation, 
anti-HA beads were pelleted, supernatant was removed, and beads were washed with 
400µl of lysis buffer, three times, for 5 min with rotation at 4 degrees. After last wash, 
wash buffer was removed and 1 ml of Trizol (Invitrogen) was added to the beads and 
incubated with rotation for 5 min at room temperature. RNA was isolated according to 
manufacturer's protocol except that 1 µl of linear acrylamide (Ambion) was added before 
precipitation with isopropanol and RNA was precipitated overnight at -20˚ C. Cell pellets 
from all 8 plates were combined and resuspended in 20 µl of Water. 
Microarrays 
Two biological replicates of Ago2 +/- miR-295 mimic IP and Total RNA were 
prepared for and hybridized to Affymetrix Mouse 430A 2.0 microarrays by MIT 
Biomicrocenter according to manufacturer's instructions. Data processing was done 
using Partek Genomics Suite 6.4 (St. Louis, MO). RMA was used to summarize and 
normalize the probe data into probe set expression values. The list of utilized probe sets 
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was defined by custom .ps and .mps files designed to include all core probes. The RMA 
procedure used included the options adjusted for GC content, probe sequence, RMA 
background correction, Quantile Normalization and median polish probe set 
summarization. Expression values for probesets were summarized to a single value per 
gene based on the same custom .mps file mentioned above using the outlier excluded 
mean method. This procedure excludes probe set values that are more than 3 standard 
deviations above the mean or more and 2 standard deviations below the mean. The log2 
fold change (LFC) value for IP or Total RNA +295/ -295 was defined as the difference 
between the mean expression in Total RNA or IP Ago2 + miR-295 mimic (+295) and the 
mean expression in Total RNA or IP Ago2 no mimic (-295). 
Western Blots 
3E5 miR-290~295 WT or KO cells were plated per well of 6 well dish. For cells 
on MEFS, MEF feeder layer was pre-plated in well 24 hours before seeding of ESCs. 
For cells with no MEFS, cells were first pre-plated on a T-25 flask for 30min to remove 
the feeder layer and the remaining cells in suspension were counted and plated. Cell 
lysates were harvested after 48 hours in mRIPA buffer (150mM NaCl, 50mM Tris pH 7.4, 
0.1% Na-Deoxycholate, 1mM EDTA, 1% NP40) with 1X complete protease inhibitor 
(Roche). Protein concentrations were measured by Bradford and normalized to 3 µg/µl 
with lysis buffer, 1X NuPAGE LDS sample buffer (Invitrogen) and 1X Sample Reducing 
agent (Invitrogen). 30µg of protein was electrophoresed on a 4-20% NuPAGE Novex 
Bis-Tris PAGE gel (Invitrogen) and transferred to nitrocellulose membrane using the 
Xcell II Mini-cell blotting module and 1X NuPAGE transfer buffer (Invitrogen). The 
membrane was blocked overnight in 5% Non-fat milk/1X PBST at 4 degrees and then 
incubated with either goat anti-Lefty antibody (R+D Systems) or mouse anti-Vinculin 
antibody (Sigma) diluted 1:000 or 1:10,000, respectively, in 5% milk/1XPBST for 2 hrs at 
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room temperature. Blots were washed 3 times for 10min with 1X PBST and then 
incubated for 30min with anti-goat IgG-HRP or anti-mouse IgG-HRP diluted 1:5000 in 
5% milk/1XPBST at rm temperature. Blots were washed 3 times for 10min with 1X PBST 
and then incubated with ECL according the manufacturer's instructions. 
Transfections 
For the microarray experiments, 24 hours before transfection 2E6 Dicer null cells 
were seeded in 19 T-25 flasks. Cells were transfected with 21µl of Lipofectamine 2000 
(Invitrogen) and either 10µg of pCAGGS-FLAG/HA-Ago2, or 10ug pCAGGS-FLAG/HA-
Ago2 with 22 pmol of miR-295 mimic (Dharmacon)/flask diluted in 2.2ml of Opti-MEM. 8 
flasks were transfected for each Ago2 alone and Ago2 with miR-295. To monitor 
transfection efficiency, one flask each was transfected with either 10µg pMAX-GFP, 
10µg pMAX-GFP with 22pmol miR-295 mimic, or Lipofectamine 2000 alone. Four hours 
after transfection, transfection mixture was replaced with ESC media. 24 hours following 
transfection, each T-25 flask was split to one 10 cm dish. Cell lysates were harvested 48 
hours after transfection and transfection efficiency was determined by flow cytometry of 
GFP-expressing cells.  
For the Lefty 3'UTR analysis, 24 hours before transfection, 1E5 cells were plated 
per well of gelatinized 24 well plate. For miR-290~295 WT and KO cell lines, cells were 
first pre-plated on a T-25 flask for 30min to remove the feeder layer and the remaining 
cells in suspension were counted and plated for transfection. Cells were transfected with 
1.7 µl of Lipofectamine 2000 (Invitrogen), 400 ng of pGL3 (Promega), 400 ng of pRL-
CMV Lefty 3'UTR construct in triplicate. For Figure 2B, cell were also transfected with 4 
pmol of miR-295 mimic or control mimic (Dharmacon). Four hours after transfection, 
transfection mixture was replaced with ESC media. Cell lysates were harvested 24 hours 
after transfection. 
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Luciferase assays 
Cells were lysed with 100µl of 1X passive lysis buffer (Promega). Dual luciferase 
activity was measured using 10µl of cell lysate and the dual luciferase assay kit 
(Promega) with the Glomax 20/20 single-sample luminometer (Promega) according to 
manufacturer's instructions. 
mESC differentiation 
For differentiation by LIF withdrawal, cells from miR-290~295 WT1, WT2, KO1, 
and KO2 cell lines were first pre-plated on a T-25 flask for 30min to remove the feeder 
layer and the remaining cells in suspension were counted and 2.5E5 cells were seeded 
per well of a 6-well dish in mESC media. For Day 0 time point, 24 hours later media was 
removed and cells were lysed with Trizol (Invitrogen) and RNA was harvested according 
to manufacturer's protocol. For Day 4 timepoint, ESC media was replaced with ESC 
media without LIF, media was replaced with new ESC media without LIF every other day 
until day 4 when cells were lysed with Trizol (Invitrogen) and RNA was harvested 
according to manufacturer's protocol.  
For differentiation by Activin, cells from miR-290~295 WT1, WT2, KO1, and KO2 
cell lines were first pre-plated on a T-25 flask for 30min to remove the feeder layer and 
the remaining cells in suspension were counted and 3E5 cells/well were plated per well 
of a 12 well plate in duplicate for Day 0 time point. For Day 7 time point, 1.08E4 cells 
were plated per well in duplicate. 24 hours later media was removed and cells were 
lysed with Trizol (Invitrogen) and RNA was harvested according to manufacturer's 
protocol for Day 0 time point. For Day 7 time point, ESC media was replaced with ESC 
media with no LIF and with 100ng/ml Activin (R&D systems), media was replaced with 
new ESC media with Activin every other day until day 7 when cells were lysed with Trizol 
(Invitrogen) and RNA was harvested according to manufacturer's protocol. 
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Quantitative Real Time PCR 
500 ng of Total RNA was used for oligo dT (IDT) primed reverse transcription 
with MMLV reverse transcriptase (Ambion). cDNA from 1/10th of RT reaction was used 
for quantitative real time PCR (qPCR) amplification of HNF4alpha, Sox17, and GAPDH 
with Power Sybr Green master mix (Applied Biosystems) and the following primers 
(HNF4alpha, 5'-AGGAGCGTGAGGAAGAACCAC, 5'-CACATTGTCGGCTAAACCTGC; 
Sox17, 5'-CGCACGGAATTCGAACAGTA, 5'-GTCAAATGTCGGGGTAGTTG; Gapdh, 
5'-GTGTTCCTACCCCCAATGTGT, 5'-ATTGTCATACCAGGAAATGAGCTT) using 
Applied Biosystems ABI750 qPCR machine with standard settings. 
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Figures 
Figure 1A: Experimental Outline 
Dicer null mESCs were transfected with either FLAG/HA tagged human Ago2 and 10nM of 
miR-295 miRNA mimic or FLAG/HA tagged human Ago2 alone. 48 hours after transfection 
cells were lysed, a portion of the lysate was reserved for extraction of total RNA (TR) and the 
remaining lysate was used for anti-HA immunoprecipitation (IP) followed by RNA extraction. 
The total RNA and IP RNA were hybridized to Affymetrix microarrays. The experiment 
consisted of two biological replicates. 
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Figure 1B: miR-295 dependent changes in Total RNA gene expression 
CDFs (cumulative distribution functions) of log2 fold change (LFC) in total mRNA expression 
between the Dicer null and Dicer null +mi295 ES cells are plotted. Grey line is control mRNAs 
that do not contain a miR-295 seed match. Colored lines are mRNAs containing miR-295 seed 
match (GCACUU) by type: Green, 6mer, only 6mer match; Blue, A1-7mer, 6mer match plus A 
in the T1 position; Red, M8-7mer, 7mer match positions 2-8; Purple, 8mer, 7mer match positions 
2-8 plus A in the T1 position. Upper left is bar graph of LFC for each seed match type with error 
bars. 
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Figure 1C: miR-295 dependent changes in IP mRNA gene expression. 
CDFs (cumulative distribution functions) of log2 fold change (LFC) in IP mRNA expression 
between the Dicer null and Dicer null +mi295 ES cells is plotted. Grey line is control mRNAs 
that do not contain a miR-295 seed match. Colored lines are mRNAs containing miR-295 seed 
match (GCACUU) by type: Green, 6mer, only 6mer match; Blue, A1-7mer, 6mer match plus A 
in the T1 position; Red, M8-7mer, 7mer match positions 2-8; Purple, M8-8mer, 7mer match 
positions 2-8 plus A in the T1 position. Upper left is bar graph of LFC for each seed match type 
with error bars. 
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Figure 1D: Changes in IP expression and Total RNA expression by gene. 
Plotted is the log2 fold change (LFC) in Total RNA (X-axis) and IP RNA (Y-axis) expression in 
Dicer null + mi295 cells as compared to Dicer null cells for each gene. Genes containing M8-A1 
8mers are colored in purple. Spearman correlation= 0.31, after excluding lowly expressed genes. 
Circled in red is the M8 A1 8mer gene with the greatest IP RNA enrichment and the least amount 
of total RNA change, Lefty1. 
Chapter 2: Identification of Lefty1 as an Ago2-associated miRNA target in mESCs 
 58 
5' ...CUGCACUGUAUGCGA--AGCACUUA... 
          |||          |||||||  
3'      UCUGAGUUUUCAUCAUCGUGAAA 
Lefty1 
miR-295 
5' ...CCAUCACCCAGUUUAAGCACUUA... 
               |||   |||||||  
3'    UCUGAGUUUUCAUCAUCGUGAAA miR-295 
Lefty2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2A: Mouse Lefty1 and Lefty2 binding sites for miR-295 and genomic 
alignment of miR-295 site. 
Theoretical pairing between miR-295 and mouse Lefty1 and Lefty2 3'UTR. Both contain an M8-
A1 8mer match for miR-295. Genomic alignment of miR-295 seed match in lefty homologs of 6 
species from Choi et al.(2007). 
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Figure 2B: Lefty protein expression in miR-290~295 cluster wild-type and 
knockout ESCs 
Western blotting for lefty protein in cell lysates from two wild-type (WT) and two knockout (KO) 
miR-290~295 mESC cell lines. Right half of blot are lysates from cells grown on irradiated 
mouse embryonic fibroblast (MEF) feeder layer. Left half of blot are cells where the MEF feeder 
layer is removed by pre-plating. Upper band is precursor form of Lefty protein, lower band is 
mature Lefty protein. Vinculin serves as the loading control. 
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Figure 2C: Repression by miR-295 of Lefty1/2 3’UTR 
Wild type (WT) and miR-295 seed mutated (MUT) versions of Lefty1 and Lefty2 were fused to 
Renilla luciferase 3'UTR sequence and expressed in Dicer null mESCs in the presence of control 
mimic siRNA or miR-295 mimic siRNA. Relative activity is ratio of Renilla expression 
normalized to Firefly luciferase transfection control expression in Dicer null cells with miR-295 
mimic compared to same ratio in Dicer null cells with control mimic. Difference between WT 
and MUT relative expression is statistically significant (two-tailed t-test, p<0.05). 
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Figure 2D: Repression of Lefty1/2 3’UTR by miR-290 cluster of miRNAs 
Wild type (WT) and miR-295 seed mutated (MUT) versions of Lefty1 and Lefty2 were fused to 
Renilla luciferase 3'UTR sequence and expressed in two independent lines of miR-290 cluster 
WT ESCs (WT) and two independent lines of miR-290~295 null ESCs (KO). Luciferase activity 
is expressed as ratio of WT 3’UTR Renilla expression normalized to Firefly luciferase 
transfection control relative to MUT 3’UTR Renilla expression normalized to Firefly luciferase 
control. Difference between WT1 and WT2 and KO2 (but not KO1) is statistically significant 
(two-tailed t-test, p<0.05). 
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Figure 3A: Expression of HNF4alpha mRNA with differentiation of miR-290~295 
cluster ESCs 
Quantitative real-time PCR of HNF4alpha mRNA in two independent lines of miR-290~295 
wild-type (WT) and knock-out (KO) ESCs after 0 days and 4 days of withdrawal of LIF. 
HNF4alpha mRNA levels are calculated relative to GAPDH expression and all are normalized to 
HNF4 expression in WT1 cell line at 0 days. HNFalpha mRNA was not detected over 
background amplification for sample from KO2 at 0 day time point. 
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Figure 3B: Induction of HNF4alpha and Sox17 mRNA in miR-290~295 cluster ESCs 
after differentiation with Activin 
Quantitative real-time PCR of HNF4alpha and Sox17 mRNA in two independent lines of miR-
290~295 wild-type (WT) and knock-out (KO) ESCs after 7 days of differentiation with Activin. 
HNF4alpha and Sox17 expression is determined relative to GAPDH expression. Fold induction is 
calculated relative to expression of HNF4alpha/Sox17 mRNA at day 0 timepoint for each cell 
line. 
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Figure 4: Model of miR-290~295 regulation of endoderm differentiation 
miR-290~295 represses Lefty1 and Lefty2, which are inhibitors of the Nodal signaling pathway. 
Reduced expression of Lefty proteins allows for activation of the TGF-B related receptors 
ALK4/AcrRIIB by Nodal protein, phosphorylation and subsequent activation of Smad2, and 
activation of endoderm related genes. When miR-290~295 expression is lost, as in the knock-out 
ES cells, there is elevated expression of Lefty proteins. When cells receive extracellular signals to 
differentiate down the endoderm lineage, like Nodal or Activin, the increased levels of Lefty 
proteins inhibit signaling through the TGF B receptor such that there is a decreased 
phosphorylation of Smad2 and thus lower expression of endoderm related genes.
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Abstract 
MicroRNAs (miRNAs) are a large family of 19-22nt non-coding RNAs that post-
transcriptionally regulate their mRNA targets. Computational algorithms predict that over 
half of all genes are regulated by miRNAs, yet few miRNA binding sites have been 
experimentally identified. To directly identify endogenous miRNA binding sites, we 
performed photo-crosslinking immunoprecipitation using antibodies against Ago2, 
followed by deep-sequencing of RNA tags (CLIP-seq) in mouse embryonic stem cells 
(mESCs). We also performed parallel CLIP-seq in Dicer null mESCs that lack mature 
miRNAs, allowing us to define whether the association of Ago2 with the identified sites 
was mediated by miRNAs. A significantly enriched motif was identified only in wild-type 
mESCs in both 3’ untranslated regions and coding sequences. This motif matches the 
seed of the most abundant miRNA family in mESCs, constituting ~68% of the total 
mESC miRNA population. Unexpectedly, a G-rich motif was highly enriched in a majority 
of sequences covalently associated with Ago2 regardless of the presence or absence of 
miRNAs. Gene expression analysis and reporter assays confirmed that the seed-related 
motif confers miRNA-directed regulation on host mRNAs and that the G-rich motif can 
modulate this regulation.  
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Introduction 
miRNAs are key regulators of gene expression in fundamental biological 
processes including cell proliferation, cell death, cell differentiation and cellular 
responses to environment (reviewed in Singh et al. 2008) . These short non-coding 
RNAs guide an RNP complex, containing a member of the conserved Argonaute (Ago) 
protein family, to sites predominantly in the 3'UTRs of their target mRNAs, and this 
results in the destabilization of the message and/or inhibition of translation (Bartel 2009; 
Carthew et al. 2009). Biochemical and computational studies have shown that base-
pairing between the “seed” (2nd -7th nucleotide) at the 5' end of the miRNA and mRNA 
target is necessary for this regulation in animals (Lewis et al. 2003; Doench et al. 2004; 
Brennecke et al. 2005; Lewis et al. 2005; Grimson et al. 2007; Nielsen et al. 2007). 
Comparative genomic analysis for miRNA seed sites in the 3'UTRs of all mammalian 
mRNAs suggests that over half of them are regulated by miRNAs (Friedman et al. 2009). 
Moreover, both comparative genomic analysis and emerging data from a handful of 
genes suggest that miRNAs also target coding sequences, but the prevalence of this 
type of interaction is unclear. Therefore, recent efforts (Chi et al. 2009; Zisoulis et al. 
2010), including the study presented here, have aimed at identifying the bona fide sites 
on a genome-wide scale in animals, including samples from whole mouse brain and 
whole-animal nematodes at 4th larval stage. However, one of the challenges of these 
studies is to deconvolute the miRNA-target relationships in the mixed cell types from 
these samples. In this study, we dissected the miRNA-target relationship in a single-cell 
population – mouse embryonic stem cells (mESCs) – with defined miRNA characteristics 
by isolating and deep-sequencing RNA tags cross-linked to Ago2 by 
immunoprecipitation (CLIP-seq) (Ule et al. 2005; Licatalosi et al. 2008; Chi et al. 2009; 
Yeo et al. 2009; Zisoulis et al. 2010) in mouse embryonic stem cells (mESCs) and a 
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derivative cell line lacking Dicer and mature miRNAs  
Results 
CLIP-seq identified microRNA-dependent and -independent sequences 
cross-linked to Ago2 
Live mESCs were UV-irradiated at 254nm to cross-link RNAs to Ago2. Cell 
lysates were treated with limited RNAse digestion and Ago2 RNPs were 
immunoprecipitated, 5' end-labeled with polynucleotide kinase and γ-32P, and a 102-
105 kDa Ago2 complex was recovered after SDS-PAGE and transferred to 
nitrocellulose. RNA of 18-40nt was isolated from these complexes, cloned, and 
sequenced by standard short RNA and Solexa sequencing protocols (Pfeffer et al. 
2005). Notably, no RNA species were detectable by autoradiography in Ago2 
immunoprecipitates without crosslinking, suggesting cloned RNA tags are in direct 
physical association with Ago2 (Fig. 1A). 
Approximately 24.5M sequenced RNA tags from 3 libraries representing two 
biological replicates (WT1A, WT1B, WT2) and 10.6M tags from two Dicer null libraries 
(KO1, KO2) were first processed for linker-matching and length criteria and mapped to 
the mouse genome using using Bowtie short read alignment tool (Langmead et al. 
2009). Across all libraries, approximately 79% of the reads had unique matches to the 
genome while 21% mapped to non-unique locations and 5% were not aligned (Fig. 1B). 
Collapsing unique matches with identical genomic coordinates, we obtained 
approximately ~1.5M distinct genomic alignments in wild-type and knockout libraries 
(1.39M for WT1A, 1M for WT1B, 1.89M for WT2, 1.35M for KO1 and 1.92M for KO2). 
Reads with unique and repeat matches to the genome were screened against 
known non-coding RNA databases to identify the miRNAs crosslinked to Ago2 in 
mESCs (Fig. 1C, D). Mature miRNAs are enriched, as expected (Calabrese et al. 2007; 
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Babiarz et al. 2008), in Ago2-crosslinked samples from Dicer WT cells compared with 
Dicer null cells. The “ES-cell and early embryonic specific cluster” miR-290~295, miR-
467 cluster, and miR-302 cluster (all share the AAGUGC seed) represents the largest 
fraction (Fig. 1C) and contributed to approximately 68% of the Ago2-crosslinked mature 
miRNA population (Houbaviy et al. 2003; Calabrese et al. 2007; Babiarz et al. 2008; 
Ciaudo et al. 2009) (Fig. 1C). In fact, the Ago2-CLIP and whole cell miRNA populations 
were correlated (Fig. 1D, Pearson coefficient r = 0.63; Spearman coefficient ρ = 0.86, 
WT1A). The specificity of CLIP-seq method is shown by the absence of significant Ago2 
crosslinking to the highly abundant ribosomal RNAs (~0.2%) and tRNAs (~0.2%). 
Unexpectedly, we also identified RNA species that crosslinked to Ago2 in Dicer 
null mESCs, suggesting that Ago2 can associate with RNA species in a miRNA-
independent manner (Fig. 1A). Some of these species mapped to pre-miRNA hairpins. 
Such binding of miRNA precursors by Ago2 has been reported recently, supporting the 
specificity of Ago2-CLIP from Dicer null ESCs (Tan et al. 2009; Yoda et al. 2010). 
Identification of enriched motifs in Ago2-CLIP RNA tags 
To search for enriched motifs that may represent miRNA binding sites, we 
generated a set of high confidence genomic clusters by subjecting 3’UTR-mapping RNA 
tags to a data processing pipeline consisting of 4 filtering steps (Fig. 1E). First, identical 
reads were collapsed as a single read to eliminate potential PCR bias, and overlapping 
reads were then clustered (Clustering filter, Fig. 1E). 25nt flanking regions were added to 
the clusters in case the RNase cleaved the mRNA at a site between where the miRNA 
bound and Ago2 crosslinked. Clusters were further considered only if they were 
significantly enriched (p-value <0.01) over background levels obtained from in silico 
CLIP data set simulations (Normalization filter, Fig. 1E). The simulations took into 
account 3'UTR lengths and endogenous transcript abundance measured using 
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Affymetrix exon array on mESCs processed in parallel with Ago2-CLIP samples (see 
Methods). Third, to select for a reproducible signal, only the clusters that overlapped with 
at least one other enriched cluster from a normalized biological replicate library were 
considered (Multi-Library filter, Fig. 1E). Fourth, of the remaining WT clusters, ones that 
had overlaps with clusters from either Normalized Dicer null library (Knockout or KO) 
were removed (Knockout filter, Fig. 1E).  Finally, after removing duplicates from 
technical replicates WT1A and 1B, 430 clusters (244 in WT1[A+B] and 186 in WT2), of 
average length 81nt, passed all four filters and were subjected to motif enrichment 
analysis using two independent approaches. 
First, significantly enriched motifs were identified in the combined set of 3'UTR-
mapped clusters across the three WT libraries and independently in the KO sets (Fig. 
1F). The motif discovery tool MEME(Bailey et al. 1994) was used to search for enriched 
motifs of variable lengths over a background simulated by a first order Markov model for 
the background composition of 3’UTR sequences (see Methods). We found significant 
enrichment for G-rich motifs in clusters from both WT and KO libraries, suggesting that 
Ago2 may be associated with G-rich sequences independent of miRNAs. We further 
identified a consensus G-rich motif by performing MEME analysis on Ago2-crosslinked 
clusters that overlapped between Dicer WT and null mESCs. This motif was highly 
statistically enriched (E-value= 2.9e-386) and present in 87% of the WT and KO 
overlapping clusters. Examination of individual libraries showed that this consensus G-
rich motif was present at approximately equal frequency in sequences crosslinked to 
Ago2 from wild-type and Dicer null mESCs, again suggesting that its association with 
Ago2 is miRNA independent (Table 1).  
One of the two significantly enriched miRNA-dependent motifs identified in 
3'UTRs was GCACU[UG] (79 instances from 430 clusters). GCACUU (48 out of 79 
GCACU[UG] motifs) is complementary to the seed AAGUGC of several highly 
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expressed families of miRNAs in mESCs, which constitutes ~68% of the Ago2-CLIP 
mature miRNA population (cf. Fig. 1D and Fig. 1C, G). The only other statistically 
enriched miRNA-dependent motif in the selected clusters was CCAGCC (51 instances in 
430 clusters). However, unlike GCACUU, this motif is not complementary to any miRNA 
sequence with significant expression in mESCs. Notably, recurrent enrichment of C and 
U nucleotides was also observed near miRNA binding sites identified in C. elegans 
(Zisoulis et al. 2010).  
To independently investigate enrichment of motifs from clusters that passed all 4 
filters within each individual library (Fig. 1H-J), we used an enumerative approach that 
guarantees global optimality by statistical overrepresentation and avoids the problem of 
being trapped at local optima inherent in most general motif-finding algorithms(Sinha et 
al. 2002). Briefly, we measured the statistical significance of the occurrence of n-mer 
sequences within each library compared to their occurrence in sequences drawn 
randomly given a background distribution. This independent analysis confirmed the 
significant enrichment of G-rich hexamers (≥3Gs, red dots, Fig. 1H) out of all possible 
hexamers in both WT and KO libraries as demonstrated by their high p-values and z-
scores at a false discovery rate FDR < 0.5% (see Methods for their derivations; brown 
dots for FDR ≥ 0.5%). It also showed enrichment of several non-G rich hexamers (blue 
dots, Fig. 1H), including GCACUU (black dot) and CCAGCC (black circle) exclusively in 
the WT libraries (cf. Fig. 1H,I and 1J). 29 non-G rich hexamers matched to other miRNA 
seeds, but these miRNAs are associated with Ago2 at a median frequency of 0.003% (p 
< 0.05; Fig. 1G). The enrichment of the miRNA-dependent motif, GCACUU hexamer, is 
particularly apparent after the application of the Knockout filter, where clusters common 
between WT and KO libraries, many of which contain G-rich hexamers (red dots), are 
removed from the WT set. In effect, the Knockout filter reveals GCACUU as the most 
enriched non-G rich hexamer in mESCs expressing miRNAs (black dot, left-most panel 
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vs. right-most panel Fig. 1H).  
Sequences mapping to coding sequences (CDS) of the genome were also 
subjected to the same data processing pipeline, resulting in a set of 197 clusters (106 in 
WT1[A+B] and 91 in WT2). As in the case of 3'UTR clusters, G-rich motifs were enriched 
in clusters from both WT and KO libraries (constituting ~25% and ~30% of clusters, 
respectively according to MEME motif analysis; data not shown). Moreover, GCACUU 
hexamer was observed in the CDS clusters from wild-type libraries (22 instances in 197 
clusters, from MEME analysis; data not shown), but not KO libraries. Similarly, in the 
enumerative analysis of individual libraries, G-rich hexamers were highly enriched in 
both WT and KO libraries and enrichment for the GCACUU hexamer was only observed 
in WT libraries (Fig. 1I, J). The degree of enrichment of the GCACUU hexamer in the 
CDS was slightly weaker than in 3’UTR clusters across WT libraries (Table 1; p-values 
<2.0e-5 in CDS vs. <1.5e-6 in 3'UTR). Unlike 3'UTR-mapped clusters, both MEME and 
enumerative analyses indicated that no enrichment for CCAGCC was observed in the 
CDS-mapped clusters (data not shown). 
Ago2- CLIP genes exhibit a miRNA dependent gene expression signature 
mRNAs targeted by miRNA are often destabilized (Bagga et al. 2005; Lim et al. 
2005; Wu et al. 2006) and resulting in an increase in abundance of targeted transcripts 
upon loss of miRNAs (Nielsen et al. 2007; Baek et al. 2008). To determine if the stability 
of Ago2-CLIP GCACUU transcripts is miRNA-regulated, their corresponding mRNA 
expression profiles in wild-type and Dicer null mESCs were compared. We examined the 
expression profiles of two sets of genes that were above the microarray signal threshold 
and contained GCACUU motifs in 3’UTR-mapping clusters identified by Ago2-CLIP. The 
high-confidence “Overlap” set is comprised of 43 distinct genes that passed the 
Normalization and Multi-Library filters, and a more inclusive “All” set, that is comprised of 
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201 distinct genes that passed the Normalization filter for any WT library. The Ago2-
CLIP 3'UTR GCACUU-motif genes from both “Overlap” and “All” sets showed a 
significant increase in expression upon deletion of Dicer as compared to a control set of 
genes that lacked the GCACUU-motif, but were matched for 3'UTR length, dinucleotide 
composition, and expression level (Fig. 2A, B). These results independently support the 
identification of these mRNAs that are physically bound to Ago2 as in vivo targets of 
miRNA regulation in mESCs. 
Given that similar significant miRNA-dependent changes in expression have 
previously been shown for high-confidence predicted targets based on computational 
analysis of conservation and context around the seed site (Lim et al. 2005; Grimson et 
al. 2007; Friedman et al. 2009), the properties of these predicted targets of the AAGUGC 
seed-related family were compared with the set of mRNAs identified by Ago2-CLIP. 
First, the expression levels, as determined by exon array analysis of Dicer wild-type 
mESCs, of these two sets were compared. This analysis showed that the Ago2-CLIP 
3'UTR GCACUU-motif genes have a bias towards the higher expression bins as 
compared to the predicted targets (Fig. 2C, D). This is not surprising, as biochemical 
enrichment protocols tend to more effectively sample the highly expressed genes. 
To further compare inherent properties of the predicted targets and CLIP-
identified mRNAs other than expression level, two expression-matched sets of predicted 
targets for the AAGUGC miRNA seed family were generated. The first set, "All predicted 
targets", contains the profile of 1469 TargetScan predicted targets that matched the 
expression profile of CLIP-identified mRNAs. Compared with this predicted set, both 
Ago2-CLIP “Overlap” and “All” gene sets have significantly greater miRNA-dependent 
changes in expression (Fig. 2A, B), suggesting that the CLIP-identified mRNAs possess 
additional features on top of the miRNA seed match requirement.  
To assess the importance of conservation and context around the seed site, we 
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created another predicted set (“Conserved predicted targets”) with the same number of 
genes as Ago2-CLIP 3'UTR GCACUU-motif genes. This second set contains the 
highest-confidence bioinformatically predicted targets, which are first ranked by branch 
length (i.e. high conservation), then by context score, which is scored combinatorially by 
its site-type, 3’pairing, local AU content, and position relative to the stop codon (Grimson 
et al. 2007; Friedman et al. 2009). This set was also expression-matched to the 43 
genes in the Ago2-CLIP 3’UTR GCACUU-motif “Overlap” set. Interestingly, while the 
TargetScan database includes all GCACUU miRNA binding sites in annotated mouse 
3’UTRs, there is only 1 gene in common between the “Conserved predicted targets” and 
the CLIP “Overlap” set. This could be partly because the lack of sampling depth in the 
current Ago2-CLIP libraries thereby failing to capture all in vivo targets. In terms of the 
miRNA-dependent expression change, no statistically significant difference was 
observed between the “Overlap” gene set and the "Conserved predicted targets" (Fig. 
2A).  Yet, the CLIP-identified GCACUU seed sites from the “Overlap” set are generally 
less conserved and surrounded by a relatively less favorable sequence context (Fig. 
2E). Taken together, our results suggest that there are factors, besides conservation and 
context around the GCACUU seed motif, that govern which sites miRNAs target and/or 
are bound by Ago2 in mESCs.  
A similar comparison was performed between the 201 genes in the Ago2-CLIP 
3’UTR GCACUU-motif “All” set (Fig. 2B) and an additional expression-matched 
“Conserved predicted targets” set with the top 201 TargetScan predicted targets ranked 
by branch length, then context score (Fig. 2F). In this case, the expression change of the 
"Conserved predicted targets” is greater than the expression change of the Ago2-CLIP 
3'UTR GCACUU-motif genes. Therefore, compared with the “All” set, the “Overlap” gene 
set probably represents a higher confidence set of miRNA-regulated mRNAs.  
We also sought to determine whether the GCACUU-motifs identified in CDS 
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were associated with a miRNA-dependent gene expression signature. To this end, 
expression of Normalization filtered Ago2-CLIP CDS GCACUU-motif genes from all WT 
libraries was compared to a set of controls that lacks GCACUU in the CDS, but were 
matched for length, dinucleotide composition, and expression level. In this analysis, 
genes that also have the GCACUU-hexamer in the 3'UTR (23 genes) were excluded 
from both sets to avoid signal contribution from the 3'UTR. The resulting set of 80 Ago2-
CLIP CDS GCACUU-motif genes showed an increase in mRNA expression compared 
with the control set upon deletion of Dicer (Fig. 2G). Interestingly, other expression-
matched GCACUU-motif genes in CDS (“Predicted set” in Fig. 2G) showed a similar 
profile as the Ago2-CLIP identified set and showed a significant increase compared with 
the control. Thus, this indicates that the presence of the GCACUU motif in CDS, as in 
the case of 3’UTR, is also associated with a miRNA-dependent gene expression 
signature (Grimson et al. 2007; Baek et al. 2008). 
The expression profile change between wild-type and Dicer null mESCs was 
further examined for genes with the other enriched motifs in the Ago2-CLIP set – the G-
rich motif, whose association with Ago2 appears to be miRNA-independent and 
CCAGCC, whose association with Ago2 might be miRNA-dependent. Neither the G-rich 
motif nor the CCAGCC motif is complementary to any miRNA sequence expressed at 
significant levels in mESCs. To test for changes in gene expression in wild-type versus 
Dicer null mESCs, we compared those CCAGCC-containing genes that passed the 
Normalization filter in at least one library with expression-matched sets of all mouse 
genes that do not contain CCAGCC (control) in the 3’UTR (Fig. 2H). In this analysis, 
genes that contain GCACUU in their 3'UTRs or CDS were excluded. Surprisingly, we 
observed a significant increase in gene expression for the CCAGCC containing genes 
upon deletion of Dicer. For the G-rich motif from Fig. 1F, we compared the expression 
change for Ago2-CLIP genes that contain matches to this motif, but lack GCACUU in 
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their 3’UTRs, and passed the Normalization and Multi-library filters (Fig. 2H) with a set of 
3’UTRs randomly chosen from the mouse genome that was matched for expression 
level, dinucleotide CG composition and 3’UTR length. As is the case for GCACUU- and 
CCAGCC-containing genes, a significant increase in gene expression was observed 
upon deletion of Dicer, when compared with the control, for these G-motif containing 
genes identified by Ago2-CLIP.  
Interestingly, the degrees of change in mRNA expression observed for G-motif or 
CCAGCC containing genes were not significantly different from those observed for the 
Ago2-CLIP identified GCACUU-motif genes (Fig. 2H) and their expression-matched 
predicted GCACUU set (cf. Fig. 2H). Correlated with this, previous data suggests that 
the effect of miRNAs can be mimicked in cells by miRNA-independent tethering of 
Argonaute family members to reporter mRNAs (Pillai et al. 2004; Djuranovic et al. 2010).  
Thus, the observed miRNA-dependent change in the gene expression profile for Ago2-
CLIP genes examined here could be due to the close proximity (a prerequisite for the 
covalent bond formation by photo-crosslinking) between Ago2 and the identified mRNA 
targets. 
Identified GCACUU-seed match containing cluster is sufficient to confer 
miRNA-mediated repression 
Next, we sought to independently determine whether the regions in the 3’UTR or 
CDS where GCACUU-motif sites crosslinked to Ago2 are sufficient to confer miRNA-
dependent repression on luciferase reporter transgenes in the presence of endogenous 
levels of the corresponding miRNAs. Since only four genes (Cdkn1a/p21(Wang et al. 
2008b), Rbl2(Benetti et al. 2008; Sinkkonen et al. 2008), Stat3(Foshay et al. 2009), 
Lats2(Wang et al. 2008b)) have been validated as GCACUU seed match targets in 
mESCs, it was difficult to evaluate our dataset with the existing literature. Instead, the 
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~80nt cluster sequence identified by Ago2-CLIP was inserted into the 3’UTR of 
luciferase and the expression of this construct was compared to an equivalent construct 
with the motif GCACUU mutated to CCUCAU. The ratio of wild-type to mutant construct 
expression was evaluated in 3 cellular states: (1) Dicer wild-type (endogenous miRNA 
levels), (2) Dicer null mESCs (no mature miRNAs) and (3) Dicer null mESCs transfected 
with a miR-295 mimic, as illustrated for Slc31a1 in Fig. 3A. The relative repression in 
each cellular state was then calculated by normalizing to the ratio in Dicer null cells. We 
found that 8 out of 8 Ago2-CLIP 3'UTR GCACUU-motifs (3 from the “Overlap” set and 5 
from the “All” set) showed significant miRNA-dependent repression in Dicer WT cells but 
not in Dicer null cells (Fig. 3B). However, the repression in Dicer null cells can be 
restored by addition of a miR-295 mimic, suggesting that a member from this mESC-
specific miRNA family (with AAGUGC seed) is sufficient to provide the specificity for 
such regulation. Additionally, Ago2-CLIP-identified binding sites were present in three 
genes that have previously been shown to be regulated by the AAGUGC-related miRNA 
seed family. These include E2F1(O'Donnell et al. 2005) (in “Overlap” and “All” sets), 
Pten(Xiao et al. 2008) (in “Overlap” and “All” sets), and Cdkn1a(Wang et al. 2008b) (in 
“All” set only) (data not shown). These data show that the Ago2-CLIP 3'UTR bearing 
GCACUU-motif sites are indeed endogenous targets for direct regulation by miRNAs in 
mESCs and the short fragment containing such sites is sufficient to confer mESC-
specific miRNA-mediated repression through the miR-290~295 cluster. 
To determine whether the Ago2-CLIP CDS GCACUU-motif sites are sufficient for 
miRNA regulation, we inserted the CDS cluster sequence (~80nt), or a seed mutant 
equivalent, in the 3'UTR of Renilla luciferase. 7 out of 8 clusters containing CDS 
GCACUU-motifs when put in the 3'UTR conferred downregulation on the luciferase 
reporter (Fig. 3C), suggesting that these sequences are recognized by the endogenous 
miRNA machinery even in the heterologous context of the 3’UTR.  
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In two cases (Herc1 and Eif2c2), two hexamer motifs were observed in the same 
cluster plus flanking sequence. Both sites independently conferred miRNA mediated 
repression but the repression was neither fully additive nor synergistic as expected from 
previously published reports (Doench et al. 2003; Brennecke et al. 2005; Grimson et al. 
2007). This may reflect contributions of surrounding sequences when miRNA binding 
sites are derived from CDS sequences. In the case (Tnrc6a) where we did not see any 
effect of the cluster sequence on luciferase expression, this could be due to other 
sequences surrounding the binding site that are necessary for miRNA-dependent 
regulation. 
miRNA regulation can be modulated by G-rich motif that is associated with 
Ago2 
The G-rich motif was strongly enriched in Ago2-CLIP sequences from both wild-
type and Dicer null mESCs (Fig. 1F). Therefore, the motif probably represents a miRNA-
independent binding site for Ago2. We previously determined that the CLIP-identified 
3’UTR GCACUU mRNAs have a miRNA-dependent expression change comparable to 
the high-confidence predicted targets, despite having a lesser degree of conservation 
and being in a less favorable sequence context (Fig. 2A, E). To explore whether the G-
motif is a feature in these sequences that can contribute to miRNA-dependent 
regulation, we focused on a new microRNA target Txnip identified in this study based on 
the following evidence. First, compared to Dicer null mESCs, both endogenous protein 
levels of Txnip were decreased in Dicer wild-type mESCs (Fig. 4A). Moreover, similar to 
a previously identified miR-295 target, Cdkn1a(Wang et al. 2008b), such repression can 
be restored in Dicer null mESCs by addition of a miR-295 mimic (Fig. 4A). Second, the 
cluster identified from this gene by Ago2-CLIP was one of the most repressed in our 
3’UTR luciferase assay (Fig. 3B). This provides a good range of sensitivity to test 
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whether a neighboring G-motif affects the miRNA-dependent activity of the GCACUU 
seed site (Fig. 4B). 
The relationship between this G-motif and seed-motif was investigated by 
generation of 4 different luciferase constructs bearing in the 3’UTR either (1) the WT 
Txnip cluster, (2) with GCACUU seed motif mutated to CCUCAU, (3) a mutant G motif 
where all Gs mutated to Cs, (4) or both motifs being mutated. As in Fig. 3A, the 
expression of these constructs was evaluated in 3 cellular states: Dicer wild-type, Dicer 
null mESCs, and Dicer null mESCs transfected with miR-295 mimic. Repression was the 
strongest where the GCACUU seed motif and G-motif were wild-type (Fig. 4C). 
Interestingly, the repression was relieved by 40% when the G-motif was mutated (Fig. 
4C). However, in the absence of the seed, the presence of G motif alone did not confer 
any repression (Fig. 4C). Taken together, these data suggest that the G motif is 
important for the full activity of the Txnip miRNA seed, but does not contribute activity in 
the absence of the miRNA seed. A similar effect was observed for the relationship 
between the G-motif and GCACUU seed present in the cluster from another gene Ei24 
(Fig. 4D, E). 
Given that the CLIP identified G-motif modulated the miRNA-mediated 
repression in the two contexts examined, we further investigated the general features of 
this motif, including its composition, conservation, and location within the sequence 
associated with Ago2. We searched for enrichment of 4mer and 5mer motifs in the 
3’UTR clusters to determine whether the G-motif is composed of any smaller motifs. 
Indeed, we found several significantly enriched G-rich 4mers and 5mers within the 
original 8mer G-motif (Fig. 4H). Next, we analyzed the conservation of the 8mer G-motif. 
The conservation score of each nucleotide position in the G-motifs was first calculated 
using phastCons based on the alignment of 11 mammalian species(Siepel et al. 2005) 
(see Methods). The scores across all G-motifs were then averaged and compared with a 
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background set of other 8mers randomly chosen from all mouse 3'UTRs. We found that 
G-motifs are generally more conserved than random sequences (p<0.005) at multiple 
cutoffs of conservation score (Fig. 4F). We also analyzed nucleotide positional 
conservation scores of an alignment of G-motif instances with 10nt flanks at either end. 
The level of conservation sharply decreased immediately after the 3’end of the motif 
whereas the higher level of conservation persists in the 10nt 5’ of the motif (Fig. 4G). 
Interestingly, further MEME analyses suggest that the 8-mer G-motif is likely to be 
embedded in a more extended G-motif (Fig. 4H). The excess conservation observed for 
G-motifs was true for all clusters from 3'UTRs including those clusters lacking the 
GCACUU motif (Table 3), indicating that the excess conservation of the G-motif is not a 
bystander effect from being near this particular miRNA seed match, but rather the G-
motif has attributes of a typical functional regulatory element (Xie et al. 2005). 
Another common feature of this G-motif is that it tends to be present in the 5’ half 
of the sequence that is physically associated with Ago2 (Fig. 4I, J). In contrast, there is 
no positional bias for the GCACUU seed motif (Fig. 4J). In cases where both motifs are 
present in the Ago2-CLIP sequences, there are no biases as to whether the G-motif is 5’ 
or 3’ of the GCACUU motif (data not shown).  For the two G-motifs examined, its activity 
is independent of its location relative to GCACUU (Fig. 4C, E), suggesting that the 
vicinity rather than the directionality is important for modulating miRNA repression. 
Discussion 
Photo-crosslinking followed by Ago2 immunoprecipitation, Ago2-CLIP, was used 
to identify miRNA binding sites in RNAs that crosslink to Ago2 in mESCs. We found 
significantly enriched motifs in 3'UTRs and CDS that correspond to miRNA seed motifs, 
representing 201 and 103 potential mESC miRNA targets in 3'UTRs and CDS, 
respectively. In regards to the latter point, this study is in agreement with other studies 
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that the presence of miRNA binding sites in CDS is more widespread than has been 
previously considered and nearly as prevalent as in 3'UTRs(Chi et al. 2009; Hafner et al. 
2010; Zisoulis et al. 2010). Here we provided gene expression data suggesting that 
these sites in CDS regulate mRNA stability much like sites in 3'UTRs. Moreover, these 
sites can be recognized by miRNAs at endogenous levels of expression and confer 
repression in a heterologous 3’UTR context. Given that the predictive power of 
comparative genomics for miRNAs sites in CDS is relatively low, Ago2-CLIP is a robust 
method to identify these sites. Since mRNAs containing Ago2-CLIP CDS sites increase 
in levels upon deletion of Dicer, these binding sites are probably mediating regulation in 
mESCs. Recent experiments have indicated that some miRNA complexes can be 
displaced by ribosomes during translation while some complexes resist displacement 
(Kloosterman et al. 2004; Grimson et al. 2007; Tay et al. 2008; Gu et al. 2009). 
Unlike other cell types (Landgraf et al. 2007; Hafner et al. 2010), mESCs appear 
to be dominated by a single miRNA seed family associated with Ago2 and this family is 
probably responsible for most of the miRNA regulation in this cell type. Essentially all of 
the GCACUU-motif containing CLIP 3'UTR clusters conferred miRNA-dependent 
regulation when tested in luciferase reporter assays in the presence of endogenous 
levels of miRNAs. These included 3 out of 3 clusters from the high-confidence “Overlap” 
set that required their presence in 2 biological replicates, but also 5 out of 5 clusters that 
were only present in one of the biological replicates (“All” set). Therefore, a large fraction 
of the latter total set of 201 GCACUU-motif containing genes expressed in mESCs most 
likely represents bona fide miRNA targets. Previous studies have already shown that this 
miRNA family plays important roles in mESCs, including maintaining pluripotency, self-
renewal and cell cycle control (Benetti et al. 2008; Sinkkonen et al. 2008; Wang et al. 
2008b; Judson et al. 2009; Melton et al. 2010). But, few targets have been identified and 
validated. This study identifying a few hundred new miRNA targets by Ago2-CLIP is a 
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significant step in the exploration of this biology. 
To understand the extent of miRNA-regulated pathways represented by the 
Ago2-CLIP 3’UTR GCACUU-motif genes (“All” set, 201 genes), we performed pathway 
enrichment analysis (see Methods) and compared this set with the top 201 “Conserved 
predicted targets” and all mRNAs expressed in mESCs that contains GCACUU hexamer 
in the 3’UTR (“All predicted targets”, 2969 genes). 37 and 11 pathways were enriched in 
the CLIP and “Conserved predicted targets” sets, respectively (Table 4). The pathways 
enriched in CLIP included “Early S-phase” (4 genes), “BRCA1-related DNA damage 
response” (4 genes) and “TGF-beta receptor signaling” (5 genes). The role of the miR-
290~295 cluster in controlling G1/S phase transition has been previously 
described(Wang et al. 2008b), however this cluster has not been implicated in the 
regulation of the latter two pathways.  
Out of these two pathways, “TGF-beta receptor signaling” (p-value 0.013) is one 
out of six pathways that are also found in the top 50 enriched pathways in “All predicted 
targets” (Fig. 5A and Table 4). Amongst those genes identified by Ago2-CLIP in this 
pathway, they include two known intracellular pathway inhibitors, the cytoplasm-localized 
Smad7 and the nucleus-localized Skil , and an extracellular inhibitor, Lefty1(Zovoilis et 
al. 2009). Our reporter assay confirmed that these 3 genes are indeed targeted by this 
miRNA family (Fig. 5B). We extended this analysis to Lefty2, a gene that was not 
identified in the CLIP results, but plays an inhibitory role in the pathway and contains the 
GCACUU hexamer, and showed that this is another target for this miRNA family (Fig. 
5B). Correlated with this, the miR-302 cluster and miR-430, which is related in miRNA 
seed to miR-290~295 cluster, have been shown, respectively, in human ESCs (Rosa et 
al. 2009) and zebrafish embryos (Choi et al. 2007) to regulate differentiation through 
targeting Lefty members. Here using a genome-wide approach, we found that the 
abundant miR-290~295 cluster regulates not only the extracellular Lefty members, but 
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also additional inhibitory nodes of the TGF-beta pathway localized in different cellular 
compartments (Fig. 5C). This coordinate inhibition, as observed for other miRNAs 
(Tsang et al. 2007; Marson et al. 2008; Li et al. 2009), might confer robustness in this 
signaling network.  
We unexpectedly identified a G-rich motif in most of the sequences associated 
with Ago2 regardless of the miRNA status in the cell. The enrichment of G residues in 
our cloned sequences is not likely due to the use of RNase A, which cleaves after C and 
U residues, based on the following observations. First, we observed a bias of the G-motif 
enrichment primarily in the 5’half of the cloned sequence, but not in the 3’ half or flanking 
sequences. However, if this is a result of RNase A cleavage, we would expect biases 
present at both ends since each cloned sequence is created by two cleavage events. 
Second, this motif is conserved well above the general 3'UTR background even when 
matched for sequence content.  
Yet it remains unclear whether the sequence specificity for crosslinking to this G-
rich sequence is due to Ago2 itself or a binding partner of Ago2. Given that UV-
crosslinking forms covalent bonds between protein and RNA that are in direct contact 
(within angstroms), a potential binding partner would have to be positioned near Ago2 
and within close proximity of the mRNA target. Indeed, several proteins known to co-
immunoprecipitate with Ago2 have binding preference for G-rich sequences including 
HNRNP-H and FMRP (Caudy et al. 2002; Hock et al. 2007; Edbauer et al. 2010). 
Alternatively, Ago2 itself could have a previously unidentified preference for binding G-
rich sequences. In either case, when a G-rich sequence occurs near a miRNA binding 
site it could give the Ago2/miRNA complexes a higher affinity for this region and thus 
lead to increased probability that the given mRNA is targeted for degradation and/or 
inhibition of translation. In two cases examined, this G-rich motif modulates the level of 
miRNA dependent regulation by the miR-290~205 related seed motif, but imparts no 
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regulation in and of itself.  
Finally, our data suggests that Argonaute can associate with mRNA in a 
microRNA-independent manner. Therefore, Ago2-CLIP data from Dicer null mESCs 
cells provides an invaluable background in delineating bona fide microRNA targets. 
Given the potential for adding individual miRNAs to Dicer null mESCs and then 
performing Ago2-CLIP, this method will greatly enhance the genome-wide identification 
and characterization of targets for any miRNA. 
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Methods  
Cell culture 
Dicer wild-type mESCs and Dicer null mESCs were cultured in DME/HEPES 
supplemented with 2mM L-glutamine, 100 Units Penicillin, 100 ug Streptomycin, 1X 
Non-essential amino-acids (Invitrogen), 15% Defined FBS (Hyclone-ES screened), 
1000U/ml ESGRO (Chemicon) on gelatinized flasks.  For Ago2-CLIP, 2E6 mESCs were 
plated in 10cm dishes 48 hrs before irradiation and cell lysis. 
Derivation of Dicer wild-type and Dicer null mESCs 
Dicer wild-type ES cells were derived from mice carrying Dicer floxed allele 
described in (Harfe et al. 2005) and Dicer was deleted via transient transfection of Cre 
recombinase similarly to (Calabrese et al. 2007). Cells also carry a Cre-ER transgene 
(Metzger et al. 1995), but this system was not exploited for derivation of the cells. 
Ago2-CLIP-seq and Total short RNA-seq protocols 
REAGENTS 
10X PBS (Ambion) 
Dynabead protein G (Invitrogen 1ml 100.03D) 
anti-mouse Ago2 mAb lot# PEM0820 (WAKO 2x100ul 018-22021) 
RNase A (USB, 70194Y) 
10X dephosphorylation buffer (Roche, 712023) 
alkaline phosphatase (Roche, 712023) 
32P-γ-ATP (6000Ci/mml, 10mCi/ml) 
10X PNK Buffer (NEB) 
T4 PNK enzyme (NEB, M0201L) 
LDS sample/loading buffer (Invitrogen) 
20X MOPS SDS loading buffer (Invitrogen) 
10-well Novex NuPAGE 10% Bis-Tris gels (Invitrogen) 
Novex antioxidant solution (Invitrogen) 
rainbow marker (Amersham, RPN800) 
Sharp marker (Invitrogen) 
20X Transfer Buffer (Invitrogen) 
Rnl2 mutant ligase (NEB, M0242S) 
IDTDNA 10/60 and 20/100 ssDNA ladders 
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Novex TBE running buffer (Invitrogen, LC6675) 
Novex TBE-Urea sample buffer (Invitrogen, LC6876) 
10% TBE-urea gel (Invitrogen, EC6875BOX) 
15% TBE-urea gel (Invitrogen, EC6885BOX) 
6% TBE gel (Invitrogen, EC6265BOX) 
Sybr Gold (Invitrogen, S11494) 
Costar Spin-X columns (Sigma, cls8162) 
RNA ligase (Fermentas, EL0021) 
Superscript III RT (Invitrogen, 18080-093) 
DNTP (Roche, 04638956001) 
Amplitaq with GeneAmp 6 pack (Applied Biosystems, N808-0166) 
Complete Protease Inhibitor (Roche, 04693124001) 
Phosphatase Inhibitor Cocktail (Sigma, P2850 & P5726)  
EQUIPMENT 
Invitrogen Novex gel apparatus 
Invitrogen Novex transfer apparatus and pads 
Eppendorf Thermomixer 
Dark Reader transilluminator, small size 
(http://www.clarechemical.com/transilluminator.htm)  
SOLUTIONS 
lysis (mRIPA*) buffer 
Prepare 30 ml for 16 100 mm plates: 
5M NaCl 900 µl 
1M Tris pH 7.4 1500 µl 
1X DOC 3000 µl 
500 mM EDTA 60 µl 
10% NP-40 3000 µl 
ddH2O 21.54 ml 
Complete Protease Inhibitor (Roche)  
Phosphatase Inhibitor cocktail mix 1 and 2 
(Sigma) 
 
wash buffer 
1X PBS (tissue culture grade; no Mg++, no Ca++) 
0.1% SDS 
0.5% deoxycholate 
0.5% NP-40 
high-salt wash buffer 
5X PBS (tissue culture grade; no Mg++, no Ca++) 
0.1% SDS 
0.5% deoxycholate 
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0.5% NP-40 
1X PNK buffer 
50 mM Tris-Cl pH 7.4 
10 mM MgCl2 
0.5% NP-40 
1X PNK+EGTA buffer 
50 mM Tris-Cl pH 7.4 
20 mM EGTA 
0.5% NP-40 
PK Buffer 
100 mM Tris-Cl pH 7.5 
50mM NaCl 
10mM EDTA 
 
Ago2 CLIP protocol 
 
Day1 
Section I: Preparation of Dynabeads Protein G 
1. Make Citrate-Phosphate Buffer (CPB) 
50 ml citrate-phosphate buffer (CPB) 
0.257g Citric acid 
0.367g Dibasic sodium phosphate 
pH: 5.0 
 
2. Vortex new vial of Dynabeads for 1.5min, pipette 50ul to 4 eppis 
3. Put on magnet for 1min, discard supernantant. 
4. Resuspend beads in 500ul of CPB + 0.01% Tween (CPBT) 
5. Repeat 3-4 1 time. Put on magnet for 1 min, discard supernatant. 
6. Resuspend beads in 10ul of Ab and 90ul of CPB 
7. Rotate for 40min at rm temp. Go to Section II. Keep on ice until ready. 
8. During ultracentrifugation: Put beads on magnet for 2min then discard 
supernatant. 
9. Wash with 500ul CPBT 3 times. 
10. Wash with mRIPA* 1 time. 
11. Proceed to Section III, step 5 
Section II: UV Cross-linking of Cells 
1. Grow 10x107 cells in 100 mm plates per treatment  
2. Wash plates twice with 10 ml 1X PBS (diluted from 10X PBS) (WT1 with rm temp 
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PBS, WT2, KO2, and KO3 with 37˚C PBS), and add 4 ml 1X PBS 
3. Remove cap, and place in Stratalinker. Irradiate once with 4000 µJ/cm2 
4. add 300 µl lysis buffer (mRIPA*) per plate  and Transfer plates to ice tray,  
5. Scrape cells, and transfer to ultracentrifuge tubes (4 plates  1 tube) [2 tubes 
per treatment] 
6. Incubate on ice for 10 min 
7. Cool ultracentrifuge to 4 °C 
8. Place P1000 tips in cold room to cool 
Section III: Immunoprecipitation 
1. Remove 150 µl (5%) [75 µl from each tube] for each treatment (for total RNA 
analysis) 
2. Add 14.5 ul of RNase A per tube and invert to mix 
3. Incubate in Thermomixer R at 37 °C for 10 min (invert to mix every 3 minute). 
Take to ultracentifuge. 
4. Press “Door” to open, press on middle of rotor to activate, and press “Start” once 
cooled to 4 °C, 30,000 rpm, 20 min 
5. In cold room: Add supernatant (~1.2 ml) to tube with Dynabeads protein and 
resuspend. Try to avoid creating bubbles at all steps. 
6. Incubate for 60 min on rotisserie 
Section IV: Wash 
1. Place 10 new eppendorf tubes in rack on ice (4 for Wash, 4 for CIP, 2for End) 
2. Apply tubes to magnet, incubate 2min. and discard supernatant 
3. Add 1 ml wash buffer per tube, pipet to mix, apply to magnet for 2min, and 
remove supernatant (x2) 
4. Add 1 ml high-salt wash buffer per tube, pipet to mix, apply to magnet for 2min, 
and remove supernatant (x2) 
5. Add 1 ml 1X PNK buffer wash buffer per tube, pipet to mix, apply to magnet for 
2min, and remove supernatant (x2) 
6. Add 1 ml 1X PNK buffer wash buffer per tube, resuspend slurry, and transfer to 
first set of fresh tubes, pipet to mix, apply to magnet for 2min, and remove 
supernatant (x2) 
Section V: CIP Treatment (On-Bead) 
1. Prepare CIP mix: 
CIP mix (80 µl per sample  8 µl 10X buffer + 3 µl phosphatase + 69 µl 
water) x4.4 = 35.2 µl 10X dephosphorylation buffer + 13.2 µl phosphatase 
+ 303.6 µl water 
2. Add 80 µl of CIP mix to each sample 
3. Incubate in Thermomixer R at 37 °C for 10 min (1000 rpm every 3 min for 15 sec) 
Note: It is very important to get rid of all CIP in order to get good end-
labeling (i.e. yield) because need 5’ phosphate for adaptor ligation  Mix 
washes well (5 min on rotisserie) 
4. Wash with 1 ml PNK+EGTA buffer, mix on rotisserie for 5 min, apply to magnet 
for 2min, and remove supernatant (x2) 
5. Wash with 1ml 1X PNK buffer, mix on rotisserie for 5 min, apply to magnet for 
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2min, and remove supernatant 
6. Resuspend in 1ml 1X PNK buffer, transfer to fresh tubes, apply to magnet for 
2min, and remove supernatant (x2) 
Section VI: PNK Treatment (On-Bead) 
1. Prepare PNK mix [HOT]: 
PNK mix (80 µl per sample  8 µl 10X PNK buffer + 2 µl 32P-γ-ATP + 4 µl 
T4 PNK enzyme + 66 µl water) x4.4 = 35.2 µl 10X PNK buffer + 8.8 µl 
P32-γ-ATP + 17.6 µl T4 PNK + 290.4 µl water 
2. Add 80 µl of PNK mix to each sample 
3. Incubate in Thermomixer R at 37 °C for 10 min (1000 rpm every 3 min for 15 sec) 
4. Add 10 µl of 1mM ATP, and let the reaction go for an additional 5 min at 37 °C 
5. Set Thermomixer R to 70 °C 
6. In cold room: wash with 200 µl 1X PNK buffer, mix by pipet, apply to magnet for 
2min, and remove supernatant (x3) 
7. Remove supernatant, leaving ~30 µl behind 
8. Add 30 µl LDS loading buffer 
9. Incubate in Thermomixer R at 70 °C for 10 min at 1000 rpm 
10. Spin down for 1 min (in each tube orientation) 
11. Collect supernatant in two fresh tubes  
12. Store at -20 °C overnight in a HOTBOX 
 
Day2 
Section VII: SDS-PAGE & Nitrocellulose Transfer 
1. Prepare 800 ml of MOPS SDS Running Buffer (40 ml 20X stock + 760 ml ddH2O) 
2. Set up Novex NuPAGE apparatus 
3. In cold room: add 500 µl Novex antioxidant solution to middle section of box 
4. Load gel: lanes 1,10 = 4.5 ul of pre-mixed Rainbow marker (2 µl) and Sharp 
marker (2.5 µl, make enough for 2 ladder lanes/gel and keep at rm. temp until 
loading);  
lanes 2-8 = Ago2 (for samples, load 3x 10 µl per well)  
[can do quick spin down to pellet residual beads to bottom] 
5. Run gel at 70 V for 20 min and 200 V for 4 hr 
6. Prepare 400 ml of Transfer Buffer (20 ml 20X NuPAGE Transfer Buffer + 40 ml 
methanol + 360 ml ddH2O), and cut out nitrocellulose (same size as Whatman 
paper) 
7. After gel run, transfer gel to S&S BA-85 nitrocellulose using the Novex wet 
transfer apparatus 2 hour, 30V 
8. After transfer, rinse the nitrocellulose filter for 20min 1X PBS  
9. Wrap membrane in plastic wrap while still moist, and expose to X-ray film, length 
of exposure must be determined empirically. Wako mAgo2=1hr.  
Day3 
Section VIII: RNA Isolation and Purification  
1. Cut three thin bands between 105 kDa and 108 kDa using a clean scalpel blade, 
and put the nitrocellulose piece into a microfuge tube[ this need to be optimized]-  
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2. Make a 4mg/ml proteinase K (Roche, 1373196) solution in PK buffer and pre-
incubate it at 37 °C for 20 min to digest any RNases. The concentration of 
proteinase K will be on the product sheet and varies from lot to lot. 
3. Add 200 µl proteinase K solution to each tube of isolated nitrocellulose pieces; 
incubate 20 min at 37 °C at 1000 rpm in Thermomixer (Eppendorf) 
4. Add 200 µl of 1X PK/7M urea solution; incubate another 20min at 37 °C at 1000 
rpm 
5. Add 530 µl Ambion 9720 Phenol/Chloroform and incubate at 37 °C for 20 min at 
1000 rpm in Thermomixer 
6. Add 1/10th volume (50 µl) 3M sodium acetate, pH 5.5 (Ambion, 9740), 1ul linear 
acrylamide and 1ml of 1:1 EtOH: isopropanol  
7. Precipitate overnight at -20 °C  
8. Spin down RNA for 30 min at max speed in microcentrifuge. Wash pellet once 
with 1ml of -20 °C 75% ethanol, remove 1ml ethanol and quick spin to pellet 
remaining ethanol and remove. Air-dry for 5–10min at room temperature. 
Solexa-based small RNA cloning protocol 
Required oligos: 
3’ ligation: 
Modban: AMP-5’p=5’pCTGTAGGCACCATCAATdideoxyC-3’ 
  IDT – Product name: miRNA cloning linker 1 
 
5’ ligation: 
Solexa linker: 5'-GUUCAGAGUUCUACAGUCCGACGAUC-3' 
  IDT – Custom oligo – HPLC purified 
 
RT: 
3’ RT primer: 5’-ATTGATGGTGCCTACAG-3’ 
(BanOne) IDT – Custom oligo – HPLC purified 
 
PCR: 
Sol_5_SBS3: 5'-AATGATACGGCGACCACCGACAGGTTCAGAGTTCTACAGTCCGA-
3' 
  IDT – Custom oligo – Desalt 
Sol_3_Modban: 5'-CAAGCAGAAGACGGCATACGATTGATGGTGCCT ACAG-3' 
  IDT – Custom oligo – HPLC purified 
3’ Linker Ligation 
1. Resuspend in 13µl DEPC MQ  
2. Set up the following reaction: 
Gel purified RNA (in water) 13 µl 
ATP-free T4 RNA ligase buffer (10X) 2 µl 
DMSO 2 µl 
Modban oligo (0.5 µM, 1/100 dilution of 1 µl 
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50 µM stock ) 
Mutant RNA ligase 2 µl 
Total 20 µl  
2. Incubate at RT for 1 hr (in meantime proceed to step 1 of gel purification) 
3. Add 20 µl 2X Invitrogen TBE-Urea loading dye 
4. Proceed to section III 
*** 
10X ATP-free T4 RNA ligase buffer: 
500mM Tris-HCl (pH 7.5-7.6), 100mM MgCl2, 100mM DTT, 600µg/mL BSA 
*** 
Gel Purification of Ligated RNA Product 
1. Prepare Novex 15% TBE-Urea gel in 1X TBE buffer (Invitrogen) 
2. Pre-run gel for 15-30min at 200V 
3. Dilute IDT ssDNA 10/60 and 20/100 DNA ladders to .1ug/20ul. Add 20ul of 
Invitrogen TBE-urea buffer. Make 1 of each ladder for each gel. 
4. Heat samples and ladder at 95 oC for 3 min, then chill for 5 min. Clean wells of 
gel. 
5. Load the 10/60 ladder in lane 2, Load the sample in lane 5. Load the 20/100 
ladder in lane 8. 
6. Run gel at 200V until bromophenol blue is ¾ the way down. Consult gel pkg 
insert on mobility of dyes. 
7. Dismantle gel and incubate gel for 15min in 1X Sybr gold (Invitrogen) in water. 
8. Prepare gel tubes. Take .6 ml eppendorf tube and poke 1 hole 5 times in the 
bottom of tube with 21.5 gauge needle. Put this tube in a 1.5ml centrifuge tube. 
Do this for each sample. 
9. Set-up Dark Reader lightbox. Put 1 piece of saran wrap on box. Put gel on top of 
that. Put another piece of saran wrap on top of gel. –We use the blue light box to 
prevent UV damage of DNA/RNA during gel isolation. 
10. With thin sharpie pen and ruler, mark horizontal lines at 35 and 60nt according to 
ladders. Mark outline of lanes. 
11. Use razor blade or scalpel to cut between marked lines. Put gel piece in 0.6ml 
epi tube. 
12. Take a picture of the gel after being cut. 
13. Spin small epi in large epi in microfuge at rm temp for 2min at full speed 
14. Remove tubes, and use pipette tip to transfer any remaining gel in small tube to 
big tube. Use a top from a clean tube to cover big tube. 
15. Add 400 µl of 0.4M NaCl to gel in big tube. 
16. Incubate with rotation for 2hrs at room temp and/or overnight at 4˚ 
17. Transfer gel/salt slurry to Costar Spin-X column Spin 2min at full speed at rm 
temp. Transfer eluate to new tube. 
18. Add 1 µl linear acrylamide and 2.5 volume of 100% EtOH (RNase-free) 
19. Incubate at –20 oC 3 hours- O/N 
20. Spin at 4 oC for 30 min 
21. Wash with 1ml cold 75% EtOH. Remove all EtOH 
22. Air dry (2 min), and store at –20 oC until 5' linker ligation. 
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5’ Linker Ligation 
1. Resuspend in 12 µl DEPC MQ 
2. Prepare the following reaction mixture by combining 
1 µl 100 µM 5’ adapter oligonucleotide (see sequences above) 
2 µl  10X RNA ligase buffer with ATP (0.5 M Tris–HCl, pH 7.6; 0.1 M 
MgCl2; 0.1 M 2-mercaptoethanol; 1 mg/ml acetylated BSA (Sigma, B-
8894); 2 mM ATP) 
3 µl  100% aqueous DMSO 
 
3. Denature the RNA by incubation for 30 s at 90 oC. Place the tube immediately on 
ice for 20 s 
4. Add 2 µl of T4 RNA ligase 1 (Rnl1) (Fermentas), mix gently, and incubate for 1 h 
at 37 oC. Meanwhile prepare gel. 
5. Add 20ul of Invitrogen TBE-Urea buffer. 
Gel purification of ligated product 
6. Prepare Novex 10% TBE-Urea gel in 1X TBE buffer (Invitrogen) 
7. Pre-run gel for 15-30min at 200V 
8. Dilute IDT ssDNA 20/100  ladder to .1ug/20ul. Add 20ul of Invitrogen TBE-urea 
buffer. Make 2 of ladder for each gel. 
9. Heat samples and ladder at 95 oC for 3 min, then chill for 5 min. Clean wells of 
gel. 
10. Load one ladder in lane 2, Load the sample in lane 5. Load the other ladder in 
lane 8. 
11. Run gel at 200V until bromophenol blue is all the way down. Consult gel pkg 
insert on mobility of dyes. 
12. Dismantle gel and incubate gel for 15min in 1X Sybr gold (Invitrogen) in water. 
13. Prepare gel tubes. Take .6 ml eppendorf tube and poke 1 hole 5 times in the 
bottom of tube with 21.5 gauge needle. Put this tube in a 1.5ml centrifuge tube. 
Do this for each sample. 
14. Set-up Dark Reader lightbox. Put 1 piece of saran wrap on box. Put gel on top of 
that. Put another piece of saran wrap on top of gel. 
15. With thin sharpie pen and ruler, mark horizontal lines at 60 and 90nt according to 
ladders. Mark outline of lanes. 
16. Use razor blade or scalpel to cut between marked lines. Put gel piece in 0.6ml 
epi tube. 
17. Take a picture of the gel after being cut. 
18. Spin small epi in large epi in microfuge at rm temp for 2min at full speed 
19. Remove tubes, and use pipette tip to transfer any remaining gel in small tube to 
big tube. Use a top from a clean tube to cover big tube(its top probably broke off 
in microfuge). 
20. Add 400 µl of 0.4M NaCl to gel in big tube. 
21. Incubate with rotation for 2hrs at room temp and/or overnight at 4˚ 
22. Transfer gel/salt slurry to Costar Spin-X column (Sigma, cls8162). Spin 2min at 
full speed at rm temp. Transfer eluate to new tube. 
23. Add 1 µl linear acrylamide and 2.5 volume of 100% EtOH (RNase-free) 
24. Incubate at –20 oC 3 hours- O/N 
25. Spin at 4 oC for 30 min 
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26. Wash with 1ml cold 75% EtOH. Remove all EtOH 
27. Air dry (2 min), and store at –20 oC until 5' linker ligation. 
Reverse Transcription 
1. Set up the following 
Ligated RNA product (in water) 4.7 µl 
BanOne primer (5 µM) 3.2 µl 
2. Incubate at 72 oC for 2 min 
3. Centrifuge at RT (14,000 rpm) for 1 min 
4. Cool on ice for 2 min 
5. Add 6.3 µl RT Mix 
RT Mix stock: 30 µl 5X first strand buffer (from SSIII), 15 µl dNTP (10mM 
each) 3 µl 0.1M DTT, 12 µl MQ 
6. Add 0.8ul Superscript III RT 
7. Incubate at 50 oC for 1 hr.  
8. To hydrolyze the RNA, add 40 µl of 150 mM KOH/20 mM Tris base and incubate 
for 10 min at 90 oC 
9. Neutralize the solution by addition of 40 µl of 150mM HCl and check the pH value 
of the mixture by spotting 1 µl on pH paper. It should be between 7.0 and 9.5 so 
that the subsequent PCR is not inhibited. If necessary, readjust the pH by adding 
more base or acid. Store at -20 until ready to do PCR. 
1ml 150mM KOH/20mM Tris Base 
15ul 10M KOH 
20ul 1M Tris pH8.5 
965 H2O 
1ml 150mM HCl 
12.9ul conc HCl (36-38%) 
987.1ul H2O 
PCR Amplification of cDNA 
1. Perform a standard 100 µl PCR with Taq polymerase (10 µl from the neutralized 
cDNA solution, 0.5 µM primers, 2 mM MgCl2) 
2. To determine the necessary number of cycles for amplifying the cDNA library, 
remove 12 µl aliquots every other cycle starting with cycle number 15. To remove 
aliquots from the PCR tube, temporarily pause the PCR cycler at the end of the 
72 oC step. For PCR, use the following cycle conditions: 45 s at 94 oC, 85 s at 50 
oC, 60 s at 72 oC. Do not amplify for more than 30 cycles because it will result in 
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distortion of the small RNA ratios. Analyze the samples on an 8% native 0.75mm 
acrylamide gel. Use 5x Hi-Density TBE sample buffer (For 10mls: 1.5g Ficoll400, 
2ml 5X TBE buffer, 1ml 1% Bromophenol blue, 1ml 1% Xylene cyanol, 4.5 
Water) for loading dye.  
3. The PCR product appears as a double band with the higher band running at the 
expected length of about 100 nt and a lower band corresponding to the 3’ 
adapter to 5’ adapter ligation products running at about 90 nt. Define the optimal 
cycle number for cDNA amplification, which has to be within the exponential 
amplification phase of the PCR, about 5 cycles away from reaching the 
saturation level of PCR amplification 
4. Perform a 600 µl PCR with the optimal cycle number and combine PCR 
products. Ethanol precipitate with 1/10th volume 3M NaOAc, 1ul linear 
acrylamide, and 2.5vol 100% Ethanol for 3 hrs-O/N. Resuspend in 8ul of Water. 
5. Run on 6% Invitrogen TBE gel in 1X Invitrogen TBE buffer with Invitrogen 10bp 
ladder at least 2 lanes away from sample, isolate the PCR product, gel elution as 
before and ethanol precipitation overnight. Resuspend pellet in 20 ul of water. 
6. Second round of PCR with 1/10 of primers and 10ul of 1/100 dilution of 1st PCR 
product, taking every 2 cycles from cycle # 6 onwards to determine the linearity. 
Analyze on 8% acrylamide gel.  
7. Perform 1600ul PCR and ethanol precipitate the product. Resuspend in 24ul of 
water. 
8. Run sample in 3 lanes on 6% Invitrogen TBE gel in 1X Invitrogen TBE buffer 
with Invitrogen 10bp ladder at least 2 lanes away from sample, isolate the PCR 
product, gel elution as before and ethanol precipitation overnight. Resuspend 
pellet in 5 ul of EB (brand new from a Qiagen kit). 
9. To quantify DNA, 1ul of PCR product was run on a 8% native gel with NEB 
ladder with known mass. We have found this is more accurate because the salts 
throw off the nanodrop. We calculate amount of product by comparing band 
intensities. If you use NEB 100bp ladder, run ½ and1/4 dilution of ladder to give 
you 10.5 and 21ng for 100bp band. We typically get between 5-20ng/ul. 
Short RNA cloning from Total RNA protocol: 
1. Isolate Total RNA from cells with Trizol reagent (Invitrogen) according to 
manufacturer's instructions.  
2. Prepare 15% Novex TBE-Urea gel (Invitrogen) and pre-run for 15-30min at 200V 
in 1X TBE. 
3. Dilute IDT ssDNA 10/60  ladder to .1ug/20ul. Add 20ul of Invitrogen TBE-urea 
buffer. Make 2 of ladder for each gel. 
4. Heat 5ug of Total RNA in 40ul volume in 1X Invitrogen TBE-urea buffer and 
ladder at 95 oC for 3 min, then chill for 5 min. Clean wells of gel. 
5. Load one ladder in lane 2, Load the sample in lane 5. Load the other ladder in 
lane 8. 
6. Run gel at 200V until bromophenol blue is all the way down. Consult gel pkg 
insert on mobility of dyes. 
7. Dismantle gel and incubate gel for 15min in 1X Sybr gold (Invitrogen) in water. 
8. Prepare gel tubes. Take .6 ml eppendorf tube and poke 1 hole 5 times in the 
bottom of tube with 21.5 gauge needle. Put this tube in a 1.5ml centrifuge tube. 
Do this for each sample. 
9. Set-up Dark Reader lightbox. Put 1 piece of saran wrap on box. Put gel on top of 
that. Put another piece of saran wrap on top of gel. 
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10. With thin sharpie pen and ruler, mark horizontal lines at 18 and 35 nt according 
to ladders. Mark outline of lanes. 
11. Use razor blade or scalpel to cut between marked lines. Put gel piece in 0.6ml 
epi tube. 
12. Take a picture of the gel after being cut. 
13. Spin small epi in large epi in microfuge at rm temp for 2min at full speed 
14. Remove tubes, and use pipette tip to transfer any remaining gel in small tube to 
big tube. Use a top from a clean tube to cover big tube(its top probably broke off 
in microfuge). 
15. Add 400 µl of 0.4M NaCl to gel in big tube. 
16. Incubate with rotation for 2hrs at room temp and/or overnight at 4˚ 
17. Transfer gel/salt slurry to Costar Spin-X column (Sigma, cls8162). Spin 2min at 
full speed at rm temp. Transfer eluate to new tube. 
18. Add 1 µl linear acrylamide and 2.5 volume of 100% EtOH (RNase-free) 
19. Incubate at –20 oC 3 hours- O/N 
20. Spin at 4 oC for 30 min 
21. Wash with 1ml cold 75% EtOH. Remove all EtOH 
22. Resuspend in 13 µl Water. 
23. Proceed with 3'ligation as indicated above for CLIP cloning, EXCEPT use 1 µl of 
50 µM stock of Modban 3' cloning linker. All the rest of the steps are the same. 
 
Library Summary 
Five CLIP libraries and 2 short RNA libraries were prepared. CLIP libraries are 
represented as “Ago2_XY”, where X indicates the mESC line from which the library is 
derived, “WT” for Dicer wild-type mESCs and “KO” for Dicer null mESCs; Y indicates the 
library replicate. For WT libraries, “1A” and “1B” are separate PCR amplifications and 
Solexa sequencing runs from the same CLIP RNA sample and “2” is an independent 
biological replicate. For KO libraries, “1” and “2” are independent biological replicates. 
Two short RNA libraries were prepared for cloning and sequencing from total RNA 
extracted from Dicer WT mESCs. These are represented as TR_WT.  
Data processing and bioinformatics 
Raw sequence processing 
Linker Stripping 
A 37nt linker sequence was used in these experiments. Varying lengths of the 
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linker sequence from its 5’ end were attached to the 3’ end of individual reads depending 
on their length. Illumina sequence reads with a maximum length of 39nt that passed 
Illumina’s quality filter were processed to identify and strip any linker sequence. In order 
to maximize the number of reads that could be aligned to the genome, exact and fuzzy 
matches to the linker were allowed as follows:  
1. Perfect linker subsequence match at the 3’ end of the read: A match to 
the first six or more nucleotides (5’ to 3’) of the linker at the 3’ end of the read 
was identified wherever possible. [TERMINAL_LINKER_SEG] 
2. Perfect linker subsequence match within read while allowing for errors 
towards the end of the linker: To allow for possible sequencing errors in the 
linker, a perfect match to six or more nucleotides of the 5’ end of the linker 
within the read were identified. The corresponding segment up to the 3’ end 
of the read was stripped. [INTERNAL_ LINKER_SEG] 
3. Fuzzy match to allow for errors at the start of the linker: To allow for 
sequencing errors within the initial part of the linker, a 2nt anchor consisting 
of the first two nucleotides of the linker was used to identify the start of 
possible 10mers where one error was allowed in nucleotides 3 to 6 and a 
perfect match was required for nucleotides 7 to 10. In effect, a possible 
sequencing error of one base was allowed within nucleotides 3 to 6 within the 
first 10 bases of the linker sequence. The 10mer and the subsequent 
sequence were stripped from the read. [1err_10mer_INIT_LINKER_SEG] 
4. Short terminal linker subsequence: For the remaining cases where there 
was a weak signal of the linker (exact match of less than six nucleotides) at 
the end of the read, it was stripped off to increase the probability of 
alignment. Sequences lacking a linker were retained with their original length 
intact. [SHORT TERMINAL_LINKER_SEG] 
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5. Sequences lacking a linker (based on the above criteria) were retained with 
their original length intact.[NO_LINKER] 
FASTQ sequence files with quality scores were processed to strip linker 
sequences (as above) and trim quality score strings accordingly. The distribution of 
various linker categories is shown in Methods Figure 1. The distribution of read lengths 
after linker stripping and the total number of raw reads per library are shown in Methods 
Figure 2. 
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Methods Figure 1: Linker distribution by type for each CLIP library 
Y axis is the type of linker segment identified/stripped as match types are described in methods. 
Total raw reads for each library: WT1A: 9,098,036; WT1B: 5,667,749; WT2: 5,667,749; KO1: 
3,136,343; KO2: 7,209,770. 
 
Methods Figure 2: Distribution of read length in each linker-stripped CLIP library 
before genomic alignment 
Y axis is processed read length. X axis is percentage composition of total reads. 
 
Genome alignment 
The FASTQ formatted reads following linker stripping were then mapped to the 
mouse genome (build mm9) using Bowtie short read alignment tool (Langmead et al. 
2009), allowing up to two base pair mismatches per unique alignment. Specifically: 
1. Unique alignments against the mouse genome (mm9) were identified with 
an allowance for up to two nucleotide mismatches to allow for sequencing 
errors. 
2. Reads that did not align against the mouse genome sequence were 
identified. These were then processed for alignment against mouse 
mRNA sequences (RefSeq). 
3. In an attempt to extract maximum signal from the input dataset, reads that 
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did not align in either of the two cases above were subjected to further 
processing. Allowing for possible sequencing errors towards the 3’ ends 
of the reads, these unaligned sequences were truncated to 18nts and 
were processed for alignment against the mouse genome (mm9) and 
subsequently the mouse RefSeq sequences. 
4. All unique matches to the genome with a maximum of 2nt mismatches 
were used in subsequent processing. Unique and repeat matches to the 
genome were further processed to identify any hits to microRNA (from 
miRbase release 14(Griffiths-Jones et al. 2006))  or non-coding RNA 
(ncRNA annotations from fRNAdb ver. 3.4(Mituyama et al. 2009), 
Genomic tRNA Database (Chan et al. 2009), Rfam ver. 9.1(Griffiths-
Jones et al. 2005)) sequences. Those reads that were contained within 
mature miRNA or miRNA* annotations from miRbase were categorized 
as mature miRNAs (Griffiths-Jones et al. 2006). Those that mapped to the 
pre-miRNA hairpin but did not meet the mature miRNA criteria were 
categorized as pre-miRNA overlaps. Reads that overlapped ncRNA 
annotation were considered valid hits only if they were completely 
contained within the ncRNA with the added stringency that repeat 
matches with no mismatches were allowed. Additionally, repeats from the 
truncated set of 18mer reads were not considered for ncRNA mapping. 
Sequences were also mapped to the coding subset of genic annotations 
for mm9 from the UCSC genome browser (Kent et al. 2002) using 
BEDTools (Quinlan et al. 2010). Sequences with no matches were not 
included in further analysis.. 
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Data filtering 
Overview 
In order to minimize data noise and enhance the signal captured by CLIP reads, 
we employed a four step filtering process to reduce background contributions (Fig. 1B). 
This includes length and abundance normalization of the data and independence from 
KO library hits among other things, as described below. The focus of this analysis was 
hits to 3’UTR and CDS regions of the mouse genome (mm9). 
Filter 1: Cluster formation 
Following mapping of reads to the genome, reads with identical start and end 
coordinates on the same chromosome were collapsed to a single observation. This 
conservative step compensates for any PCR amplification bias. Following this step, 
overlapping reads were aggregated into clusters. Continuing with our conservative 
approach, we filtered out and ignored any clusters that did not have more than one read. 
This step selects only those genomic regions that were cloned more than once, reducing 
the chance of spurious hits. We then added a flank of 25nt of genomic sequence on 
either side of the cluster to include its genomic context. At the end of this step, we are 
left with a filtered set of clusters (with more than one component read) for each of 3’UTR 
and CDS genomic regions. 
Filter 2: Normalization 
CLIP datasets were normalized for length and abundance in order to select 
clusters with an overlapping read count greater than that expected by chance (i.e. the 
background). Our simulation based approach is similar to that employed earlier in the 
literature (Chi et al. 2009): 
• Exon array data was used to obtain normalized probe intensity levels per 
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transcript, as an indication of transcript abundance (An) in mESCs. 
• Lengths of CDS and 3’UTR segments (Ln) were obtained from UCSC 
(http://genome.ucsc.edu) annotation sets for the mouse genome (mm9). 
• The total number of CLIP tags mapping to each of CDS and 3’UTR regions were 
counted to give a total count (T) in each case (CDS, 3’UTR). 
• Similar to earlier work by Chi et al. (2009), we estimated the total number of 
fragments in mESCs for our CLIP dataset. However, we made a distinction 
between CDS and 3’ UTR datasets per gene, rather than deriving a single 
estimated fragment count per gene. Considering the average cloned sequence to 
be 50nt (similar to Chi et al.), we derived the estimated number of fragments per 
gene for each of 3’UTR and CDS regions as follows: 
Fragn = An * Ln / 50 
• From the total pool of CLIP hits per region (3’UTR and CDS), we then allocated 
the expected number of CLIP hits per gene per region based on the proportion of 
estimated fragments for that gene and region: 
Expn = (Fragn / Fragn) * T 
• A simulation-based approach similar to Chi et al. was then used to determine the 
maximum background cluster height for each transcript (separately for each of 
3’UTR and CDS regions of that transcript). Starting with An reads of length Ln for 
a given transcript and given genomic region, the reads were randomly cleaved 
until the average length of the resulting fragments was 50nt. From this set of 
fragments, Expn fragments were randomly selected to match the expected 
number of CLIP targets for this transcript in a genomic region (3’UTR or CDS). 
The resulting fragments were then analyzed for overlaps by building clusters of 
overlapping fragments. The maximum cluster height from this process was 
noted. This simulation was repeated 500 times similar to Chi et al., and the 
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frequency of maximum observed cluster heights was captured across these 
simulations. This gives us a p-value reflecting the false discovery rate (FDR) 
estimate for clusters of various heights for a given transcript’s 3’UTR or CDS 
regions.  
• We used an FDR cutoff of p < 0.01 to determine the maximum background 
cluster height for each of the CDS and 3’UTR regions for each transcript. Going 
back to our CLIP clusters for each library, only those clusters that had an 
overlapping read count greater than the maximum background cluster height 
were included in further analysis. This was tagged as the “normalized set” for 
each library. 
Filter 3: Multi-library 
In order to distill the signal further, we sought to retain normalized clusters that 
had support (i.e. genomic overlap) from one or more clusters from a biological replicate. 
This filtering was performed for the WT libraries in our dataset and clusters without 
“overlap support” were dropped from further consideration. Specifically, WT1A 
normalized clusters that had overlap support from normalized WT2 clusters were 
retained (similarly WT1B with support from WT2). WT2 normalized clusters with support 
from either one of WT1A or WT1B normalized sets were retained. Since WT1A and 
WT1B were separate amplifications of the same biological starting material, overlaps 
between these two libraries were not considered. 
Filter 4: Dicer knockout subtraction 
We used the normalized KO libraries (Ago2_KO1, KO2) as another means to 
eliminate some of the background clusters in our WT CLIP datasets. Hence, any WT 
library cluster from the earlier filtering step that had a genomic overlap with a cluster 
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from one of the normalized KO libraries was dropped from further analysis.  
As a result, we obtained a set of clusters for each WT library that were filtered 
using four criteria to exclude background components and enhance the signal from the 
CLIP reads. These sets were then used for downstream enrichment analyses.  
Motif enrichment analysis 
Overview 
We employed the general motif finding tool MEME (Bailey et al. 1994), which 
uses an expectation maximization approach, for motif discovery in the aggregate set of 
WT library clusters and KO library clusters. Both 3’UTR and CDS mapped cluster sets 
were analyzed. For a detailed analysis of enriched hexamers within each individual 
library, an enumerative approach was used in order to guarantee global optimality by 
statistical overrepresentation (Sinha et al. 2002). This avoids the problem of locally 
optimal solutions inherent in the local search algorithms employed by most general 
motif-finding tools including MEME. Briefly, we measured the statistical significance of 
the occurrence of n-mer sequences within each library compared to their occurrence in 
sequences drawn randomly given a background distribution. Two measures of 
significance were employed, a p-value to denote enrichment over background and a z-
score to quantify the magnitude of the enrichment. 
MEME analysis 
Input sets 
We took as input the set of clusters from each WT library that had passed filter 4 
(Figure 1). These are length and abundance filtered clusters (normalized) that have 
passed through the additional filtering criteria of overlap with at least one other cluster 
from a biological replicate and no overlap with any cluster from one of the KO libraries. 
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For aggregate analysis, all WT library clusters were pooled together. Exact duplicates 
from WT1A and WT1B libraries were removed and only one copy was retained in the 
aggregate set (as these are technical replicates). This combined set of clusters was 
used as input for MEME motif analysis. 
For the KO sets, we took the normalized KO libraries with the additional criteria 
that they overlap one or more WT library clusters. This allowed us to explore motif 
enrichment within the set of clusters common to the KO and WT libraries, i.e. in the 
presence and absence of miRNAs. 
Background models 
For each of 3’UTR and CDS regions, we used MEME to find motifs enriched over 
a background simulated by a first order Markov model. The nucleotide frequencies and 
transition frequencies were determined by analyzing a set of 4500 randomly chosen 
3’UTR sequences (and similarly 4500 CDS sequences). Sequences were picked 
randomly from the UCSC (http://genome.ucsc.edu) annotation set for the mouse 
genome (mm9). 
MEME settings 
We searched for motifs on the given strand only (RNA sequences). The 
appropriate 3’UTR or CDS background model (from above) was supplied to MEME with 
a first order Markov model. Separately, we also analyzed input sets for motifs in the 
absence of a background model. We specified a maximum of 50 motifs to be reported in 
each run. In order to cover the search space of variable sized motifs we used MEME to 
report motifs in three classes: variable length motifs between 4nt and 8nt, fixed size 
motifs of length 6nt (to match the miRNA seed length), and fixed size motifs of length 
7nt. The “zoops” sequence model was used to specify zero or one occurrence of a motif 
per input cluster sequence. 
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Correlation between variably sized motifs 
We used MAST (Bailey et al. 1998) to determine the Pearson correlation 
between variably sized motifs reported by MEME. All the distinct significant motifs 
reported by MEME in any one of the three length constrained runs (described above), 
were highly correlated (Pearson correlation cutoff 0.6) with their counterparts in other 
runs. So, for example, the most significant motif in the width 4nt to 8nt run was 
significantly correlated to its counterpart in the width 7 MEME run and so on. 
Hexamer enumeration 
Background models 
In order to get a true measure of statistical overrepresentation for each library, 
background sequence replicates were generated per library to match the sequence 
length and count in each library. Similar to the hexamer enumeration approach, the 
GenRGenS random sequence generator (Ponty et al. 2006) was used with a first order 
Markov model to reflect genomic composition (for 3’ UTR or CDS, as the case may be) 
to generate these background sets. For each library, 200 replicates of the background 
sets were generated. Separate sets were generated for each of the different filtered sets 
per library (see main text for filtering steps that each library undergoes). These sets of 
replicates were used during hexamer enrichment for determination of statistical 
overrepresentation. 
Calculation of statistical significance 
For each of the hexamers in the enumerated sequences set described before, 
we first calculated its frequency in each of the library-specific background replicate sets. 
One or more occurrences per sequence were considered to be a single occurrence, 
simplifying the computation to reflect the number of sequences that contain the 
hexamer. The mean frequency and standard deviation were also computed. This gives a 
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measure of the expected frequency and expected standard deviation of occurrence of a 
specific hexamer for a given library with identical sequence length and number 
distribution. We also measured the number of sequences containing a given hexamer in 
the input file of cluster sequences for a given library.  
If we consider a random variable Rs to be the number of sequences in the set R 
of background sequences that contain the hexamer h, and denote the mean and 
standard deviations as E(Rs) and σ(Rs) respectively, we can define the z-score as (Sinha 
et al. 2002):  
  zs = (Ns – E(Rs)) / σ(Rs) 
where Ns is the number of sequences containing the given hexamer in the input 
file of cluster sequences. In effect, the z-score is the number of standard deviations by 
which Ns exceeds the expected value. We compute this and use it as one measure of 
the statistical significance of hexamer occurrence. All computations were performed 
using a custom Perl script. 
We then employed a two-sided Fisher’s exact test to compute the probability of 
observing a given hexamer in a library with a certain frequency as opposed to its 
expected frequency calculated from the background set. These calculations were 
performed using a custom Perl script and were validated using the statistical software R 
(Ihaka et al. 1996). 
An additional filter was implemented to account for false discovery rate. A false 
discovery rate cutoff of p < 0.005 was used and any Ns that were below the maximum 
background Rs  at this significance level were dropped from the analysis.  The resulting 
set of FDR < 0.005 enriched hexamers in the library sets were then matched with any 
known miRNA seed sequence from miRBASE (Griffiths-Jones et al. 2008) 
(complementary to the miRNA seed) and tagged if there was such a match.  
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G-motif conservation analysis 
Overview 
We selected the 8mer G-motif reported by MEME (Bailey et al. 1994) (E < e-385) 
using the KO1 set that passed normalization and overlap (with at least one WT library) 
filters as a representative motif for the G-rich regions found in WT and Dicer null libraries 
(i.e. in the presence and absence of miRNAs). This analysis focused on the 3’UTR 
mapped cluster sets. 
G-motif hits in CLIP libraries 
The log-odds matrix reported by MEME for the representative 3’UTR G-motif 
(described above) was used to infer high scoring G-motif hits in CLIP library clusters. We 
used MAST ver. 4.3.0 to locate these hits in CLIP libraries using a p-value cutoff of p < 
0.05. Additionally, we used the same first order Markov model to model the background 
for 3’UTR genomic regions. In order to be consistent, this model, derived from 4500 
randomly chosen 3’UTR regions, is the same one used elsewhere in the analysis of 
CLIP data.  
G-motif hits were sorted by the strength of their match to the log-odds matrix (the 
MAST match score) for each set of filtered clusters for each CLIP library. In downstream 
analyses, we selected sets of top-scoring G-motif hits based on score cutoffs. In earlier 
analysis, MEME reported 710 instances of the G-motif using the KO1 overlaps with WT 
set (this is the representative G-motif). We derived a score cutoff of 360.88 (p<0.05) for 
the MAST match score based on the sorted score of the 710th unique exemplar MAST 
G-motif hit on the KO1 (overlaps with WT) dataset itself. In various analyses on other 
libraries, one (highest scoring) or more MAST hits (G-motif instances) per cluster were 
allowed, as noted. This cutoff was also used to locate G-motif hits to analyze positional 
bias in G-motif locations within clusters. We also used a more relaxed cutoff of >0 for 
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some analyses, as indicated, to investigate a larger sample size. 
Occurrences of G-motifs and GCACUU hexamers within clusters 
We tested G-motif hit locations to see if there was a bias in G-motif position with 
respect to the cluster length. As mentioned before, all CLIP clusters were extended with 
25nt of genomic flanks on either side. The length of each cluster was normalized to 30nt, 
resulting in a representative length of 80nt for each cluster (25nt 5’ flank + 30nt 
normalized cluster length + 25nt 3’ flank). For each library, we analyzed various 
combinations of score cutoffs with an allowance of one or more than one non-
overlapping G-motif instances on a cluster. High scoring G-motif hit start locations (score 
cutoffs 360.88 and 0) were collected. Additionally, all GCACUU hexamer exact match 
locations (starts) were collected. The totals of these two sets were individually 
normalized between 0 and 1. Radar plots of these start locations for the most relaxed 
score cutoff set (score cutoff > 0) with allowance of one G-motif instance per cluster (top 
scoring) are shown in Figure 4J. Results are similar between various other combinations 
of scores and G-motif instances (one or more allowed). 
G-motif 8mer conservation 
We used phastCons nucleotide conservation scores for the mouse genome 
(mm9) from the UCSC whole genome alignments (http://genome.ucsc.edu). Specifically, 
we used the Euarchontoglire subset which includes the following species: mouse(mm9), 
rat(rn4), Guinea Pig(cavPor2), Rabbit(oryCun1), Human(hg18), Chimp(panTro2), 
Orangutan(ponAbe2), Rhesus(rheMac2), Marmoset(calJac1), Bushbaby(otoGar1), Tree 
Shrew(tupBell). For G-motif hits in each library (match score > 0), we averaged the 
phastCons (Siepel et al. 2005) score across each instance of the G-motif. Motif hits 
where less than two nucleotides had a positional alignment/score were filtered out. To 
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estimate the background conservation of 8mers within the 3’UTR annotated regions, we 
randomly selected 8mers from UCSC 3’UTR annotations for the mouse genome. Score 
from three sets of 12000 8mers each were averaged and analyzed in the same fashion 
as the G-motif 8mer hits. Three scoring buckets were used to classify conservation of G-
motif 8mers versus background 8mers (Fig. 4F) and the overrepresentation of G-motif 
conservation at various levels was computed with respect to the background expectation 
(Fisher’s Exact test). 
G-motif positional conservation profile 
To further explore G-motif conservation, we analyzed the positional nucleotide 
conservation of G-motif occurrences across libraries. In this case, rather than looking at 
the average phastCons scores of individual G-motif hits, we averaged the phastCons 
score of each nucleotide position for all G-motif instances. We similarly derived an 
average positional score for 10nt genomic flanks on either side of each G-motif instance. 
We again used a conservative score cutoff for G-motif hits (cutoff score of 360.88) to 
analyze high-scoring hit locations and a relaxed score cutoff (score > 0) with similar 
results. We also employed this strategy for three sets of 12000 background 3’UTR 
8mers (as before) with 10nt flanks. Results using the relaxed score cutoff (score > 0) 
and allowing for upto one (top-scoring) G-motif per cluster are shown in Fig. 4G 
Pathway enrichment analysis 
For pathway analysis, we used MetaCore from GeneGO Inc. Pathways are 
curated in MetaCore as sets of signals or transformations confirmed by experimental 
evidence or inferred relationships. Each of the gene sets was analyzed individually for 
enriched pathways represented in the set using an FDR < 0.57 cutoff. All annotated 
mouse genes are used as background for the set of All TargetScan GCACUU predicted 
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targets (see Target statistics). And the “All GCACUU predicted targets” set was used as 
background for Ago2-CLIP GCACUU-motif “All set” and TargetScan top-ranked (by 
branch length, and context score) set of 201 genes with expression on microarray >4. 
Results are outlined in Table 4. 
Western Blot analysis 
For comparison of protein expression level in Dicer WT and Dicer null mESCs, 
2E6 cells were plated in 10cm dishes 48 hrs before lysis with 300µl of modified RIPA 
buffer (150mM NaCl, 50mM Tris pH 7.4, 0.1% Na-Deoxycholate, 1mM EDTA, 1% 
NP40). 24 hour prior to transfection of 10nM or 100nM miR295 mimics using 
Lipofectamine 2000 (Invitrogen), 2E6 Dicer null mESCs were seeded in a T-25 flask. 24 
hours after transfection, the cells were trypsinized and replated to 10cm dishes; 24 hours 
later, cells were lysed with 300µl of modified RIPA buffer as above. Cells were 
transfected with 10µg GFP plasmid to show that the transfection efficiency is about 80%. 
Generation of luciferase constructs, mESCs transfection, and luciferase 
assays 
For the 3'UTR and CDS cluster constructs, cluster sequence plus 25nt flanking 
regions were amplified by PCR from mouse genomic DNA and cloned into the 3’UTR of 
a CMV-driven Renilla luciferase vector with the oligos listed in the subsequent table. The 
position 2, 4, and 6 (right to left) of the GCACUU seed motif were mutated by 
Quikchange site-directed mutagenesis (Stratagene) to CCTCAT with the oligos listed in 
the subsequent table. For Lefty1 and Lefty2, the whole 3’UTR was cloned into same 
expression vector with oligos listed in the subsequent table. GCACUU motif was 
mutated as in cluster constructs. 
For 3'UTR and CDS cluster construct transfection, 24 hrs before transfection 
0.8E5 mESCs were plated/well of gelatinized 24-well plate. Cells were washed 1X with 
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Opti-MEM (Invitrogen) and transfected with 1.5ul Lipofectamine 2000 (Invitrogen), 10 ng 
of Renilla plasmid, 100 ng of pGL3 (Promega), and 690 ng of pWhitescript with or 
without 0.3 pmol of miR-295 miRNA mimic (Dharmacon) in 300µl of Opti-MEM 
(Invitrogen) in triplicate. With exception of Fig. 5b, where 100ng of GL3 and 700ng of 
Renilla plasmid was transfected with or without 0.4 pmol of miR-295 miRNA mimic 
(Dharmacon) in 400 µl of Opti-MEM. 4hrs after transfection, transfection mix was 
removed from cells and replaced with ESC media.  
24 hrs after transfection, cells were lysed with 1X Passive Lysis Buffer (Promega) 
and Dual luciferase was measured using Dual Luciferase reporter assay system 
(Promega) according to manufacturer's instructions with either the Promega Glomax 
20/20 single-sample luminometer or the Berthold Microlumat Plus 96-well plate-format 
luminometer. For Fig. 3, 4, 5, all experiments were performed at least 3 times. To 
calculate fraction WT/MUT luciferase activity, the ratio of Firefly to Renilla luciferase 
activity was determined for each replicate well in each experiment and averaged across 
replicate wells. The average Renilla activity normalized to Firefly for the Wild-type 
construct was divided by the average Renilla activity normalized to Firefly for the Mutant 
construct for Dicer +/+, Dicer -/-, and Dicer -/- + miR-295 mimic mESCs. The ratio of 
WT/MUT luciferase activity for Dicer WT and Dicer -/- + miR-295 mimic mESCs was 
then normalized to same ratio in Dicer -/- mESCs for each experiment. These ratio were 
described as “Relative Luciferase Activity and these data points are represented in 
boxplots in Fig. 4 for each independent experiment. T-test was used to calculate 
significance of the differences in WT/MUT ratio between Dicer wild-type and Dicer -/- 
+miR-295 mESCs to Dicer -/- mESCs. P-value ≤ 0.05 (two-tailed t-test) was considered 
significant.  
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mESC mRNA microarray analysis 
Total RNA was collected using Trizol (Invitrogen) from independently from three 
10cm dishes of Dicer wild-type and Dicer null mESCs that were plated with 2E6 cells 
48hrs prior to collection. RNA quality was determined by analysis of integrity of 
Ribosomal RNA by formaldehyde-agarose gel and Agilent Bioanalyzer. Sample 
preparation, labeling, and hybridization to Affymetrix Mouse Exon 1.0 ST arrays were 
performed according to manufacturer's instructions by the MIT Biomicrocenter. Data 
processing was done using Partek Genomics Suite 6.4 (St. Louis, MO). RMA was used 
to summarize and normalize the probe data into probe set expression values. The list of 
utilized probe sets was defined by custom .ps and .mps files designed to include all core 
probes and all probes targeting miRNA transcripts. The RMA procedure used included 
the options adjusted for GC content, probe sequence, RMA background correction, 
Quantile Normalization and median polish probe set summarization. Expression values 
for probesets were summarized to a single value per gene based on the same custom 
.mps file mentioned above using the outlier excluded mean method. This procedure 
excludes probe set values that are more than 3 standard deviations above the mean or 
more and 2 standard deviations below the mean. The log fold change (LFC) value for 
WT/Dcr_null was defined as the difference between the mean expression in Dicer WT 
mESCs (Dcr_WT) and the mean expression in Dicer null mESCs (Dcr_null). 
TargetScan predictions and controls 
TargetScan predictions were downloaded from TargetScanMouse 5.1 website 
(http://www.targetscan.org/mmu_50/). To identify predicted targets, we looked at all 
miRNAs that contain AAGUGC in their 2-8nt region, such that their 7mer or 8mer seed 
matches contain GCACUU. More specifically, they include TargetScan5.1 predictions 
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for: “miR-17-5p/20/93.mr/106/519.d”, “miR-291b-3p/519a/519b-3p/519c-3p”, “miR-290-
3p/292-3p/467a”, “miR-467cd”, “miR-106/302”, “miR-21/590-5p”, “miR-105.m”, and “miR-
467b”. We excluded all the targets of “miR-302ac/520f”, as well as T1A 7mer targets of 
“miR-17-5p/20/93.mr/106/519.d”, and “miR-467b”, as they do not contain GCACUU in 
the seed match. Targets were sorted first by their branch length, then by their context 
scores. The top-ranked TargetScan 5.1 “Conserved predicted targets” were picked from 
the sorted target list, such that their expression profile also matched the Dicer WT 
expression profile of CLIP 3’ UTR hits. Control mRNAs sets for Fig. 2A, B, G lacked 
GCACUU motif in 3’UTR but matched to CLIP in expression profile, dinucleotide 
composition, and 3’UTR length. G-motif control mRNAs for Fig. 2H are matched for CG 
content, 3’ UTR length, and WT expression of G-motif CLIP mRNAs. CCAGCC control 
mRNAs for Fig. 2H are matched for dinucleotide compositionand do not have GCACUU 
in 3’UTR or CDS. 
Target statistics 
Ago2-CLIP 3’UTR GCACUU-motif overlap set mapped to 44 genes that passed 
the normalization and overlap filters. One gene was not considered because it did not 
pass the microarray signal threshold. 36 of them have predicted binding sites according 
to TargetScan 5.1. 6 targets are not predicted by TargetScan 5.1 because their 3’UTRs 
are not deposited in the database, and 1 was not predicted by TargetScan 5.1 because 
of their differences in alternative 3’ UTR annotation. Ago2-CLIP 3’UTR GCACUU-motif 
All set mapped to 208 genes that passed the normalization filter in at least one WT 
library. Seven genes were not considered because they did not pass the microarray 
signal threshold. 185 of them have predicted binding sites according to TargetScan. 11 
targets were not predicted by TargetScan 5.1 because their 3’UTRs were not deposited 
in the database, and 5 were not predicted because of differences in alternative 3’UTR 
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annotation.  
In terms of clusters, 5 overlap with the 201 top-ranked conserved predicted 
targets. In addition, 1 overlaps with the 43 top-ranked Conserved predicted targets. If we 
look at top 10% TargetScan targets, 50 out of 201, and 5 out of 43 overlap.  
4662 mRNAs were predicted targets of miRNA seed AAGUGC by TargetScan, of 
which 1469 mRNAs have the same expression profile as the Ago2-CLIP overlap set and 
the all set.  
Ago2-CLIP CDS GCACUU-motif All gene set mapped to 116 genes that passed 
the normalization filter in at least one wild-type library and microarray signal threshold. 
13 genes were excluded because they did not pass the microarray signal threshold. An 
addition 23 genes were excluded because they contained GCACUU hexamer in their 
3’UTR. To test whether the expression of CLIP mRNAs are upregulated in Dicer null 
mESCs, we compared their expression to the expression of 1409 genes that contain the 
GCACUU-motif in the CDS (and not the 3’UTR), and had a matched expression profile 
to the Ago2-CLIP CDS set.  
Statistical analyses 
All test statistics for Figure 2 were calculated using R (http://www.r-project.org). 
The Wilcoxon rank sum test was used because it does not assume normality of the 
underlying distributions. T-tests and Kolmogorov–Smirnov (KS) test using these data 
gave generally similar results.  
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Figures 
 
Figure 1A: Association of radio-labeled species with Ago2 in Dicer WT and Dicer 
null mESCs with and without cross-linking 
Autoradiograph of Ago2-complex in Dicer null (-), WT (+) cells and WT cells without UV 
crosslinking. Bracketed area indicates the region of the blot that was excised and analyzed. 
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Figure 1B: Mapping of Ago2-CLIP reads 
Reads >= 15nt in length obtained after the linker stripping step (see Methods) were mapped to the 
mouse genome (mm9) with the Bowtie short read alignment tool(Langmead et al. 2009), to 
miRNA annotations from miRbase (release 14), and to non-coding RNA annotations (from 
fRNADB, Genomic tRNA Database, and Rfam). 98% of the ncRNA population is from reads that 
align with more than one location in the genome (repeat class). A major fraction of the ncRNA 
population mapped to snoRNA annotations and Argonaute association with snoRNA was 
previously reported (Ender et al. 2008). Reads that uniquely matched the genome with 0, 1, or 2 
mismatches were further categorized by genic regions. 
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Figure 1C: miRNA distribution by seed family in Ago2-CLIP 
Pie chart of miRNA seed distribution in Ago2_WT1A. Those hexamers that represented <1% of 
the population were consolidated into “Others”. 
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Figure 1D: miRNA correlation 
Log plot of mature miRNA cloning frequency in the WT1A Ago2-CLIP library vs. whole cell 
miRNA from Dicer wild-type mESCs (Pearson coefficient r = 0.63; Spearman coefficient ρ = 
0.86).  
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Figure 1E: Data processing pipeline 
Data processing pipeline: Pre-processing for length sequence length requirement and linker 
matching and mapping to the mouse genome. Clustering Filter: reads with the same exact 
genomic alignment were collapsed to a single distinct genomic alignment and reads that 
overlapped were joined into clusters, 25nt flanking regions were added to either side of the cluster 
and those with only 1 read were discarded. Normalization Filter: An in silico CLIP dataset was 
simulated based on gene expression analysis of Dicer wild-type mESCs using Affymetrix exon 
microarrays and mouse 3’UTR annotations. CLIP clusters containing more reads than the 
background from the in silico CLIP simulations (p< 0.01) were selected. Multi-Library Filter: 
Normalized clusters that overlapped by at least 1 nucleotide with another normalized cluster from 
a wild-type biological replicate library were selected. Knockout filter: Wild-type clusters that had 
overlaps with normalized clusters from either one of the Dicer null mESC libraries were 
discarded (see methods for more details). 
Chapter 3: Genome wide identification of Ago2 binding sites in mESCs 
 123 
 
Figure 1F: Motif enrichment in Ago2-CLIP 3’UTR clusters in Dicer wild-type and 
Dicer null mESCs  
Sequence logos and statistics of the top three enriched motifs derived from motif analysis of 
Ago2-CLIP 3’UTR-mapping clusters using the motif tool MEME (see Methods for details). The 
number of sites containing each motif out of the number of clusters examined is as indicated. In 
the heatmap, red indicates significant enrichment (E < 1e-5 cutoff) and blue indicates not 
enriched in either the WT or KO libraries. The G-rich motif (far left) was enriched in all libraries 
analyzed, and the representative consensus sequence was taken from MEME analysis on 
Normalized KO1 clusters that had overlaps with clusters from any Normalized WT library. The 
GCACU[UG] motif (middle) and CC[AG]GCC (far right) were enriched in only the clusters that 
passed all 4 filters in the wild-type libraries and not in the Ago2-CLIP 3’UTR clusters from any 
Normalized KO library. There were 48 instances of GCACUU and 31 instances of GCACUG.  
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Figure 1G: Enrichment of seed-match hexamers in clusters from WT CLIP library 
Scatter plot of the hexamers in Normalized CLIP clusters from WT1A that have miRNA seed 
matches. On the Y-axis is the –log p-value of enrichment of the hexamer. On the X-axis is 
fraction of the CLIP miRNA population (WT1A) that the corresponding hexamer seed represents.  
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Figure 1H: Enrichment of hexamers in Ago2-CLIP 3’UTR-clusters from a 
representative individual Dicer wild-type and Dicer null libraries 
Hexamer enrichment analysis by statistical overrepresentation within individual libraries, using 
an enumerative approach (see Methods). Two measures of significance are plotted: The X axis 
shows the z-score, which is a measure of the number of standard deviations the observed 
frequency of a hexamer exceeds its expectation. The Y axis is the negative log10 p-value (two-
sided Fisher’s exact test) of the hexamer enrichment above background. All hexamers with a false 
discovery rate (FDR) ≥ 0.5% are in brown and not considered as enriched. Enriched hexamers 
(FDR < 0.5%) are classified into two types: G-rich (≥3Gs, red) and non-G-rich (blue). G-rich 
hexamers are enriched in both WT and KO libraries, but GCACUU (black dots) and CCAGCC 
(black circle) are only enriched in WT. Note the change in scale for the far right plot. 
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Figure 1I: Hexamer enrichment in KO-filtered 3’UTR clusters and CDS from 
individual WT Ago2-CLIP libraries 
Hexamer enrichment by statistical overrepresentation was performed using an enumerative 
approach (see Methods). Two measures of significance are plotted: The X axis shows the z-score, 
which is a measure of the number of standard deviations by which the observed frequency of a 
hexamer exceeds its expectation. The Y axis is the –log10 p-value (two sided Fisher’s exact test) 
of the hexamer enrichment above background. All hexamers with False Discovery Rate FDR ≥ 
0.5% are in brown and not considered as enriched. Enriched hexamers (FDR < 0.5%) are 
classified into two types, G-rich (≥3Gs, red) and non-G-rich (blue) Individual WT library plots 
for Knockout-filtered clusters from 3’UTR (top) and CDS (bottom) are shown.  
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Figure 1J: Hexamer enrichment in 3’UTR and CDS clusters from individual KO 
Ago2-CLP libraries that overlap with WT libraries 
Hexamer enrichment by statistical overrepresentation was performed using an enumerative 
approach (see Methods). Two measures of significance are plotted: The X axis shows the z-score, 
which is a measure of the number of standard deviations by which the observed frequency of a 
hexamer exceeds its expectation. The Y axis is the –log10 p-value (two sided Fisher’s exact test) 
of the hexamer enrichment above background. All hexamers with False Discovery Rate FDR ≥ 
0.5% are in brown and not considered as enriched. Enriched hexamers (FDR < 0.5%) are 
classified into two types, G-rich (≥3Gs, red) and non-G-rich (blue). Individual KO library plots 
for Normalized 3’UTR (top) and CDS (bottom) clusters that had overlaps with clusters from any 
WT library. Note that GCACUU is not enriched in either KO library. A large number of G-rich 
hexamers are highly enriched in KO libraries.  
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Library Normalization Multi-Library 
WT1A 77.9 87.2 
WT1B 77.5 88.9 
WT2 81.3 87.3 
KO1 86.4 88.0 
KO2 88.7 91.7 
 
 
Table 1 and 2: Summary of motif enrichment in 3’UTR and CDS-mapping clusters 
Upper table (1): Shown are p-values (computed by Fisher’s exact test) of the enrichment for the 
GCACUU hexamer with False Discovery Rate (FDR) < 0.5% in 3’UTR and CDS-mapping 
clusters that passed Normalization, Multi-library, and Knockout filters in each WT library. Lower 
table (2): Percent of total 3’UTR clusters per library from sets that passed the indicated filters and 
contain a high-scoring G-motif instance matching the G-motif shown in Fig. 1F (match score > 
360.88 using MAST). 
Library 3' UTR CDS 
WT1A 2.84E-10 8.44E-05 
WT1B 2.82E-06 5.67E-05 
WT2 1.54E-06 2.00E-05 
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Figure 2A: miRNA-dependent gene expression changes of Ago2-CLIP 3’UTR 
GCACUU-motif overlap set and TargetScan GCACUU predicted targets 
CDFs (cumulative density functions) of the log2 fold change (LFC) in mRNA expression 
between the wild-type (WT) and Dicer null (KO) mESCs. Fold change is ratio of expression level 
in WT cells to expression level in KO cells, such that a more negative CDF indicates that the 
distribution has higher aggregate mRNA expression in Dicer null mESCs (i.e. after miRNA loss) 
than in Dicer wild-type mESCs. Gene sets include CLIP 3’ UTR GCACUU-motif mRNAs that 
passed Normalization and Multi-library filter (CLIP “Overlap”-green line), Conserved predicted 
expression-matched TargetScan GCACUU targets (dark pink), All predicted expression-matched 
TargetScan GCACUU targets (light pink), and control mRNAs (grey). Conserved TargetScan 
predicted targets contains the Top 43 ranked (by branch length, then by context score) mRNAs 
predicted from TargetScan for GCACUU seed matches. All TargetScan predicted targets contains 
1469 mRNAs predicted by TargetScan for GCACUU seed matches. Both predicted sets were 
selected to have an expression distribution that matches to that of CLIP mRNAs in WT mESCs. 
The control mRNA set was selected to match the predicted targets 3’UTR length, dinucleotide 
composition, and mRNA expression level in WT mESCs.  The mean LFC of CLIP mRNAs not 
significantly different than that of the conserved TargetScan predicted class (p=0.663 by rank 
sum test). However, the mean LFC of CLIP mRNAs is significantly more negative than that of all 
TargetScan predicted class, as well as the control (p = 3.0e-3 and p = 1.07e-6 by rank sum test, 
respectively).  
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Figure 2B: miRNA-dependent gene expression changes of Ago2-CLIP 3’UTR 
GCACUU-motif All set and TargetScan GCACUU predicted targets 
CDFs (cumulative density functions) of the log2 fold change (LFC) in mRNA expression 
between the wild-type (WT) and Dicer null (KO) mESCs. Fold change is ratio of expression level 
in WT cells to expression level in KO cells, such that a more negative CDF indicates that the 
distribution has higher aggregate mRNA expression in Dicer null mESCs (i.e. after miRNA loss) 
than in Dicer wild-type mESCs. Gene sets include CLIP 3’ UTR GCACUU-motif mRNAs that 
passed the Normalization filter in at least one WT library (CLIP “All”-green line), Predicted 
conserved expression-matched TargetScan GCACUU predictions (dark pink), All predicted 
expression-matched TargetScan GCACUU predictions (light pink), and control mRNAs (grey). 
Conserved TargetScan predicted set contains the top 201 ranked (by branch length i.e. 
conservation, then by context score) mRNAs predicted from TargetScan for GCACUU seed 
matches. All TargetScan predicted contains 1469 mRNA targets predicted by TargetScan for 
GCACUU seed matches. Predicted sets have expression distribution also matched to that of CLIP 
mRNAs in WT ES cells. The control mRNA set was selected to match the predicted targets in 
3’UTR length, dinucleotide composition, and mRNA expression level in WT ES cells.  The mean 
LFC of CLIP mRNAs is significantly less negative than that of the Conserved TargetScan 
predicted class (p = 3.3e-4 by rank sum test). However, the mean LFC of CLIP mRNAs is 
significantly more negative than that of all TargetScan predicted class as well as the control (p = 
3.53e-5 and p < 2.2e-16, respectively, by rank sum test).  
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Figure 2C, D: Expression of Ago2-CLIP mRNAs and TargetScan predicted targets 
in Dicer wild-type mESCs 
C) Distribution of expression of Ago2-CLIP 3’ UTR GCACUU-motif genes that passed 
Normalization and Multi-library filter (CLIP “Overlap”, green), the top (201) TargetScan 
GCACUU predicted targets ranked by branch length, than by context score (Conserved predicted, 
dark pink), and All TargetScan GCACUU predicted targets (ALL predicted, light pink) in Dicer 
wild-type (WT) mESCs. (D) Distribution of expression of Ago2-CLIP 3’ UTR GCACUU-motif 
genes that passed Normalization filter in any WT library (CLIP “All”, green), the top (43) 
TargetScan GCACUU predicted targets ranked by branch length, than by context score 
(Conserved predicted, dark pink), and All TargetScan GCACUU predicted targets (ALL 
predicted, light pink) in Dicer wild-type (WT) mESCs. 
CLIP 
Conserved 
All 
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Figure 2E: Distribution of conservation and context scores of Ago2-CLIP overlap 
gene set and TargetScan predicted targets 
The average conservation scores (i.e. branch length) and context scores from TargetScan 5.1 were 
determined for the following gene sets: Ago2-CLIP 3’UTR GCACUU-motif Overlap gene set  
(CLIP) (contains 36 out of 43 genes) that passed the Normalization and Multi-library filters, and 
mapped to sites predicted by TargetScan. The remaining genes either were not in the TargetScan 
database or TargetScan used a non-overlapping alternative 3’UTR. “Conserved predicted targets” 
contains the top 43 mRNAs ranked by conservation score, than by context score predicted by 
TargetScan for GCACUU seed matches. “All predicted targets” contains all the mRNA targets 
predicted by TargetScan. Both predicted sets are matched to CLIP set in expression of genes in 
Dicer WT mESCs. 
 
The average conservation score of CLIP mRNAs is significantly lower than conserved predicted 
targets (p =3.6e-13 by rank sum test), by approximately 1.9 (median = 0.92 vs. 2.87). However, 
the average conservation score of CLIP mRNAs is significantly higer than all predicted targets (p 
= 3.0e-2 by rank sum test), by approximately 0.79 (median = 0.92 vs. 0.13). The context scores of 
CLIP mRNAs are significantly less negative than conserved predicted targets (p = 2.8e-8 by rank 
sum test), by approximately 0.20 (median = -0.16 vs. -0.36). However, the context scores of CLIP 
mRNAs are not significantly different from the all predicted targets (p = 0.41 by rank sum test, 
median = -0.16 vs. -0.19). 
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Figure 2F: Distribution of conservation and context scores of Ago2-CLIP All gene 
set and TargetScan predicted targets 
The average conservation scores (i.e. branch length) and context scores from TargetScan 5.1 were 
determined for the following gene sets: Ago2-CLIP 3’UTR GCACUU-motif All gene set (CLIP) 
(containing 186 out of 201 genes) that passed the Normalization filter in at least one WT library 
and that were mapped to sites predicted by TargetScan. The remaining genes either were not in 
the TargetScan database or TargetScan used a non-overlapping alternative 3’UTR. “Conserved 
predicted targets” contains the top 201 mRNAs ranked by conservation score, then by context 
score predicted from TargetScan for GCACUU seed matches, whose expression distribution 
matches to that of CLIP mRNAs in WT ES cells. “All predicted targets” contains all the mRNA 
targets predicted by TargetScan for GCACUU seed matches, whose expression distribution 
matches to that of CLIP mRNAs in WT ES cells.  
 
The conservation score of CLIP mRNAs is significantly smaller than the conserved predicted 
targets (p < 2.2e-16 by rank sum test), by about 1.1 (median = 0.53 vs. 1.67). However, the 
conservation score of CLIP mRNAs is significantly higher than All predicted targets (p = 2.1e-4 
by rank sum test), by approximately 0.40 (median = 0.53 vs. 0.13). The context scores of CLIP 
mRNAs are significantly less negative than conserved predicted targets (p < 2.2e-16 by rank sum 
test), by about 0.15 (median = -0.20 vs. -0.35). However, the context score of CLIP mRNAs is 
significantly more negative than all predicted targets  (p = 4.9e-2 by rank sum test), by 
approximately 0.01 (median = -0.20 vs. -0.19).  
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Figure 2G: miRNA-dependent gene expression changes of Ago2-CLIP CDS 
GCACUU-motif All set and GCACUU predicted targets 
CDFs (cumulative distribution functions) of log2 fold change (LFC) in mRNA expression 
between the wild type (WT) and Dicer null mESCs are plotted. Gene sets include: Ago2-CLIP 
CDS GCACUU-containing mRNAs that passed the Normalization filter in any WT library 
(“CLIP”, green), “Predicted” GCACUU-containing CDS mRNAs (pink) that were expression-
matched to the “CLIP” set but lacked GCACUU in their 3’UTRs, and matched “control” mRNAs 
(grey). Predicted CDS target set contains 1012 mRNAs that have GCACUU in their coding 
regions, and whose expression matches CLIP CDS target mRNA expression level in WT ES 
cells. The control mRNA set was sampled to match the predicted targets in dinucleotide 
composition and mRNA expression level in WT ES cells. mRNAs that have GCACUU target 
sites in their 3’ UTRs have been removed from the CLIP, Predicted, and control sets. Repression 
of CLIP mRNAs is significantly more than that of the control, but not significantly more that the 
repression of the Predicted mRNAs (p = 7.28e-5 and p = 0.11 by rank sum test, respectively). 
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Figure 2H: miRNA-dependent gene expression changes of Ago2-CLIP 3’UTR 
CCAGCC and G-motif genes 
CDFs (cumulative density functions) of the log2 fold change (LFC) in mRNA expression between 
the wild-type (WT) and Dicer null (KO) mESCs. Gene sets include: Ago2-CLIP 3’ UTR 
GCACUU-containing (green) and G-motif-containing mRNAs (orange) that passed the 
Normalization and Multi-Library filters in WT libraries, Ago2-CLIP 3’UTR CCAGCC-
containing mRNAs (blue) that passed the Normalization filter in at least one WT library, and 
corresponding matched controls (grey). Any mRNAs with GCACUU in the 3’UTR or CDS were 
removed from the “G-motif” and “CCAGCC” sets. G-motif control mRNAs are matched for CG 
content, UTR length, and WT expression of G-motif CLIP mRNAs (light grey). CCAGCC 
control matched for dinucleotide content and gene expression. LFC of CLIP G-motif mRNAs is 
significantly more negative than G-motif control upon loss of miRNA expression, but not 
significantly different from CLIP mRNAs (p= 2.0e-9, p=0.052, respectively by rank sum test). 
LFC CCAGCC mRNAs is significantly lower than CCAGCC control, and not significantly 
different CLIP G-motif (p = 0.039, p=0.080, respectively by rank sum test).
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Figure 3A: Ago2-CLIP 3’UTR GCACUU-motif cluster confers miRNA-dependent 
repression on a luciferase reporter gene. 
Exemplary luciferase reporter assay testing Renilla luciferase transgenes bearing Slc31a1 Ago2-
CLIP 3’UTR cluster plus 25nt flanking regions in the 3’UTR. All raw Renilla luciferase values 
are normalized first to values from Firefly luciferase transfection control. Shown are box plots for 
the ratio of the expression level of a luciferase reporter containing a wild-type Slc31a1 CLIP 
cluster in its 3’UTR to an identical luciferase reporter where the GCACUU seed was mutated to 
CCUCAU. This ratio is defined as “WT/Seed Mutant Activity” and calculated in three different 
cellular states: Dicer null mESCs (black), Dicer wild-type mESCs (white), and Dicer null mESCs 
transfected with miR-295 mimic (grey).  
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Figure 3B: Ago2-CLIP 3'UTR GCACUU-motif clusters confer regulation on 
luciferase reporters 
Box plots of relative activity of Renilla luciferase transgenes bearing 3’UTR CLIP clusters plus 
25nt flanking regions in the 3’UTR in Dicer WT mESCs (dark green) and Dicer null mESCs 
transfected with miR-295 mimic (light green). All raw Renilla luciferase values are normalized 
first to values from Firefly luciferase transfection control. “Relative Luciferase Activity” is 
defined as “WT/Seed Mutant Activity” in specific cellular state normalized to the corresponding 
value in Dicer null mESCs. Genes that passed both the Normalization and Multi-library filters 
(i.e. “Overlap” set) are marked with an asterisk. All remaining genes passed the Normalization 
filter in one WT library. All box plots are from at least 3 independent experiments. Relative 
Luciferase Activity is significantly less than one in all genes examined (p<0.05, two-tailed paired 
t-test). 
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Figure 3C: Ago2-CLIP CDS GCACUU-motif clusters confer regulation on luciferase 
reporters 
Box plots of relative activity of Renilla luciferase transgenes bearing CDS CLIP clusters plus 
25nt flanking regions in the 3’UTR in Dicer WT mESCs (dark green) and Dicer null mESCs 
transfected with miR-295 mimic (light green). All raw Renilla luciferase values are normalized 
first to values from Firefly luciferase transfection control. “Relative Luciferase Activity” is 
defined as “WT/Seed Mutant Activity” in specific cellular state normalized to the corresponding 
value in Dicer null mESCs. Genes that passed both the Normalization and Multi-library filters 
(i.e. “Overlap” set) are marked with an asterisk. All remaining genes passed the Normalization 
filter in one WT library. All box plots are from at least 3 independent experiments. Herc1 and 
Eif2c2 each have two GCACUU motifs. Relative luciferase activity is significantly less than one 
for all genes examined except Tnrc6a (p<0.05, two-tailed paired t-test).
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Figure 4A: Endogenous protein levels of miR-290 seed family targets are 
repressed in mESCs 
Western blot of GCACUU-motif targets, Txnip and p21(CDKN1A), tubulin (loading control), 
and Dicer (genotype control) in Dicer wild-type mESCs (WT) and Dicer null mESCs (KO) (left 
panel), and Dicer null mESCs transfected with miR-295 mimic at different concentrations (nM), 
0 (control), 10, 100 , (right panel). 
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Figure 4B: Txnip cluster 
Genomic schematic of Txnip 3’UTR. The following features are depicted: the cluster sequence 
(thick black bar) with flanking regions (thin black bar), highest-scoring 8mer G-motif in the 
cluster (green bar), TargetScan 5.1(Friedman et al. 2009) predicted miR-290 family GCACUU 
binding site (purple), PITA(Kertesz et al. 2007) predicted miR-290 family GCACUU binding site 
(green-blue), UCSC genome browser Mammalian Multiz alignment and conservation(Blanchette 
et al. 2004; Siepel et al. 2005) (blue, heights indicate degree of conservation at aligned position). 
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Figure 4C: G-motif in Txnip 3’UTR cluster modulates repression by GCACUU seed 
site 
Luciferase reporter constructs were created as in Fig. 3, using an Ago2-CLIP cluster, plus 25nt 
flanking regions, from the Txnip 3’UTR.  Along with the GCACUU seed mutant construct, a G-
motif mutant construct with all the Gs in the G-motif changed to Cs as well as a construct with 
both the seed and G motif mutated were created. The presence or absence of an intact GCACUU 
seed match or G-motif in the construct is indicated by + (WT) or - (mutated). Relative Luciferase 
Activity was calculated similarly as in Fig. 3 as the expression level of each indicated construct 
relative to the seed(-) G-motif(-) double mutant construct in either Dicer wild-type mESCs (WT) 
(left, white) or Dicer null mESCs transfected with miR-295 mimic (right, black), normalized to 
the same ratio in Dicer null mESCs (KO).  Values shown are averages of three independent 
experiments and p-values < 0.05 deemed significant and marked as asterisk. 
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Figure 4D, E: G-motifs in Ei24 3’UTR cluster modulate repression by GCACUU 
seed site 
(D) Genomic schematic of Ei24 3’UTR cluster. The following features are depicted: the cluster 
sequence (thick black bar) with flanking regions (thin black bar), 8mer G-motifs in the cluster 
(green bar, G motif mutated is indicated by the pink circle, p-value = 0.03), TargetScan 5.13-
predicted miR-290 family GCACUU binding site (purple), and UCSC genome browser 30-way 
mammalian Multiz alignment and conservation4,5 (blue, heights indicate degree of conservation 
at aligned position). (E) Luciferase assay of a reporter transgene bearing the Ei24 cluster with 
25nt flanking regions in its 3’UTR. Four versions of reporter construct were created, wild-type 
GCACUU (seed) motif (+) and wild-type G motif (+), wild-type GCACUU motif (+) and G-
motif mutated Gs to Cs (-), GCACUU motif mutated to CCUCAU(-) and wild-type G-motif (+), 
and the double mutant GCACUU motif mutated to CCUCAU (-) and G-motif mutated Gs to Cs (-
). Shown is expression of each construct relative to the double mutant seed motif (-) and G-motif 
(-) in Dicer wild-type mESCs (WT) (white) and Dicer null mESCs transfected with miR-295 
mimic (KO+miR295; black) normalized to the same ratio in Dicer null mESCs (KO). The 
difference between relative activity of wild-type construct (seed +, G-motif +) and wild-type 
seed, mutant G-motif (seed +, G-motif -) for WT and KO+miR-295 is significant (p<0.05, paired 
two-tailed t-test; marked as asterisks). 
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Figure 4F: G-motif sequences exhibit excess conservation 
Average phastCons score was determined for each G-motif (match score > 0, data for Normalized 
Ago2-WT1A shown in black) along with a background set of random 8mers drawn from 
annotated mouse 3’UTRs (grey) (see Methods). On the X axis are bins for phastCons score 
cutoffs, ≥0.25, ≥0.50, ≥0.75. On the Y axis is the percentage of total G-motifs or random 8mers 
that are in each phastCons score cutoff bin. Ago2-CLIP G-motifs are on average more conserved 
than random 8mers (p < 0.005, Fisher’s exact test). 
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Figure 4G: G-motif positional conservation 
Meta-G-motif conservation analysis of Ago2-CLIP 3’UTR G-motifs (GGG[GA][AU]GGG) and 
10nt flanking sequences from indicated filtered libraries that matched with a score >0 to the G-
motif log odds matrix (using MAST, see Methods). The G-motif hit with the highest MAST score 
was allowed per cluster. The X axis shows nucleotide position centered around the G-motif with 
10nt flanks on either side. The Y axis is the average positional phastCons score (see Methods) for 
those G-motifs and background 8mers examined. Background conservation is from three 
replicates of 12,000 8mers ± 10nt flanks randomly chosen from annotated mouse 3’UTRs (UCSC 
genome browser). G-motifs examined are from 3’UTR clusters from the individual library and 
data-processing filter indicated.
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WT1A All G-motif clusters 
Non-GCACUU G-motif 
clusters 
Conservation Hits p-value Hits p-value 
≥ 0.25 651 1.24E-04 590 4.26E-04 
≥ 0.50 524 1.54E-05 476 4.85E-05 
≥ 0.75 408 2.29E-03 366 1.02E-02 
Total 1506  1373  
 
  
 
Table 3: Excess G-motif conservation is independent of co-occurrence of 
GCACUU motif in the same cluster 
G-motif conservation of clusters with and without GCACUU hexamer. PhastCons scores were 
averaged across individual positions of each G-motif instance (MAST match score > 0, the top-
scoring G-motif per cluster) in all clusters from the Normalized WT1A library. These G-motif 
instances were binned by average phastCons score with the indicated cut-offs (first column). The 
“Hits” column indicates the number of G-motif instances in the given scoring bin. The “p-value” 
indicates the significance of the enrichment of G-motifs in the indicated bin over the expected 
background (see Methods).   
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Figure 4H: Significantly enriched G-rich 15mer in Ago2-CLIP 3’UTR clusters 
MEME motif analysis of Ago2-CLIP 3’UTR clusters from KO1 that had overlaps with any 
cluster from a Normalized WT library. Represented is the only significantly enriched 15mer, (E 
value=1.7e-588, in 749 out of 815 sequences). Independent analysis of 4mer, 5mer, and 8mer 
subsequences was also performed using a statistical overrepresentation by enumeration approach 
(see Methods). Lines indicate mapping onto the 15mer of exemplary enriched 4mers (blue, Top 4 
enriched 4mers, p < e-10, GAGG, GGGA, TGGG, GGGG), 5mers (red, Top 4 enriched 5mers, p 
< e-10n GAGGG, GGTGG, TGGGG, GTGGG), and 8mers (black, Top 4 enriched 8mers, p < 5e-
6, TGTGTGTG, GGTGGGGA, GGGAAGGA, GAGGGAGG). 
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Figure 4I: Positional bias of G-motif in Ago2-CLIP 3’UTR clusters 
Histogram of 8mer G-motif (MAST match score > 0, the top-scoring G-motif per cluster) start 
sites from Ago2-CLIP 3’UTR clusters that passed the Normalization filter in WT1A. X-axis 
coordinates 1 to 80 represent the nucleotide positions of the cluster plus flanking sequences in 5’ 
to 3’direction from left to right: 1-25, 5’flanking region; 26-55, cluster sequence normalized to 
30nt; 56-80, 3’ flanking region. The Y axis is the number of clusters with a G-motif starting at the 
indicated position. 
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Figure 4J: No positional bias for GCACUU-motif relative to G-motif in Ago2-CLIP 
3’UTR clusters 
Radar plot of 8mer G-motif (blue; MAST match score > 0, at most one top-scoring G-motif per 
cluster) and GCACUU-motif (red) start sites from Ago2-CLIP 3’UTR clusters that pass the 
Normalization filter in WT1A. 80 nucleotides of the cluster plus flanking regions (as in Fig. 4I) 
are represented 5’ to 3’ in the clockwise direction:1-25 nucleotides represent the 5’ flanking 
region, 26-55nt represents the cluster sequence normalized to 30 nucleotides, 56-80 represents the 
3’ flanking region. Heights are normalized in both sets individually in order to represent the G-
motif and GCACUU-motif on the same plot (see Methods).  
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Category All (Top 50 
pathways)
CLIP (31) Conserved 
Prediction (11)
Cytoskeleton remodeling_TGF, WNT and cytoskeletal remodeling
Cytoskeleton remodeling_Cytoskeleton remodeling
Development_FGFR signaling pathway
Transcription_CREB pathway
Translation _Regulation activity of EIF4F
Development_TGF-beta receptor signaling
Cell cycle_Role of SCF complex in cell cycle regulation
Cell cycle_ESR1 regulation of G1/S transition
Cell cycle_Regulation of G1/S transition (part 1)
Cell cycle_Regulation of G1/S transition (part 2)
Cell cycle_Cell cycle (generic schema)
Cell adhesion_PLAU signaling
Immune response_IFN gamma signaling pathway
Immune response_IFN alpha/beta signaling pathway
Immune response_Oncostatin M signaling via MAPK in human cells
Apoptosis and survival_BAD phosphorylation
Development_PIP3 signaling in cardiac myocytes
Cell adhesion_Chemokines and adhesion
Transcription_Receptor-mediated HIF regulation
Translation _Regulation activity of EIF2
Development_Flt3 signaling
Transcription_Ligand-dependent activation of the ESR1/SP pathway
Regulation of lipid metabolism_Insulin regulation of glycogen metabolism
Development_Angiopoietin - Tie2 signaling
Neurophysiological process_Receptor-mediated axon growth repulsion
Transcription_Androgen Receptor nuclear signaling
Role of alpha-6/beta-4 integrins in carcinoma progression
Development_Thrombopoietin-regulated cell processes
Cytoskeleton remodeling_Fibronectin-binding integrins in cell motility
Development_IGF-1 receptor signaling
Development_Gastrin in cell growth and proliferation
Signal transduction_PTEN pathway
Development_EGFR signaling via small GTPases
Regulation of lipid metabolism_Insulin signaling:generic cascades
Development_HGF signaling pathway
Development_Membrane-bound ESR1: interaction with growth factors signaling
Apoptosis and survival_nAChR in apoptosis inhibition and cell cycle progression
NGF activation of NF-kB
Development_Ligand-independent activation of ESR1 and ESR2
Cell adhesion_Ephrins signaling
DNA damage_Brca1 as a transcription regulator
Immune response_Oncostatin M signaling via MAPK in mouse cells
Cytoskeleton remodeling_FAK signaling
Immune response_Inhibitory action of Lipoxins on pro-inflammatory TNF-alpha signaling
Cell cycle_Role of 14-3-3 proteins in cell cycle regulation
Immune response_CCR5 signaling in macrophages and T lymphocytes
Regulation of degradation of wt-CFTR
Translation_Insulin regulation of translation
G-protein signaling_G-Protein alpha-12 signaling pathway
Development_HGF-dependent inhibition of TGF-beta-induced EMT
Cell cycle_Start of DNA replication in early S phase
Cytokine production by Th17 cells in CF Mouse model
Development_VEGF signaling and activation
Signal transduction_AKT signaling
Immune response_TLR3 and TLR4 induce TICAM1-specific signaling pathway
Development_Cross-talk between VEGF and Angiopoietin 1 signaling pathways
Cholesterol and Sphingolipids transport / Influx to the early endosome in lung (normal and CF)
Transcription_P53 signaling pathway
Apoptosis and survival_Regulation of Apoptosis by Mitochondrial Proteins
Muscle contraction_Regulation of eNOS activity in endothelial cells
TTP metabolism
Mucin expression in CF via IL-6, IL-17 signaling pathways
6.53E-16
2.03E-13
4.30E-12
2.49E-10
2.75E-10
5.41E-10 1.32E-02
4.80E-09 2.49E-02
4.94E-09
7.62E-09
7.99E-09
3.97E-08
9.46E-08
1.12E-07 8.46E-02
2.82E-07
2.89E-07
3.22E-07
3.31E-07
5.62E-07
6.53E-07 3.92E-02
6.53E-07
6.77E-07
7.23E-07 1.21E-02
8.34E-07
8.81E-07
9.62E-07
9.62E-07
9.62E-07
9.62E-07
1.14E-06
1.26E-06
1.29E-06
1.35E-06
1.77E-06
1.88E-06
1.88E-06
2.78E-06
3.53E-06
3.53E-06
3.87E-06
5.32E-06
5.40E-06 1.69E-02
5.80E-06
7.05E-06
7.24E-06
8.51E-06
9.15E-06
9.24E-06
1.10E-05
1.18E-05
1.19E-05 3.15E-03
8.22E-03
1.86E-02
1.86E-02
3.92E-02
4.24E-02
4.24E-02
4.24E-02
5.25E-02
5.25E-02
5.25E-02
6.66E-02
6.66E-02
Chapter 3: Genome wide identification of Ago2 binding sites in mESCs 
 150 
Table 4: Pathway enrichment of CLIP genes, Conserved Predicted targets, and All 
predicted targets 
Pathway enrichment analysis using MetaCore from GeneGo Inc. (see Methods for details) was 
performed on Ago2-CLIP 3’UTR GCACUU-motif genes that passed the Normalization filter in 
at least one WT library (CLIP “All” set from Fig. 2), top-ranked 201 genes (by branch length, 
then by context score) predicted by TargetScan for GCACUU-seed matches (“Conserved 
prediction”), and all genes predicted by TargetScan for GCACUU-seed matches (“All”). The 
TargetScan genes are not expression-matched to the CLIP set but were selected to be above the 
microarray signal threshold from WT mESCs. The CLIP and Conserved TargetScan sets used All 
TargetScan as the background to calculate enrichment. The All TargetScan set used all mouse 
genes as the background to calculate enrichment. The CLIP “All” set has 37 enriched pathways 
(p<10E-2), and the Conserved TargetScan set has 11 enriched pathways (p<3E-2). The top 50 
enriched pathways for All TargetScan are shown. The pathways in common are as indicated. 
Category All (Top 50 
pathways)
CLIP (31) Conserved 
Prediction (11)
Possible pathway of TGF-beta 1-dependent inhibition of CFTR expression
Development_VEGF signaling via VEGFR2 - generic cascades
Regulation of lipid metabolism_Regulation of lipid metabolism via LXR, NF-Y and SREBP
Immune response_IL-1 signaling pathway
Glycolysis and gluconeogenesis p.3 / Human version
Ubiquinone metabolism
Regulation of lipid metabolism_Regulation of acetyl-CoA carboxylase 2 activity in muscle
Transport_RAB1A regulation pathway
Glycolysis and gluconeogenesis p. 2 / Human version
Glycolysis and gluconeogenesis p.3
Regulation of lipid metabolism_Regulation of fatty acid synthase activity in hepatocytes
Immune response_Oncostatin M signaling via JAK-Stat in mouse cells
GTP-XTP metabolism
Transcription_Role of AP-1 in regulation of cellular metabolism
Cytokine production by Th17 cells in CF
dGTP metabolism
Development_EPO-induced MAPK pathway
Neurophysiological process_EphB receptors in dendritic spine morphogenesis and synaptogenesis
Transcription_NF-kB signaling pathway
Development_NOTCH-induced EMT
Development_Notch Signaling Pathway
Neurophysiological process_Circadian rhythm
Immune response_Function of MEF2 in T lymphocytes
Cardiac Hypertrophy_NF-AT signaling in Cardiac Hypertrophy
Cardiac Hypertrophy_Ca(2+)-dependent NF-AT signaling in Cardiac Hypertrophy
Neurophysiological process_Melatonin signaling
Development_Role of HDAC and CaMK in control of skeletal myogenesis
Development_NOTCH1-mediated pathway for NF-KB activity modulation
Development_FGF-family signaling
6.66E-02
6.66E-02
6.66E-02
6.77E-02
8.99E-02
8.99E-02
8.99E-02
8.99E-02
8.99E-02
8.99E-02
8.99E-02
9.42E-02
9.42E-02
9.42E-02
9.42E-02
9.42E-02
9.42E-02
9.42E-02
9.42E-02
2.21E-03
6.77E-03
9.77E-03
9.77E-03
9.96E-03
2.03E-02
2.03E-02
2.42E-02
2.42E-02
2.42E-02
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Figure 5A: Overlap between enriched CLIP and Predicted target pathways 
Shown is a Venn diagram of overlapping pathways between the Conserved TargetScan set, the 
“CLIP All” set, and the Top 50 of the All TargetScan set from Table 4.  “Ago2-CLIP” has 6 
pathways in common with the Top 50 of All TargetScan and just 1 in common with the 
Conserved TargetScan set. Overlapping top pathways are listed. 
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Figure 5B: 3’UTRs of TGF-beta pathway members are repressed by miR-295 
Luciferase assay of reporter transgenes containing the Smad7 or Skil Ago2-CLIP 3’UTR cluster 
plus 25nt flanking in its 3’UTR or containing the Lefty1 or Lefty2 full 3'UTR. Smad7 and Skil 
were found in one Normalized WT library. The Lefty1 cluster containing GCACUU was found in 
the WT2 library. The Lefty2 region containing GCACUU was not found in any library. Shown is 
“Relative Luciferase Activity”, which is the expression of wild-type motif construct relative to 
seed mutant motif construct in Dicer null mESCs transfected with miR-295 mimic, normalized to 
the same ratio in Dicer null mESCs. The box plot for each gene is from 3 independent 
experiments. All constructs exhibit statistically significant repression (p<0.05 two-tailed paired t-
test). 
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Figure 5C: TGF-beta pathway 
Multiple inhibitors of TGF-beta pathway are targeted by miR-290~295 cluster. 
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This chapter is presented in the context of contemporary science and reprinted from 
Cell, 132(5), Ventura A, Young AG, Winslow MM, Lintault L, Meissner A, Erkeland SJ, 
Newman J, Bronson RT, Crowley D, Stone JR, Jaenisch R, Sharp PA, Jacks T, 
Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 
family of miRNA clusters, 875-86, 2008, with permission from Elsevier.  
 
Experimental contributions: 
This work was in collaboration with primary author Andrea Ventura, formerly of the 
laboratory of Dr. Tyler Jacks. Also with contributions from Monte M. Winslow (Tyler 
Jacks’ laboratory), Laura Lintault (formerly of Tyler Jacks’ laboratory), Alex Meissner 
(formerly of Rudolph Jaenisch’s laboratory), Stefan J. Erkeland (formerly of Phillip 
Sharp’s laboratory), Jamie Newman (formerly of Tyler Jacks’ laboratory), Roderick T. 
Bronson (Tufts University), Denise Crowley (Koch Institute Histology Core), James R. 
Stone (Harvard Medical School). 
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Abstract 
miR-17~92, miR-106b~25 and miR-106a~363 belong to a family of highly 
conserved miRNA clusters. Amplification and overexpression of miR-17~92 is observed 
in human cancers, and its oncogenic properties have been confirmed in a mouse model 
of B cell lymphoma. Here we show that mice deficient for miR-17~92 die shortly after 
birth with lung hypoplasia and a ventricular septal defect. The miR-17~92 cluster is also 
essential for B cell development. Absence of miR-17~92 leads to increased levels of the 
pro-apoptotic protein Bim and inhibits B cell development at pro-B to pre-B transition. 
Furthermore, while ablation of miR-106b~25 or miR-106a~363 has no obvious 
phenotypic consequences, compound mutant embryos lacking both miR-106b~25 and 
miR-17~92 die at mid-gestation. These results provide key insights into the physiologic 
functions of this family of microRNAs, and suggest a link between the oncogenic 
properties of miR-17~92 and its functions during B lymphopoiesis and lung 
development. 
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Introduction 
Vertebrate embryonic development is a carefully orchestrated process that 
requires execution of tightly regulated gene expression programs. MicroRNAs (miRNAs) 
constitute a class of small (21-24 nucleotide) non-coding RNAs that reduce translation 
and stability of target mRNAs through sequence-specific interaction with their 3’-
untranslated region (Bartel et al. 2004; Bagga et al. 2005; Lim et al. 2005). It is 
becoming increasingly clear that miRNAs play a crucial role in vertebrate development, 
as attested by the early embryonic lethality of mice with defects in the miRNA biogenesis 
pathway (Bernstein et al. 2003; Liu et al. 2004; Abbott et al. 2005). MicroRNAs could act 
either by regulating a specific set of critical developmental genes or by reinforcing gene-
expression programs through suppression of transcriptional noise (Bartel et al. 2004; 
Yekta et al. 2004; Hornstein et al. 2006). 
A close link exists between deregulation of developmental programs and 
tumorigenesis, and a growing body of evidence indicates that altered expression of 
miRNAs is involved in the pathogenesis of human cancers (Croce et al. 2005; Johnson 
et al. 2005; Lu et al. 2005; Costinean et al. 2006; Esquela-Kerscher et al. 2006; 
Hammond 2006; Voorhoeve et al. 2006; Kumar et al. 2007; Mayr et al. 2007). In this 
context, studies in mouse and human cells have led to the identification of the miR-
17~92 cluster (also known as Oncomir-1) as a potential oncogene. It consists of six 
miRNAs that are processed from a common precursor transcript and can be grouped in 
four families based on their “seed” sequence (Fig. 1A, B). A role for miR-17~92 in the 
pathogenesis of human cancers is suggested by its frequent amplification and 
overexpression in diffuse large B cell lymphomas (Ota et al. 2004) and in other tumor 
types, including small cell lung cancer (Hayashita et al. 2005; Matsubara et al. 2007). 
Additionally, miR-17~92 has been shown to cooperate with c-Myc in a mouse model of B 
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cell lymphoma (He et al. 2005) and to stimulate proliferation of the lung epithelium (Lu et 
al. 2007). Further evidence indicates that miR-17~92 can also affect tumor angiogenesis 
(Dews et al. 2006) and the expression of members of the E2F family of oncogenic 
transcription factors (O'Donnell et al. 2005; Sylvestre et al. 2007; Woods et al. 2007). 
Very little is known, however, regarding the physiologic functions of this cluster in 
vertebrates.  
 The functional analysis of miR-17~92 is complicated by the existence of two 
paralogs: miR-106a~363 and miR-106b~25. It appears likely that the three clusters 
originated via a series of duplication and deletion events during early vertebrate 
evolution (Tanzer et al. 2004). The miR-106a~363 locus maps to chromosome X in 
humans and mice and consists of six miRNAs (Fig. 1A). The miR-106b~25 cluster is 
located on mouse chromosome 5 (chromosome 7 in humans) in the 13th intron of the 
DNA replication gene Mcm7 and consists of three miRNAs (Fig. 1A). Because miR-
106a~363 and miR-106b~25 contain miRNAs that are highly similar, and in some cases 
identical, to those encoded by miR-17~92 (Fig. 1B), it is possible that they regulate a 
similar set of genes and have overlapping functions. Here we report the generation and 
initial characterization of mice deficient for each of these three miRNA clusters. 
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Results 
Expression pattern of miR-17~92 and its two paralogs 
To determine the expression patterns of the miR-17~92, miR-106b~25 and miR-
106a~363 clusters we performed RNase protection assays (RPA) in a panel of murine 
tissues and cells. This technique was preferred to Northern blots because it has higher 
sensitivity and is capable of discriminating between similar miRNAs (Fig. 1C). These 
experiments revealed that members of the miR-17~92 and miR-106b~25 clusters have 
similar expression pattern in the adult mouse, being detectable in most tissues (Fig. 1C). 
In contrast, we have not been able to detect expression of members of the miR-
106a~363 cluster in the tissue tested (Fig. 1C). Expression of members of this cluster 
was undetectable by RPA even in murine embryonic stem (ES) cells where miR-17~92 
and miR-106b~25 are abundantly expressed (Fig. 1C). 
Generation and characterization of miR-106b~25 deficient mice 
The miR-106b~25 cluster is located in the 13th intron of the protein coding gene 
Mcm7. To reduce the risk of interfering with transcription and processing of the 
surrounding gene, the targeting construct was designed to replace the miR-106b~25 
cluster with a neomycin-resistance (Neo) cassette flanked by frt sites (miR-106b~25Δneo) 
(Fig. 2A). This strategy allowed the subsequent removal of the Neo cassette by crossing 
the chimeric animals to flpe-expressing transgenic mice (Rodriguez et al. 2000), thus 
generating the miR-106b~25Δ allele (Fig. 2A). MiR-106b~25+/Δ and miR-106b~25Δ/Δ mice 
were viable, fertile and showed no obvious abnormalities (Fig. 2C). In contrast, we did 
not obtain any mutant animal homozygous for the miR-106b~25Δneo allele (Fig. 2C). This 
observation suggests that if left in place the Neo cassette interferes with the expression 
of Mcm7, and highlights the importance of carefully designing the targeting strategy for 
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intronic miRNAs. All results presented hereafter derive from the use of the miR-
106b~25Δ allele. Successful deletion of miR-106b~25 was confirmed by RPA performed 
on total RNA extracted from adult tissues (Fig. 2D). Importantly, the expression and 
splicing of Mcm7 RNA was identical in wild-type and miR-106b~25Δ/Δ animals (Fig. 2E, 
F).  
Generation and characterization of miR-106a~363-deficient mice 
A similar strategy was employed to delete miR-106a~363 on the X chromosome 
(Fig. 3A, B). This allele was generated before the identification of miR-363 as a member 
of the cluster and, as such, part of this miRNA is still present in the targeted allele. 
However, because the 5’ flanking region of miR-363 is deleted, it is unlikely that this 
miRNA will be successfully processed from the targeted allele. Unfortunately, because 
miR-106a~363 expression is undetectable by either RPA or qPCR we have not been 
able to verify whether this is indeed the case (Fig. 1C).  
Mice lacking the miR-106a~363 cluster were viable, reproduced efficiently and 
had no obvious abnormalities (Fig. 3C). Mice homozygous or hemizygous for the miR-
106a~363Δ or the miR-106a~363Δneo alleles were phenotypically indistinguishable (data 
not shown).  
Generation of miR-17~92-deficient mice 
To delete miR-17~92, a construct was designed in which this cluster is flanked by 
loxP sites and followed by a frt-Neo-frt cassette (Fig. 4A, miR-17~92 2f/2l). After 
successful homologous recombination in ES cells and germ line transmission of the 
targeted allele, the cluster was deleted in vivo by crossing to a Cre-deletor mouse strain 
in which the Cre-recombinase is expressed under the control of the human beta actin 
promoter (Lewandoski et al. 1997). The resulting allele will be referred to hereafter as 
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miR-17~92 Δneo (Fig. 4A, B). An additional allele, miR-17~92Δ (Fig. 4A, B), was generated 
by removing the Neo-cassette from the miR-17~92 Δneo allele via flpe-mediated 
recombination. Mice mutant for the miR-17~92∆neo or the miR-17~92∆ allele were 
phenotypically indistinguishable. This targeting strategy also allowed the generation of a 
conditional (“floxed”) miR-17~92 allele (miR-17~92fl; Fig. 4A, C) via flpe-mediated 
deletion of the Neo cassette from miR-17~922frt/2lox mice. In mice and cells carrying the 
miR-17~92fl allele, Cre-expression leads to efficient deletion of miR-17~92  (Fig. 4C, D). 
As predicted, miR-17~92fl/fl mice were born at the expected Mendelian ratio, showed no 
obvious abnormalities (data not shown), and expressed normal levels of miR-17~92 
(Fig. 4D). 
Early postnatal lethality of miR-17~92-deficient mice 
MiR-17~92+/Δneo mice were born at the expected Mendelian ratio, were viable, 
fertile and only slightly smaller than their wild-type littermates (Fig. 4E, F and data not 
shown). In contrast, intercrosses between miR-17~92+/Δneo mice failed to produce viable 
miR-17~92 Δneo/Δneo animals. Viable miR-17~92 Δneo/Δneo embryos were recovered 
throughout gestation at about the expected Mendelian frequency and the majority of 
them reached birth (Fig. 4F). However, miR-17~92 Δneo/Δneo newborns invariably died 
within minutes after birth, and no miR-17~92 deficient mice were observed at later time 
points (Fig. 4F).  
Deletion of miR-17~92 was verified by RPA on total RNA from wild-type and 
mutant E13.5 embryos (Fig. 4G). As predicted, miR-17-5p, miR-18a, miR-20a, miR-19a 
and miR-19b-1 were undetectable in miR-17~92 Δneo/Δneo embryos (Fig. 4G), and their 
expression in heterozygous mutant embryos was roughly halved compared to wild-type 
controls. Interestingly, the signal for miR-92 miRNA was greatly reduced, but not 
abolished, in the miR-17~92 Δneo/Δneo embryos. Because these embryos lack the entire 
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miR-17~92 locus, this observation is most likely explained by hybridization of the probes 
to identical or nearly identical microRNAs expressed from one of the paralogs.  
Lung hypoplasia and ventricular septal defect in miR-17~92-deficient mice 
Macroscopically, homozygous mutant embryos were easily distinguished from 
wild-type littermates by embryonic day 13.5 (E13.5) because of their smaller size (Fig. 
5A). At E18.5, the weight of miR-17~92-null embryos was ~60% that of wild-type 
littermates (Fig. 4E).  
To determine the cause of the postnatal lethality, miR-17~92-null late-gestation 
embryos (E18.5-P0) were subjected to necropsy and histological examination. 
Macroscopically, the most significant phenotype in the miR-17~92-null embryos was the 
presence of severely hypoplastic lungs (Fig. 5B). Despite the smaller size, histological 
examination did not reveal any specific branching defect or other obvious developmental 
abnormalities (data not shown). Interestingly, it has been recently reported that over-
expression of miR-17~92 in the developing lung can increase proliferation and impair 
differentiation of the lung epithelium (Lu et al. 2007).  
Although the hearts of miR17~92-deficient and wild-type embryos were of 
comparable size, mutant E18.5 embryos presented a clear ventricular septal defect (Fig. 
5C). This phenotype occurred in all mutant embryos (n=4) that were subjected to serial 
sectioning. Other organ systems examined, including the placenta, appeared 
histologically normal.  
miR-17~92 is essential for fetal B cell development 
The role of miR-17~92 in the pathogenesis of B cell lymphomas led us to 
investigate its function in normal B cell development. Mice deficient for miR-106a~363 or 
miR-106b~25, as well as miR-17~92 +/Δneo mice, had normal numbers of circulating B 
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cells and bone marrow B cell progenitors (Fig. 6A, B). We next examined the effects of 
deletion of miR-17~92 on B cell development. Because by mid-gestation the liver is the 
primary hematopoietic organ in mice, we performed flow cytometry analysis of fetal liver 
cells from control and miR-17~92 Δneo/Δneo embryos. Although homozygous mutant fetal 
livers contained fewer total cells than controls at E14.5, the frequency of hematopoietic 
stem cells was comparable to wild-type controls and the frequency of early B cell 
progenitors was only slightly reduced (Fig. 6C, D). In contrast, at E18.5, miR-17~92-
deficient fetal livers had a greatly reduced percentage and absolute number of pre-B 
cells (Fig. 6E). This reduction in pre-B cells in the mutant embryos was associated with 
increased apoptosis, as measured by staining with Annexin-V (Fig. 6F). Importantly, the 
increase in apoptosis was specific to the B cell compartment, since levels of apoptosis in 
non-B cells was comparable in mutant and control fetal livers (Fig. 6F).  
miR-17~92 is essential for adult B cell development 
To study adult B cell development and determine whether the defect in B cell 
development was cell autonomous, we reconstituted the hematopoietic system of 
lethally irradiated mice with fetal liver cells from wild-type or miR-17~92 Δneo/Δneo E14.5 
embryos (Fig. 7A).  Eight to ten weeks after transplantation, donor red blood cells, 
granulocytes and monocytes were present at similar frequencies in the blood of mice 
reconstituted with wild-type or miR-17~92 Δneo/Δneo hematopoietic cells (Fig. 7B, C). 
Similar numbers of granulocytes and monocytes were also present in the spleens and 
bone marrows from both groups of recipient mice (Fig. 7D, E, F). In contrast, the number 
of circulating lymphocytes was greatly reduced in mice reconstituted with miR-17~92-
deficient hematopoietic cells due to a significant and specific reduction of circulating B 
cells (Fig. 7C, G-I). The percentage and absolute number of splenic B cells were also 
significantly reduced in mice reconstituted with miR-17~92-deficient hematopoietic cells 
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(Fig. 7J). Interestingly, in all mice, splenic B cells had a comparable cell surface 
phenotype and we observed similar relative (but not absolute) numbers of transitional 
and mature B cells (Fig. 7K).  
miR-17~92 regulates B cell survival 
To characterize the effect of miR-17~92 deficiency on early B cell development 
more fully, we analyzed the bone marrow from mice reconstituted with mutant or wild-
type cells. B cells develop through well-characterized stages that are distinguished by 
expression of specific cell surface markers (Fractions A to F, (Hardy et al. 1991)).  
B220+CD43+ pro-B cells (Fr. A through C) were only slightly reduced in the bone marrow 
of mice transplanted with miR-17~92-deficient fetal liver cells (Fig. 8A, B). The subsets 
of pro-B cells were also largely unaffected by the absence of miR-17~92 (Fig. 8C). In 
contrast, the percentages of pre-B cells (B220+CD43-IgM-) and later stages (Fraction E 
and F) were substantially reduced in mice transplanted with miR-17~92-null fetal liver 
cells (Fig. 8A, B).  
To confirm the role of miR-17~92 in early B cell development, we took advantage 
of the conditional miR-17~92 allele. To achieve conditional ablation of miR-17~92 in 
hematopoietic cells in vivo, miR-17~92fl/fl mice were crossed to Mx-Cre transgenic mice 
(Kuhn et al. 1995). In these mice the Cre transgene is expressed under the control of the 
inducible Mx1 promoter, which can be activated in the hematopoietic compartment in 
response to treatment with polyinosinic-polycytidylic acid (pI:pC) double-stranded RNA. 
Two-month-old mice were injected intra-peritoneally (i.p.) with pI:pC and examined 4 
weeks later. As shown in Figure 8D and E, efficient deletion of miR-17~92 was 
accompanied by a marked reduction of pre-B cells in the bone marrow of miR-
17~92fl/fl;Mx-Cre-positive mice but not in control animals. 
The reduced number of pre-B cells could be due to either enhanced cell death or 
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to reduced proliferation of miR-17~92-deficient pro- or pre-B cells. Cell cycle analysis of 
the various stages of B cell development showed no differences in the cell cycle profiles 
of pro- and pre-B cells (Fig. 9). In contrast, pro-B cell death was increased in the 
absence of miR-17~92, as determined by Annexin-V staining (Fig. 11). The increase in 
apoptosis was specific to the early stages of B cell development, as the viability of 
immature B cells and mature B cells in the bone marrow was not significantly affected by 
the deletion of miR-17~92 (Fig. 11 and data not shown). Analysis of immunoglobulin 
heavy chain rearrangement in control and miR-17~92-null pro-B cells showed that DH to 
JH recombination occurs normally, while the next step (VH to DJH rearrangement) is 
somewhat less efficient than in controls (data not shown). These results indicate that 
miR-17~92 plays a critical role in promoting the survival of early B cell progenitors. 
Consistent with this interpretation, the expression of miRNAs belonging to the miR-
17~92 cluster appears to be tightly regulated during B cell development, reaching a 
maximum at the pre-B cell stage and then rapidly returning to basal levels at later stages 
(Fig. 12). 
Regulation of the pro-apoptotic protein Bim by miR-17~92 
The data presented above suggest the possibility that members of the miR-
17~92 cluster regulate survival of early B cell progenitors by repressing the expression 
of pro-apoptotic genes at the pro- to pre-B cell transition. We therefore surveyed the list 
of putative miR-17~92 target genes predicted by the TargetScan software 
(http://www.targetscan.org/) to identify genes that could mediate this phenotype. 
TargetScan predicts miRNA targets based on a series of criteria that include sequence 
complementarity between the miRNA and the 3’UTR, evolutionary conservation, position 
of the binding site within the 3’UTR and local “AU” content (Lewis et al. 2003; Lewis et 
al. 2005; Grimson et al. 2007; Friedman et al. 2009). Several known pro-apoptotic 
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genes, including PTEN, E2F1 and Bcl2l11/Bim are predicted targets of miR-17~92. 
PTEN and E2F1 have been previously validated (O'Donnell et al. 2005; Novotny et al. 
2007). Bim is a particularly attractive candidate target of miR-17~92 given its role in 
controlling lymphocyte apoptosis and in suppressing Myc-induced B cell 
lymphomagenesis (O'Connor et al. 1998; Bouillet et al. 1999; Bouillet et al. 2002; Egle et 
al. 2004; Hemann et al. 2005).  
The 3’-UTR of Bim contains four predicted binding sites for members of the miR-
17~92 cluster and its paralogs (Fig. 12A). Two binding sites for miR-19 and miR-92 that 
are located 42 nucleotides apart in the distal portion of the Bim 3’UTR (Fig. 12A) are of 
particular interest, as it has been shown that closely spaced sites often act 
synergistically (Grimson et al. 2007). To determine whether Bim expression is modulated 
by miR-17~92, we examined its expression in miR-17~92-null animals. A significant 
increase of Bim protein levels compared to controls was observed in miR-17~92-
deficient pro- and pre-B cells from fetal livers (Fig. 12B). Similarly, we detected higher 
Bim levels in adult pre-B cells following acute deletion of miR-17~92 in hematopoietic 
cells in vivo (Fig. 12C). Bim up-regulation was also observed in the lungs of miR-17~92-
null late gestation embryos (Fig. 12D). Next we cloned a fragment of the Bim 3’UTR 
spanning the closely spaced miR-19/miR-92 binding sites downstream of the Renilla 
luciferase coding sequence, and compared its activity in HeLa cells to an equivalent 
construct where the miR-19/miR-92 seed sites were mutated. These experiments 
demonstrated that the presence of the two binding sites in the 3’UTR confers significant 
and reproducible repression (Fig. 12E). Together these results indicate that Bim is a 
direct target of miR-17~92, and suggest a possible mechanism through which deletion or 
overexpression of miR-17~92 affects B cell development and lymphomagenesis.  
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Functional interaction between miR-17~92 and miR-106b~25 
The occurrence of multiple, highly similar miRNAs is common in animal genomes 
and raises the question of functional redundancy and compensation. Given the similarity 
in sequence and expression pattern among miRNAs expressed from miR-17~92 and 
miR-106b~25 (Fig. 1B, C and Fig. 12), we decided to investigate the consequences of 
simultaneous deletion of these miRNA clusters in the mouse. Intercrosses between 
double heterozygous animals (miR-17~92+/Δ;miR-106b~25+/Δ) led to the generation of 
viable miR-17~92Δ/+;miR-106b~25Δ/Δ mice that could not be distinguished from wild-type 
controls.  In similar experiments including the miR-106a~363Δ allele, we also obtained 
viable and fertile miR-17~92Δ/+;miR-106b~25Δ/Δ;miR-106a~363Δ/y mice, thus 
demonstrating that a single wild-type miR-17~92 allele is compatible with normal mouse 
development even in the absence of the two paralog clusters.  In contrast, neither 
double knockout (miR-17~92Δ/Δ;miR-106b~25Δ/Δ, hereafter indicated as DKO) nor triple 
knockout (miR-17~92Δ/Δ;miR-106b~25Δ/Δ;miR-106a~363Δ/y, hereafter referred to as TKO) 
animals were recovered at birth. Timed-mating experiments revealed that DKO and TKO 
embryos die before embryonic day 15 and exhibit a much more severe phenotype 
compared to embryos lacking miR-17~92 alone (Fig. 13A). Macroscopic and 
microscopic examination of E13.5 and E14.5 DKO embryos revealed edema and 
vascular congestion (n=3). This was associated with severe cardiac developmental 
abnormalities, consisting of defective ventricular and atrial septation and thinner 
ventricles (Fig. 13B).  In addition, we observed areas of intense staining for cleaved 
caspase 3, a marker of apoptosis, in the fetal liver, the ventral horns of the spinal cord, 
and the lateral ganglionic eminences of DKO and TKO embryos, but not in controls or in 
miR-17~92Δneo/Δneo embryos (Fig. 13C and data not shown). These results provide 
genetic evidence that the miR-17~92 and miR-106b~25 clusters functionally cooperate 
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in regulating embryonic development and apoptosis in the mouse. 
Discussion 
In the present study we have investigated the biological functions of the miR-
17~92 cluster and its two paralogs: miR-106b~25 and miR-106a~363. We show that 
deletion of miR-17~92 leads to neonatal lethality and very specific defects in the 
development of heart, lungs and B cells. We also provide genetic evidence of functional 
cooperation between related miRNA clusters in the mouse by showing that concomitant 
deletion of miR-106b~25 and miR-17~92 results in severe cardiac defects, increased 
apoptosis and embryonic death by mid-gestation. 
Role of miR-17~92 in heart and lung development 
Cardiac development is a carefully regulated process that is extremely 
susceptible to even small perturbations, as attested by the high frequency of congenital 
cardiac malformations in humans and in genetically-modified mice (Chen et al. 2000; 
Hoffman et al. 2004). In mice, closure of the ventricular septum is normally completed by 
gestation day 14.5 (Webb et al. 1998) and several mutations are known to interfere with 
this process (Chen et al. 2000), including deletion of miRNA pathway component, Dicer, 
and miR-1-2 (Zhao et al. 2007; Saxena et al. 2010). Specific deletion of Dicer, and thus 
all mature miRNAs, in embryonic cardiac progenitors in the mouse resulted in double-
outlet right ventricle (DORV) and ventral septal defect (VSD) in the mutant embryos 
(Saxena et al. 2010). This was accompanied by an increase in expression of Pitx2 and 
Sema3c, as well as a decrease in cell death of outflow tract myocardium (Saxena et al. 
2010). Interestingly, Sema3c is a predicted target of miR-17/20 and the cardiac defects 
due to loss of Dicer, could, in part, be attributed to loss of miR-17/20 expression. A 
defective ventricular septum can be sufficient to cause postnatal lethality, although mice 
can sometimes reach adulthood (Sakata et al. 2002). However, in the case of miR-
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17~92 deletion, it is likely that the associated severe lung hypoplasia significantly 
contributes to the complete penetrance of neonatal lethality.  
The mechanism leading to lung hypoplasia in response to miR-17~92 deletion is 
presently unclear. Over-expression and amplification of miR-17~92 has been reported in 
lung cancers (Hayashita et al. 2005), and antisense inhibition of miR-17 and miR-20 
leads to increased apoptosis in lung cancer cell lines (Matsubara et al. 2007). It is 
tempting to speculate that this cluster plays an important role in the proliferation or 
survival of normal lung cells. Consistent with this hypothesis is the recent finding that 
forced expression of miR-17~92 under the control of a lung-specific promoter leads to 
hyper-proliferation and blocks differentiation of the lung epithelium in vivo (Lu et al. 
2007). Specific inhibition of miR-17 seed-related miRNAs with anti-sense oligos in 
mouse lung explants resulted in branching defects, and no changes in proliferation 
(Carraro et al. 2009). While the miR-17~92 deletion did not impair lung morphogenesis 
in miR-17~92Δneo/Δneo embryos, this could be due to the difference between chronic and 
acute loss of expression miR-17 seed-related miRNAs. 
Role of miR-17~92 in normal B cell development and lymphomagenesis 
Pro-B cells are the committed B cell progenitors in the bone marrow and fetal 
liver. Productive V-DJ rearrangement of the immunoglobulin heavy chain leads to the 
assembly of the pre-B cell receptor (pre-BCR) and signaling via the pre-BCR allows 
progression from the pro-B to the pre-B cell stage (Hardy et al. 2001; Martensson et al. 
2007). After rearrangement of the immunoglobulin light chains, the pre-BCR is replaced 
by the B cell receptor (BCR), an event that marks the transition to immature B cells and 
eventually to mature B cells. Signaling through the pre-BCR first, and the BCR later, 
appears to be required for the survival of B cell precursors and for their progression 
through the various stages.  
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Our results suggest that miR-17~92 promotes, in a cell-autonomous manner, 
survival of early B cell progenitors. A specific role for this miRNA cluster in cell survival 
at the pre-B cell checkpoint is also suggested by our finding that its expression is tightly 
regulated during B cell development and it is induced in pre-B cells. Of note, Koralov and 
colleagues (2008) have demonstrated that deletion of the miRNA processing enzyme 
Dicer in lymphocyte progenitors leads to an arrest at the pro-B to pre-B transition that is 
highly reminiscent of what we observe in miR-17~92-deficient mice (Koralov et al. 2008). 
Although additional work is required to elucidate the detailed molecular 
mechanisms, our results suggest a model for miR-17~92 function in B cell development 
and in lymphomagenesis. We propose that miR-17~92 expression is induced at the pro-
B to pre-B transition where it acts to antagonize the expression of Bim, and possibly 
additional pro-apoptotic genes. We also propose that in the event of over-expression or 
amplification of the miR-17~92 locus, as it occurs in human B cell lymphomas, 
inappropriate suppression of the same or similar target genes facilitates transformation 
by concomitant oncogenic events. This model is consistent with the previously published 
observation that forced over-expression of miR-17~92 cooperates with the c-myc 
oncogene to induce B cell lymphomas by reducing the degree of apoptosis of lymphoma 
cells (He et al. 2005) and that loss of expression of miR-17~92 in this same model as 
the opposite effect by inhibiting lymphoma progression. Interestingly, expression of 
either two miRNAs of the cluster, miR-19a and miR-19b, largely recapitulated the 
tumorigenic effect of overexpressing the entire miR-17~92 cluster concomitantly with c-
myc in B cells, and expression of the cluster lacking miR-19a and miR-19b had no effect 
on lymphomagenesis (Mu et al. 2009; Olive et al. 2009). miR-19a/b appeared to regulate 
survival of lymphoma cells through targeting of the tumor suppressor, Pten, and not Bim 
(Mu et al. 2009; Olive et al. 2009). While Bim does have one binding site for miR-19a/b, 
this target maybe more relevant to the context of B cell development rather than 
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lymphomagenesis.  
Functional cooperation between miR-17~92 and miR-106b~25 
Given their sequence similarity, these three miRNA clusters are predicted to 
have a highly overlapping set of targets (Lewis et al. 2003; Lewis et al. 2005). However, 
the results presented in this work demonstrate that only miR-17~92 is required for 
normal mouse development, while miR-106b~25 and miR-106a~363 are dispensable. A 
function for miR-106b~25 is revealed only in the context of miR-17~92 loss, as shown by 
our analysis of DKO and TKO embryos. Furthermore, our preliminary results using the 
conditional miR-17~92 allele, show that deletion of a single allele of miR-106b~25 
synergizes with miR-17~92 deletion in causing a more severe defect in B cell 
development (data not shown). Strikingly, the DKO and TKO embryos not only exhibit 
increased severity of the defects observed in miR-17~92-null embryos, but also display 
additional defects, in particular apoptosis in specific regions of the central nervous 
system and in the liver.  
There are several possible explanations for these observations. For example, 
expression of these three clusters could be spatially and temporally segregated. This is 
probably the case for miR-106a~363, that appears to be expressed at much lower levels 
compared to the other two clusters. However, miR-106b~25 and miR-17~92 are very 
similar in terms of both tissue distribution and expression levels. One potentially relevant 
difference between these two clusters is that miR-17~92, but not miR-106b~25, 
expresses members of the miR-19 and miR-18 families (Fig. 1A, B). It is tempting to 
speculate that loss of miR-19a, miR-19b and miR-18 is largely responsible for the 
phenotype caused by deletion of miR-17~92, similarly to the observation that miR-19a/b 
out of miR-17~92 are sufficient to confer pro-survival properties to lymphoma cells (Mu 
et al. 2009; Olive et al. 2009).  
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Bim and regulation of cell death by miR-17~92 and its paralogs 
It is of great interest to determine the identity of the genes regulated by miR-
17~92 and its paralogs that are responsible for the specific defects observed in single 
and compound mutant animals. In principle, the complex phenotypes observed in the 
mutant neonates and embryos could be explained by the effects of a limited number of 
target mRNAs. Given the increased cell death observed in the B cell lineage in single 
miR-17~92 mutants and the more widespread apoptosis observed in miR-17~92;miR-
106b~25 compound mutants, obvious candidates are proapoptotic genes that have 
predicted binding sites for microRNAs belonging to these clusters. Our observation that 
expression of the pro-apoptotic gene Bim is modulated by miR-17~92 is of particular 
interest in this context. Bim belongs to the BH3-only family of pro-apoptotic genes and its 
overexpression leads to apoptosis (O'Connor et al. 1998; Bouillet et al. 2002).  
Importantly, Bim is a crucial regulator of leukocyte homeostasis, as its deletion in mice 
leads to leukocytosis, with increased number of circulating B and T cells due to reduced 
apoptosis (Bouillet et al. 1999; Bouillet et al. 2002). Moreover, Koralov and colleagues 
(2008) have shown that that Bim deletion partially rescues the defective B cell 
development caused by Dicer. Future work will determine the extent to which Bim 
deregulation is responsible for the phenotypes caused by miR-17~92 deletion. Since 
miR-19 regulation of Pten levels appears to be important for B cell lymphomagenesis 
(Mu et al. 2009; Olive et al. 2009), this targeting of Pten may also play a role in survival 
of other cell types in the embryo.  
In conclusion, we have demonstrated both essential and overlapping functions 
for the miR-17~92 family of miRNA clusters. These results provide new insights into the 
regulation of critical developmental processes by miRNAs and indicate an additional 
level of control by this class of regulatory molecules in the form of functional overlap.  
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Methods 
ES cell manipulation, generation of chimeras and tetraploid blastocyst 
complementation 
V6.5 ES cells were cultivated on irradiated MEFs in DMEM containing 15% FBS, 
leukemia inhibiting factor, penicillin/streptomycin, L-glutamine and non-essential amino 
acids. 
Targeting constructs were generated by either conventional subcloning using 
appropriate restriction enzymes (miR-17~92 and miR-106a~363) or by “recombineering” 
(Liu et al. 2003) (miR-106b~25). The constructs were electroporated in V6.5 embryonic 
stem cells and cells plated under selective conditions (2 µg/ml puromycin) 48 hours later. 
Individual clones were expanded and tested by Southern blot using probes external to 
the targeting region. Clones that had undergone successful homologous recombination 
were injected into diploid (miR-17~92 and miR-106b~25 targeting) or tetraploid 
blastocysts (miR-106a~363 targeting) as previously described (Eggan et al. 2001). 
Deletion of the floxed miR-17~92 allele was obtained by crossing mice heterozygous for 
the targeted allele to a Cre-deletor strain (Actin-Cre) (Lewandoski et al. 1997). Deletion 
of the Neo cassette was obtained by crossing to a flpe-deletor mouse (Actin-Flpe) 
(Rodriguez et al. 2000). Successful recombination was verified by PCR. Primers and 
protocols for genotyping PCR are available upon request.  
Fetal liver reconstitution experiments 
For fetal liver reconstitution experiments, 6-8 weeks old recipient mice (B6.SJL, 
Jackson Laboratories) congenic for the CD45.1 allele were irradiated with 9 Gy and 
injected retro-orbitally with 4x105- 1x106 fetal liver cells from either wild-type or miR-
17~92 Δneo/Δneo E14.5 embryos. Mice were analyzed 8-10 weeks after transplantation. 
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Peripheral blood was obtained by tail bleeding. 
RNase protection assays and qPCR 
RNA samples were isolated by homogenizing tissue or cells in Trizol (Invitrogen). 
RNAse Protection assays were performed using the Ambion miRvana miRNA detection 
kit. All probes were purchased from IDT (Supplemental Experimental Procedures) and 
end-labeled with NEB Polynucleotide Kinase and γ32P-ATP. qPCR reactions were 
performed using the Applied Biosystems miRNA-detection kit. Sno-142 was used for 
normalization. 
Probes and Oligos used 
RPA probes Sequence 
miR-17 ACUACCUGCACUGUAAGCACUUUGCCAGAG 
miR-18 UAUCUGCACUAGAUGCACCUUACCAGAG 
miR-20 CUACCUGCACUAUAAGCACUUUACCAGAG 
miR-19a UCAGUUUUGCAUAGAUUUGCACACCAGAG 
miR-19b UCAGUUUUGCAUGGAUUUGCACACCAGAG 
miR-92 ACAGGCCGGGACAAGUGCAAUACCAGAG 
miR25 UCAGACCGAGACAAGUGCAAUGaaaagggagacagg 
miR93 CUACCUGCACGAACAGCACUUUGaaaagggagacagg 
miR106a UACCUGCACUGUUAGCACUUUGaaaagggagacagg 
miR106b AUCUGCACUGUCAGCACUUUAaaaagggagacagg 
miR363 UUACAGAUGGAUACCGUGCAAUaaaagggagacagg 
miR20b UACCUGCACUAUGAGCACUUUGaaaagggagacagg 
miR16 CGCCAAUAUUUACGUGCUGCUAccagag 
miR-16+4 CGCCAAUAUUUACGUGCUGCUAaaaaccagag 
BimUTRfwd (Ttttctcgagatgtcagaacccagcgtatg) 
BimUTRrev (TTTTGGGCCCTCATTAAGAACATAAAAGATTGAGTTTCTTA) 
Seed mutant miR-92 (Gggtaattgccactgtacctggggactactgctgtaaataactgcag) 
Seed mutant miR-19 
(TTCCCTGGCTTCCTTTACGTTGTCCCCTGATGAATTTTGACAGGGT). 
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Bim 3’UTR reporter assays 
A 165 nucleotide fragment of the Bim 3’ UTR, including the distal miR-19 and 
miR-92 binding sites, was amplified from mouse genomic DNA by PCR using primer 
BimUTRfwd and primer BimUTRrev (Supplemental Experimental Procedures) and 
cloned into a modified pRL-TK vector. The mutant version was generated from the wild 
type construct by Quikchange multi site-directed mutagenesis kit (Promega) according to 
manufacturers protocol using primers QCmiR92 and QCmiR19. All constructs were 
sequenced. For luciferase assays, 24 hours before transfection 10^5 Hela cells were 
seeded per well in 24 well plates.  Cells were transfected with 100ng of pGL3 (Promega) 
and 140ng of pRL-TK Bim UTR with Lipofectamine 2000 (Invitrogen). Cell were lysed at 
24 or 48 hrs and luciferase activity was measured using Dual luciferase reporter assay 
system (Promega) on the Glomax 20/20 luminometer (Promega). Data are expressed as 
ratio between Renilla and firefly luciferase activity. Wild type Bim luciferase activity was 
normalized to mutant Bim luciferase activity. 
Antibodies, Immunohistochemistry and flow cytometry analysis 
Four-color and seven-color flow cytometry was performed using FACSCalibur 
and LSRII cytometers (BD Biosciences). Cells were sorted on a FacsAria cell sorter (BD 
Biosciences). Antibodies were from Pharmingen (TCRβ, IgD, Gr-1, CD11b, CD19, 
CD21, CD23, B220) and eBioscience (c-kit, Sca-1, IL7R, IgM, Ter119, BP-1, CD5, 
CD24, CD45.1, CD45.2, CD43, CD71). Permeabilization for DAPI staining of DNA 
content was performed with cytofix/cytoperm buffers (BD Pharmingen). Annexin V 
staining was performed with Annexin V (BD) in the recommended staining buffer. Flow 
cytometry data were analyzed with FlowJo software (TreeStar). The Mcm-7 antibody 
was from Santa Cruz (sc-300). The Bim antibody was a rabbit polyclonal from Stressgen 
(AAP-330) and was used at a dilution of 1:1000 for flow cytometry and 1:2000 for 
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western blotting experiments.  
Immunohistochemistry was performed on formalin-fixed, paraffin-embedded 4µm 
sections using the ABC Vectastain kit. Sections were developed with DAB and 
counterstained with hematoxylin. The Cleaved Caspase 3 antibody (1:200) was from 
Cell Signaling. 
Histological analysis and serial sections 
Samples for histology were fixed in 3.7% formalin in PBS for 24 hours and stored 
in 70% ethanol until embedding in paraffin. Serial sections through the heart of wild-type 
and mutant mice were stained with hematoxylin and eosin and reviewed by two certified 
pathologists (RTB and JRS). 
Mouse husbandry 
All animal studies and procedures were approved by the MIT Institutional Animal 
Care and Use Committee. Mice were maintained in a mixed 129SvJae and C57/B6 
background. The Rosa26-Cre-ERT2 mice have been previously described (Ventura et 
al. 2007). The Mx-Cre transgenic line (Kuhn et al. 1995) was obtained from Jackson 
laboratories. Cre-induction in Mx-Cre animals was achieved by injecting adult mice with 
250µg of pI:pC (from Invivogen) i.p. every two days for 9 days. 
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Figures 
 
Figure 1A, B: Genomic organization and sequence alignment of miR-17~92 family 
of miRNA clusters 
(A) Schematic representation of the three miRNA clusters. Pre-miRNAs are indicated as color-
coded boxes. Black boxes correspond to the mature miRNA. The color code identifies miRNAs 
with the same seed sequence. (B) Sequence comparison of miRNAs expressed from the three 
miRNA clusters. MiRNAs with the same seed sequence (bold) are grouped together and color-
coded according to panel (A). 
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Figure 1C: Expression analysis of miR-17~92 family of miRNA clusters in mouse 
tissues 
RNase Protection Assay (RPA) on total RNAs extracted from a panel of wild-type mouse tissues. 
Two miRNAs per cluster were probed, as indicated. Probe for miR-16 was used as a control. 
Note the absence of detectable signal for miR-106a and miR-363. 
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Supplemental Figure 1
RNAse Protection Assay on total RNAs extracted from a p nel of wild type  mouse 
tissues.Two miRNAs per cluster were assayed, as indicated. miR-16 was used s control. 
MicroRNAs fr m th  miR-106a~363 cluster were undetectable.
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Figure 2A, B: Generation of targeted deletion in miR-106b~25 
C) Targeting scheme for the deletion of miR-106b~25. Mcm-7 exons are represented by black 
boxes. The mature miRNAs are represented by colored boxes. (D) Genotyping PCR performed 
on tail DNA showing germline transmission of the targeted miR-106b~25 alleles. 
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Figure 2C, D: Deletion of miR-106b~25 results in viable and fertile mice 
(C) Genotypes of mice from miR-106b~25+/Δneo and miR-106b~25+/Δ intercrosses. (D) RPAs on 
total RNA extracted from wild-type and miR-106b~25Δ/Δ adult tissues. 
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Figure 2E, F: Characterization of Mcm7 expression in miR-106b~25 null mice 
(E) RT-PCR on RNA extracted from miR-106b~25Δ/Δ and wild-type lungs and livers. Primers 
designed to amplify the junctions of exons 13-14 were used to determine whether the deletion of 
miR-106b~25 from intron 13 affects splicing between these two exons. Amplification of the 
junction between exons 2 and 3 was used as control.  (F) Mcm-7 Western blot on whole cell 
lysates from wild type and miR-106b~25 Δneo/Δneo mouse embryo fibroblasts. 
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Figure 3: Deletion of miR-106a~363 results in viable and fertile mice 
A) Targeting scheme for the deletion of miR-106a~363. (B) Genotyping PCR performed on tail 
DNA showing germline transmission of the targeted miR-106a~363 allele. (C) Genotypes of 
mice from miR-106a~363Δ/Y X miR-106a~363+/Δ crosses. 
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Figure 4A-C: Generation of targeted deletion of miR-17~92 cluster of miRNAs 
A) Targeting scheme for the deletion of miR-17~92. (B) Genotyping PCR performed on DNA 
extracted from E13.5 embryos showing germline transmission of the miR-17~92-Δneo allele. (C) 
Genotyping PCR performed on DNA extracted from miR-17~92fl/fl;Cre-ERT2+ mouse embryo 
fibroblasts. Cre-mediated deletion of miR-17~92 was assessed 5 days after infection with Cre-
expressing recombinant Adenoviruses (Ad-Cre) or after treatment with 4-Hydroxytamoxifen. 
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Figure 4D: Characterization of the conditional miR-17~92 KO allele 
Conditional deletion of miR-17~92 in mouse embryo fibroblasts. MEFs with the indicated 
genotypes were treated with 4-Hydroxytamoxifen (4-OHT) to activate the Cre-ER allele, infected 
with Cre-expressing recombinant adenoviruses (Ad-Cre), or left untreated. Deletion of miR-
17~92 was assayed 5 days later by PCR on genomic DNA (lower panel). Loss of expression of 
members of miR-17~92 was confirmed by RNAse protection assay (upper panel). 
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Figure 4E, F: Characterization of miR-17~92 deficient mice 
E) Genotypes of mice from miR-17~92+/Δneo intercrosses determined at the indicated gestation 
stages. The asterisk indicates that all miR-17~92Δneo/Δneo newborn mice died soon after birth. (F) 
Body mass of wild-type (WT), heterozygous (HET) and miR-17~92-null (KO) E18.5 embryos. 
The boxes indicate the 25th-75th percentile range. The horizontal lines represent the median, and 
the error bars indicate the lowest and highest values. P values were calculated using the two-tailed 
t test. 
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Figure 4G: miR-17~92 expression in miR-17~92 cluster wild-type, heterozygous, 
and null embryos  
RPAs on total RNA from E13.5 embryos with the indicated genotypes. 
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Figure 5A: Appearance of wild-type and miR-17~92 cluster null embryos 
Macroscopic appearance of wild-type and miR-17~92-deficient embryos at various 
developmental stages. 
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Figure 5B, C: Appearance of miR17~92 wild-type and null lungs and hearts 
B) Macroscopic appearance of wild-type and miR-17~92-deficient lungs and hearts from E17.5 
embryos. Notice the markedly hypoplastic lungs in miR-17~92-null embryos. (C) Hematoxylin-
eosin staining of comparable transverse sections through the hearts of E18.5 wild-type and miR-
17~92-null embryos. The arrow indicates a ventricular septal defect. 
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Figure 6A, B: Normal B cell development in miR-106b~25-deficient, miR-106a~363-
deficient and miR-17~92 heterozygous mice 
Flow cytometry plots of splenocytes (A) and bone marrow cells (B) from mice with the indicated 
genotype. Total B cells (upper panel), Transitional (T1and T2) and mature (Mat) B cells are 
shown. Bone marrow cells were stained with anti B220 and anti CD43 antibodies to identify 
fractions A-C, D-E and F. Only viable cells were gated and data is representative of 3 mice per 
genotype. 
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Figure 6C, D: Comparable Fetal Liver Hematopoietic Stem Cells and Early B cells 
in E14.5 control and miR-17~92-deficient embryos  
C) Fetal Liver Hematopoietic Stem Cells (FL-HSC) were identified as Lineage 
(CD3/CD4/CD8/CD11b/NK1.1/CD19/Gr-1/Ter-119/Ly6C)negIL7Rnegc-kit+Sca-1+ cells. (D) 
Early B cells were slightly reduced in miR-17~92-deficient E14.5 embryos. The fraction of these 
cells that are AA4.1+ is comparable (data not shown). Data are representative of 5 mice per 
genotype. 
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Figure 6E, F: Analysis of fetal liver B cells from miR-17~92 wild-type and null 
embryos 
E) Flow cytometry plots of fetal liver cells from E18.5 wild-type and mutant embryos showing a 
marked reduction of B220+;CD43-;IgM- pre-B cells in mice lacking miR-17~92. The results are 
representative of three independent experiments. (F) Annexin-V staining showing increased 
apoptosis in miR-17~92-deficient fetal liver B cell progenitors (blue) compared to wild-type 
control (red). The right panel shows the same analysis performed on B220-negative cells. 
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Figure 7A-C: Analysis of circulating immune cell populations in mice constituted 
with wild-type or miR-17~92 deficient fetal liver cells 
A) Schematic of the reconstitution experiment. (B) Total number of circulating RBC per mm3 of 
blood in mice reconstituted with wild-type (black) or miR-17~92-deficient (gray) fetal livers 8 
weeks post transplantation. Error bar indicates +1 S.D. The average of seven wild-type and eight 
miR-17~92-deficient mice is shown. (C) Differential white blood cells counts in mice 
reconstituted with wild-type (black) and miR-17~92-deficient (gray) fetal livers. PMNs: 
polymorphonucleates. Error bar is +1 S.D. n=7 wild-type and 8 miR-17~92 mutants. 
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Figure 7D-F: Granulocytes and monocytes are unaffected by miR-17~92 ablation 
D) Peripheral blood cells were stained with antibodies to Gr-1 and CD11b/Mac-1 to identify 
granulocytes and monocytes/macrophages. While the absolute number of granulocytes is similar 
in mice reconstituted with wild type and miR-17~92-deficient fetal liver cells, the percent 
increase reflects the reduction in circulating B-cells. (E) CD11b+ peripheral blood cells were 
stained with anti-Gr-1 and anti-F4/80 antibodies to identify granulocytes and 
monocyte/macrophage subsets. (F) Bone marrow Gr-1/CD11b subsets are not affected by miR-
17~92 deficiency. All panels are gated on CD45.2+;CD45.1- donor cells. 
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Figure 7G-I: Analysis of circulating lymphocytes in adult mice reconstituted with 
wild-type or miR-17~92 deficient fetal liver cells  
G) Representative flow cytometry plot showing reduction of B220+ B cells in the blood of mice 
reconstituted with miR-17~92-deficient fetal liver cells. (H) Dot plot showing the number of 
circulating B cells in reconstituted mice. Horizontal bars in red indicate the median value for each 
genotype. (I) Flow cytometry plot of T cells in the periphery of reconstituted mice. On 
representative example per genotype is shown. 
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Figure 7J, K: Analysis of splenic B cells in adult mice reconstituted with wild-type 
or miR-17~92 deficient fetal liver cells 
J) Flow cytometry plot of spleen cells stained for CD11b and B220, showing a reduction in 
splenic B cells in mice reconstituted with miR-17~92-deficient cells. (K) Flow cytometry plot on 
B-220-positive splenic B cells stained with IgM and IgD to determine the relative fraction of 
Transition (T1 and T2) and Mature B cells. 
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Figure 8A, B: Analysis of early B cell development in mice reconstituted with wild-
type or miR-17~92 deficient fetal liver cells 
A) Representative flow cytometry plots of bone marrow cells from mice reconstituted with wild-
type or miR-17~92-deficient fetal liver cells. (B) Percentage of pro-B and pre-B cells in 
reconstituted mice. The median (red bars) and the p-values are indicated. 
Chapter 4: Targeted deletion reveals essential and overlapping functions of miR-17~92 cluster family 
 197 
 
Figure 8C: Analysis of Pro-B cells in mice reconstituted with wild-type or miR-
17~92 deficient fetal liver cells 
Representative flow cytometry plots showing relative proportion of fraction A-C pro-B cells in 
the bone marrow of reconstituted mice. 
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Figure 8D, E: Mx-Cre-induced deletion of miR-17~92 in bone marrow and pro-B 
cells in vivo 
D) PCR analysis on total bone marrow and on sorted pro-B cells from a miR-17~92 fl/fl;Mx-Cre- 
and a miR-17~92;Mx-Cre+ mouse. The analysis was performed four weeks after completion of 
treatment with poly-I:poly-C. (C) Mice with the indicated genotypes were treated with poly-
I:poly-C and their bone marrow was analyzed by flow cytometry four weeks after completion of 
treatment. 
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Figure 9: Analysis of cell proliferation in the bone marrow of mice reconstituted 
with control or miR-17~92-null fetal liver cells 
All plots are gated on donor (CD45.2+ CD45.1-) cells. (A) Staining with anti-B220 and anti-
CD43 to identify Hardy Fractions A-F. Notice the significant reduction in the number of Fraction 
D-F cells in mice reconstituted with miR-17~92-null fetal liver cells. (B-F) Cell cycle profiles of 
non-B cells and the different Hardy Fractions as determined by DAPI staining. Notice that 
proliferation of fraction A-C is increased in the developing B cells lacking miR-17~92. While we 
cannot rule out the possibility of a direct effect of miR-17~92 on proliferation, this result is most 
consistent with a compensatory increase in proliferation in response to the reduced number of 
more mature B cells. Data are representative of four mice per genotype.  
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Figure 10: Survival of pro- and pre- B cells in mice reconstituted with wild-type 
and miR-17~92-deficient fetal liver cells 
Histogram overlays of Annexin-V staining of pro-B (left panel) and pre-B cells (right panel), 
showing increased apoptosis of pro-B cells in the bone marrow of mice reconstituted with miR-
17~92-deficient fetal liver cells. The analysis was performed on the bone marrow of mice 
reconstituted with wild-type (red line) or miR-17~92-deficient (blue line) fetal livers. 
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Figure 11: miR-20a and miR-93 expression at different stages of B cell 
development 
qPCR analysis of miR-17~92 and miR-106b~25 expression during B cell development. Pro-,  
pre-, immature and mature B cells were sorted and their RNA assayed for miR-20a and miR-93 
expression. Data are normalized to sno-142 expression. 
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Figure 12A: Predicted miRNA binding sites for members of the miR-17~92 family 
of miRNA clusters in the Bim 3’UTR 
Schematic representation of the 3’UTR of Bim and the predicted binding sites for members of the 
miR-17~92 cluster and its paralogs. Conservation of seed match is as shown. 
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Figure 12B-D: Bim expression in B cells of mice reconstituted with wild-type and 
miR-17~92 deficient fetal liver cells and lungs of wild-type and miR-17~92 null 
embryos 
B) Detection of Bim expression by flow cytometry in miR-17~92+/∆neo and miR-17~92∆neo/∆neo pro-
B (upper panels) and pre-B cells (lower panel) from E18.5 fetal livers. (C) Detection of Bim 
expression by western blotting in pre-B cells from adult mice following conditional deletion of 
miR-17~92. miR-17~92fl/fl (left lane) and miR-17~92fl/fl;Mx-Cre mice (right lane) were treated 
with pI:pC to induce expression of the Cre transgene. Pre-B cells were sorted and analyzed by 
Western blotting four weeks after treatment. (D) Detection of Bim expression by western blotting 
in E18.5 lungs from wild-type and miR-17~92∆neo/∆neo embryos. 
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Figure 12E: Bim 3’UTR fragment confers miRNA-dependent repression on 
luciferase 
Box plot of normalized relative luciferase activity of wildtype and seed mutant Bim 3’UTR 
constructs 24 and 48 hours after transfection in HeLa cells. Data represent three independent 
experiments performed in triplicate 
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Figure 13: Functional cooperation between miR-17~92 and miR-106b~25 
A) Effects of compound mutations of miR-17~92, miR-106b~25 and miR-106a~363 on 
embryonic development. E14.5 embryos with the indicated genotypes are shown. DKO = miR-
17~92Δ/Δ;miR-106b~25Δ/Δ; TKO = miR-17~92Δ/Δ;miR-106b~25Δ/Δ;miR-106A~363∆/y (B) 
Representative transverse sections of E14.5 mice showing the presence of ventricular (arrow) and 
atrial (asterisk) septal defects in DKO and TKO embryos (upper panels). Lower panels show a 
higher magnification of the lateral wall of the left ventricle. Notice the thinner wall in double and 
triple mutant embryos. The black bars correspond to 500 µm (upper panels) and 100 µm (lower 
panels). The controls were a miR-17~92+/+;miR-106b~25+/Δ;miR-106a~363Δ/y (left) and a miR-
17~92+/Δ;miR-106b~25+/Δ;miR-106a~363wt (right) mouse. (C) Cleaved caspase 3 immunostaining 
of sections from an E14.5 DKO miR-17~92Δ/Δ;miR-106b~25Δ/Δ (DKO) embryo, and a miR-
17~92+/+; miR-106b~25Δ/Δ (control) embryo showing the presence of areas of apoptosis in the 
liver (right panels), the ventral horns of the spinal cord (middle), and the lateral ganglionic 
eminence (left) in the DKO.
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This thesis presents an analysis of the biological functions of miRNAs in both an 
in vitro and in vivo model of mouse embryonic development by two methodologies, 
biochemical purification of Ago2-associated putative target mRNAs and targeted deletion 
of three miRNA clusters. These approaches have both contributed to the understanding 
of the cellular activities of specific miRNA species, as well as more general 
understanding of mechanisms by which miRNAs recognize and regulate their target 
mRNAs. 
Distribution of short RNA populations associated with the Ago2-
miRNP 
The work presented in this thesis included an in-depth analysis of the short RNA 
population in total RNA from mESCs and that cross-linked to Ago2 in CLIP, and 
expression of specific miRNA species in the mouse developing embryo and adult tissue. 
In general, studies comparing the abundance of particular miRNA species in total RNA 
with their abundance in the Ago-miRNP showed a good correlation. The work presented 
in Chapter 3 also demonstrated the same trend and that ~60% of the miRNAs 
expressed in mESCs and cross-linked to Ago2 belong to the AAGUGC-seed family. 
Interestingly, there are some significant differences in the most abundant miRNAs in the 
total RNA and the Ago2-CLIP population. This may reflect a preference for Ago2 to load 
specific miRNA species or differences in the cloning procedures from the two protocols, 
including efficiency of UV-crosslinking of different sequences to Ago2. In either case, 
mESCs are unusual as a cell type in that one miRNA seed family predominates, and 
therefore a large extent of the miRNA dependent regulation of these cells could be 
attributed to this miRNA seed family. While the miR-290~295 cluster is specifically 
expressed in mESCs and the early embryo, other members that share the same 
hexamer, including miRNAs from miR-17~92, miR-106b~25, miR-467 family, miR-302 
family (Figure 1), are also very highly expressed in the developing embryo, as shown in 
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Chapter 4, and most likely have important contributions to later embryonic development. 
This and other short RNA cloning studies of mESCs showed that about 10-20% 
of the short RNA population are derived from other non-coding RNAs, including tRNAs, 
snoRNAs, snRNAs, rRNAs or genic and intergenic regions. There has been much 
speculation in the literature that short RNAs coming from other non-coding RNAs could 
enter the miRNA pathway and function similarly to repress target mRNAs. The Ago2-
CLIP libraries had a similar distribution of miRNAs and non-coding RNAs as in the whole 
cell short RNA population. However, many of the CLIP non-coding RNA annotations are 
from the fRNADB category of snoRNA, rather than tRNA and rRNA, which are more 
abundant in the whole cell non-coding short RNA population. While these short RNA 
fragments from tRNAs and rRNAs are clearly stable enough in the cell to be cloned from 
the total RNA, they are not preferentially loaded into Ago2-miRNP. The binding of 
snoRNAs by Ago2 has been reported previously. Ender and colleagues (Ender et al. 
2008) identified a human snoRNA that is processed by Dicer and appears to have 
miRNA-like functions in human cells. It is possible that these snoRNAs crosslinked to 
Ago2 in mESCs may be part of a hairpin structure that could be recognized by the RLC 
and loaded into Ago2-miRNP. A more in-depth analysis of the short non-miRNA non-
coding RNAs crosslinked to Ago2 in mESCs will be necessary to determine whether 
these species regulate target mRNAs.  
In the absence of Dicer, we found pre-miRNA hairpins crosslinked to Ago2. This 
is in agreement with other studies that showed Ago2 can bind pre-miRNA hairpins in 
vitro (Yoda et al. 2010) and in cells (Tan et al. 2009). Both mRNA expression analysis 
comparing Dicer wild-type and Dicer null cells (Nielsen et al. 2007) and luciferase 
reporter assays (Kanellopoulou et al. 2005; Murchison et al. 2005{Kanellopoulou, 2005 
#88; Leung et al. 2006) suggest that endogenous and exogenous miRNA targets are de-
regulated in the absence of Dicer. However, it remains possible that pre-miRNA hairpins 
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in Ago2 have some, as of yet, undetectable activity in Dicer null cells. 
miRNA-targeted pathways in mESCs and developing mouse 
embryo 
Biochemical purification of putative miRNA target mRNAs bound to Ago2 
described in Chapter 2 and Chapter 3 provides a wealth of information about the extent 
of miRNA-regulated pathways in mESCs. The genes identified by Ago2-CLIP containing 
the GCACUU motif clearly showed miRNA-dependent gene expression signature and all 
the 3’UTRs tested were responsive to miRNA regulation in the luciferase reporter assay. 
An exhaustive analysis of the putative targets identitifed by Ago2-IP in Chapter 2 was 
not performed. Given the low levels of enrichment achieved by this protocol, there are 
probably a significant number of false positives in this dataset.  
Nonetheless, the Ago2 IP-microarray experiment did identify one miR-290~295 
target, Lefty1, and its homolog Lefty2. Lefties are inhibitors of TGF-ß signaling molecule 
Nodal, and are important regulators of endoderm and mesoderm differentiation. 
Interestingly, miR-290~295 null mESCs fail to upregulate markers of endoderm when 
induced to differentiate, suggesting a link between Lefty misregulation and endoderm 
differentiation. While this link has yet to be conclusively shown in mESCs, this pathway 
is deployed in both zebrafish embryonic development and human ESC differentiation. 
Interestingly, the Ago2-CLIP 3’UTR GCACUU-motif gene set also is enriched in 
members of TGF-ß pathway as shown by gene ontology pathway analysis. Interestingly, 
three of the other genes identified by Ago2-CLIP in the TGF- ß pathway, Smad6, 
Smad7, and Skil, are intracellular inhibitors of this pathway. This suggests that miR-
290~295 may regulate multiple nodes of the TGF- ß pathway in concert to promote its 
activation.  
The Ago2-CLIP 3’UTR GCACUU-motif gene set was also enriched in genes 
related to cell cycle and cell death. While control of the cell cycle by AAGUGC seed-
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family miRNAs has been well-documented, control of cell death by these miRNAs has 
not been previously described. Both pro- and anti-apoptotic genes appear in this gene 
set, so at this point it is unclear whether misregulation of these targets will promote cell 
survival or cell death in mESCs. It is likely to be the latter based on the observation that 
deletion of all Argonaute proteins in mESCs, and thus elimination of all miRNPs in the 
cell, results in apoptosis (Su et al. 2009). At this point, it is unclear why acute deletion of 
Dicer causes cell cycle arrest of mESCs, but acute deletion of all Ago proteins causes 
cell death. Further studies of these two cell lines and cell cycle and cell-death related 
miRNA targets will be necessary to understand these two phenotypes. 
Interestingly, Su et al. (2009) implicated upregulation of BIM in the Ago null 
mESCs as the potential reason these cells undergo apoptosis. BIM is also upregulated 
in miR-17~92-deficient B cells, as demonstrated in Chapter 4, and we suggest this 
upregulation is responsible for apoptosis of pro-B cells in the fetal liver. miR-17~92 
contains two miRNAs, miR-17 and miR-20, that have AAGUGC as part of their seed. It is 
thus possible that loss of the function of AAGUGC seed-related miRNAs, miR-17, miR-
20, and/or miR-290~295, in the Ago null mESCs leads to upregulation of BIM. 
Furthermore, cells in several other tissues in the mouse embryo, including liver, the 
ventral horns of the spinal cord, and the lateral ganglionic eminence, undergo apoptosis 
due to the loss of miR-17~92 and miR-106b~25. This further suggests that AAGUGC 
seed-related miRNAs have a general role in controlling cell survival in multiple tissues of 
the developing embryo. 
Functional overlap between miRNAs with similar seeds 
Many miRNA genes have arisen via gene duplication events, thus a sizable 
number of miRNAs with similar sequences exist in mammalian genomes. The similarity 
between these miRNAs can range from exact sequence matches, to 1-3 nt of base 
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changes, to over half the sequence being different. Selective pressure appears to have 
left the seed sequence intact, while allowing larger amounts of variation in the 3’ end of 
the miRNA. Thus, it is quite possible that many miRNAs are functionally redundant, 
similarly to protein-coding gene families.  
There are a few aspects to miRNA mechanisms of target recognition and 
regulation that suggest functional overlap maybe more nuanced than presumed a priori. 
While six nucleotides of basepairing between the seed and the target is sometimes 
sufficient for repression, further pairing (either in the seed or 3’ end of the miRNA) or an 
‘A’ in the first position of the target confers greater downregulation on the target (Doench 
et al. 2004; Brennecke et al. 2005; Lewis et al. 2005; Grimson et al. 2007; Nielsen et al. 
2007). For example, while miR-290~295, miR-17, miR-20, miR-106a, miR-106b, miR-25 
all share the same hexamer, they possess different 7mers, and have differing 3’ ends 
(Figure 1). Therefore, when expressed in the same cell, they may regulate different 
targets to a greater or lesser degree depending on the complementarity. Comparing the 
gene expression profiles of mESCs deleted for different 7mer seed families, miR-17 
seed family vs. miR-290~295 seed family would be one way to investigate this issue. 
miRNA function is quite likely to be subject to gene dosage effects as increasing 
abundance of miRNA in the cell results in decreasing expression of its target mRNAs 
(Doench et al. 2003). This is likely due to the 1:1 stoichiometry of the miRNP-target 
complex. The cellular concentration of a specific miRNP must be sufficiently high relative 
to the expression of its target mRNAs to lead to appreciable amounts of translational 
inhibition and degradation. This could explain why concomitant deletion of miR-17~92 
and miR-106b~25 in the mouse embryo results in more severe phenotypes, as there is 
likely some compensation between the two miRNA clusters. While deleting only one 
copy of miR-17~92 results in a 50% decrease in miRNA expression, these mice only 
have a very mild B cell phenotype, and no VSD or lung hypoplasia. This could indicate 
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that there is a critical miRNA per/cell concentration that is sufficient for target regulation, 
and below this threshold there is enough target misregulation to result in a cellular 
phenotype. Surprisingly, very few mammalian miRNAs exhibit tissue-exclusive 
expression, and only 1/3 have some degree of tissue specificity (Landgraf et al. 2007). In 
light of this, consideration of a potential miRNA concentration threshold may indicate that 
some miRNA expression maybe non-functional under normal cellular conditions and 
more cell-type specificity exists than previously thought. While this threshold may vary 
between miRNA families and cell types, investigation of the correlation between miRNA 
concentration and target regulation may provide important insights into the phenotypic 
consequences of target disregulation. 
Understanding miRNA-targeting specificity 
The short stretch of complementarity between the miRNA and the mRNA target 
that is sufficient for regulation has led to the bioinformatic prediction that over half of 
mammalian genes are subject to evolutionarily conserved miRNA-mediated effects. 
Regulation by miRNAs of non-conserved sites in 3’UTRs, as well as sites 5’UTRs and 
CDS, could further increase the number of predicted targets. Yet, the effects of targeted 
deletion in the mouse of ubiquitously expressed miRNAs, like miR-17~92 and miR-
106b~25, seem to be surprisingly limited and tissue-specific. There are many possible 
explanations for this, including some discussed previously in this section. Additionally, 
there may be other protein factors and/or sequence elements that guide the miRNP to 
specific target mRNAs.  
One such sequence element could be the G-rich motif present in mRNAs that 
crosslink to Ago2 in mESCs. This motif was enriched in Ago2-CLIP sequences from 
Dicer wild-type and Dicer null mESCs, so association of Ago2 with this motif appears to 
be miRNA independent. The crosslinking of G-rich sequences to Ago2 could be the 
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result of a physical interaction of between these two species or the crosslinking is the 
result of another RNA binding protein mediating this interaction. Towards this latter point, 
several studies have shown that Ago proteins associate with other RNA binding proteins 
that bind G-rich sequences. Specifically, in the case of FMRP family members, they act 
concertedly with Ago to regulate target mRNAs, although in one case to mediate 
repression (Edbauer et al. 2010) and in another case to mediate activation (Vasudevan 
et al. 2007a). It maybe that Ago itself has a previously unrecognized preference for 
binding G-rich sequences. In either case, it is possible that G-rich motifs occurring near 
miRNA binding sites in 3’UTRs confer additional specificity on miRNA-dependent 
regulation. 
The data presented in Chapter 3 provide evidence that the G-rich motif is a 
functional sequence element in this context. First, mutation of the G-rich motifs occurring 
near miRNA binding sites in two different 3’UTRs affects the miRNA-dependent 
regulation. Second, G-rich motifs bound by Ago2 in 3’UTRs are generally more 
conserved than random 8mers from mouse 3’UTR sequences. Excess conservation has 
been used as a criterion to indicate the likelihood that a miRNA seed match site is a 
bona fide miRNA binding site. The excess conservation of the G-motif sequences may 
provide similar evidence of their functionality. Therefore, its possible that G-motif 
sequences occurring near miRNA binding sites increase the affinity that the miRNP has 
for the target mRNA, and thus increase the likelihood that a given mRNA is 
translationally repressed or destabilized and degraded. This hypothesis could be tested 
by analyzed the miRNA-dependent gene expression signatures of mRNA targets with 
and without G-motifs near the miRNA binding sites. Also, G-motifs could be introduced 
near particularly weak miRNA binding sites to see if they increase the amount of miRNA-
dependent downregulation. 
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Roles for Ago2-directed regulation distinct from the miRNA 
pathway 
All of the work in this thesis has focused on the role of the Ago protein and 
miRNAs in mammalian gene regulation. However, a significant amount of the sequences 
crosslinked to Ago2 in mESCs were derived from regions of the genome where the 
miRNA pathway has not been implicated, including introns, repetitive elements, and 
intergenic regions. At this point, we have not investigated these sequences beyond 
mapping them to the mouse genome. The population of RNA that crosslinked to Ago2 in 
the Dicer null mESCs could represent Ago-directed gene regulation that is distinct from 
the miRNA pathway. Ago2-CLIP may also have identified previously unknown short 
RNAs since it does not require that the original RNA fragment have a 5’ phosphate like 
the conventional miRNA cloning protocols. There is some evidence that Ago may have a 
gene-regulatory function in the nucleus through promoter-associated RNAs (Janowski et 
al. 2006; Janowski et al. 2007; Schwartz et al. 2008; Weinmann et al. 2009), and this 
could be more extensive evidence of that phenomenon.  
Silencing by repeat-associated RNAs and piRNAs is quite extensive in S. pombe, 
Drosophila, and vertebrates, (see (Chu et al. 2007), however, it is not clear whether this 
pathway is active in mESCs. Several groups have identified short RNAs derived from 
SINE elements in mESCs, as well as other endogenous siRNAs that are processed from 
hairpins distinct from miRNA precursors (Calabrese et al. 2007; Babiarz et al. 2008). 
Overlap between these previously described short RNAs and the RNA species identified 
in Ago2-CLIP may indicate a functional role for them in mESCs. Thus, further 
characterization of the non-miRNA dependent RNA populations bound to Ago2 in 
mESCs may reveal a larger breath of Ago-directed gene regulation than has previously 
been appreciated. 
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Figure 1: Seed match types for AAGUGC seed-related miRNAs 
Sequences of seed match types (A1-7mer, m8-7mer, 8mer) for AAGUGC seed-related miRNAs. 
The complement of AAGUGC (GCACTT) is indicated in bold. Like colors indicate the sequence 
of the seed-match type is the same for different miRNAs.  
 
 
 
 
A1-7mer m8-7mer 8mer
miR-295/291a-3p/294/302a,b,d GCACTTA AGCACTT AGCACTTA
miR-467a/290-3p/292-3p GCACTTA GGCACTT GGCACTTA
miR-20/17/93/106 GCACTTT GCACTTTA
miR-467b GCACTTA GCACTTAA
miR-467c/d GCACTTA CGCACTT CGCACTTA
miR-105 GCACTTG GCACTTGA
Chapter 6: Bibliography 
 216 
 
 
 
 
CHAPTER 6: Bibliography 
Chapter 6: Bibliography 
 217 
Abbott, A. L., Alvarez-Saavedra, E., Miska, E. A., Lau, N. C., Bartel, D. P., Horvitz, 
H. R. and Ambros, V. (2005). "The let-7 MicroRNA family members mir-48, mir-84, 
and mir-241 function together to regulate developmental timing in Caenorhabditis 
elegans." Dev Cell 9(3): 403-14. 
Alisch, R. S., Jin, P., Epstein, M., Caspary, T. and Warren, S. T. (2007). "Argonaute2 
is essential for mammalian gastrulation and proper mesoderm formation." PLoS 
Genet 3(12): e227. 
Anderson, P. and Kedersha, N. (2009). "RNA granules: post-transcriptional and 
epigenetic modulators of gene expression." Nat Rev Mol Cell Biol 10(6): 430-6. 
Babiarz, J. E., Ruby, J. G., Wang, Y., Bartel, D. P. and Blelloch, R. (2008). "Mouse 
ES cells express endogenous shRNAs, siRNAs, and other Microprocessor-
independent, Dicer-dependent small RNAs." Genes Dev 22(20): 2773-85. 
Baek, D., Villen, J., Shin, C., Camargo, F. D., Gygi, S. P. and Bartel, D. P. (2008). 
"The impact of microRNAs on protein output." Nature 455(7209): 64-71. 
Bagga, S., Bracht, J., Hunter, S., Massirer, K., Holtz, J., Eachus, R. and Pasquinelli, 
A. E. (2005). "Regulation by let-7 and lin-4 miRNAs results in target mRNA 
degradation." Cell 122(4): 553-63. 
Bailey, T. L. and Elkan, C. (1994). "Fitting a mixture model by expectation 
maximization to discover motifs in biopolymers." Proc Int Conf Intell Syst Mol Biol 
2: 28-36. 
Bailey, T. L. and Gribskov, M. (1998). "Combining evidence using p-values: 
application to sequence homology searches." Bioinformatics 14(1): 48-54. 
Bartel, D. P. (2009). "MicroRNAs: target recognition and regulatory functions." Cell 
136(2): 215-33. 
Bartel, D. P. and Chen, C. Z. (2004). "Micromanagers of gene expression: the 
potentially widespread influence of metazoan microRNAs." Nat Rev Genet 5(5): 
396-400. 
Baskerville, S. and Bartel, D. P. (2005). "Microarray profiling of microRNAs reveals 
frequent coexpression with neighboring miRNAs and host genes." Rna 11(3): 241-
7. 
Beddington, R. S. and Robertson, E. J. (1989). "An assessment of the 
developmental potential of embryonic stem cells in the midgestation mouse 
embryo." Development 105(4): 733-7. 
Behm-Ansmant, I., Rehwinkel, J., Doerks, T., Stark, A., Bork, P. and Izaurralde, E. 
(2006). "mRNA degradation by miRNAs and GW182 requires both CCR4:NOT 
deadenylase and DCP1:DCP2 decapping complexes." Genes Dev 20(14): 1885-98. 
Chapter 6: Bibliography 
 218 
Beilharz, T. H., Humphreys, D. T., Clancy, J. L., Thermann, R., Martin, D. I., Hentze, 
M. W. and Preiss, T. (2009). "microRNA-mediated messenger RNA deadenylation 
contributes to translational repression in mammalian cells." PLoS One 4(8): e6783. 
Beitzinger, M., Peters, L., Zhu, J. Y., Kremmer, E. and Meister, G. (2007). 
"Identification of human microRNA targets from isolated argonaute protein 
complexes." RNA Biol 4(2): 76-84. 
Benetti, R., Gonzalo, S., Jaco, I., Munoz, P., Gonzalez, S., Schoeftner, S., 
Murchison, E., Andl, T., Chen, T., Klatt, P., et al. (2008). "A mammalian microRNA 
cluster controls DNA methylation and telomere recombination via Rbl2-dependent 
regulation of DNA methyltransferases." Nat Struct Mol Biol 15(3): 268-79. 
Bernstein, E., Caudy, A. A., Hammond, S. M. and Hannon, G. J. (2001). "Role for a 
bidentate ribonuclease in the initiation step of RNA interference." Nature 
409(6818): 363-6. 
Bernstein, E., Kim, S. Y., Carmell, M. A., Murchison, E. P., Alcorn, H., Li, M. Z., 
Mills, A. A., Elledge, S. J., Anderson, K. V. and Hannon, G. J. (2003). "Dicer is 
essential for mouse development." Nat Genet 35(3): 215-7. 
Bhattacharyya, S. N., Habermacher, R., Martine, U., Closs, E. I. and Filipowicz, W. 
(2006a). "Relief of microRNA-Mediated Translational Repression in Human Cells 
Subjected to Stress." Cell 125(6): 1111-24. 
Bhattacharyya, S. N., Habermacher, R., Martine, U., Closs, E. I. and Filipowicz, W. 
(2006b). "Stress-induced reversal of microRNA repression and mRNA P-body 
localization in human cells." Cold Spring Harb Symp Quant Biol 71: 513-21. 
Blanchette, M., Kent, W. J., Riemer, C., Elnitski, L., Smit, A. F., Roskin, K. M., 
Baertsch, R., Rosenbloom, K., Clawson, H., Green, E. D., et al. (2004). "Aligning 
multiple genomic sequences with the threaded blockset aligner." Genome Res 
14(4): 708-15. 
Bouillet, P., Metcalf, D., Huang, D. C., Tarlinton, D. M., Kay, T. W., Kontgen, F., 
Adams, J. M. and Strasser, A. (1999). "Proapoptotic Bcl-2 relative Bim required for 
certain apoptotic responses, leukocyte homeostasis, and to preclude 
autoimmunity." Science 286(5445): 1735-8. 
Bouillet, P., Purton, J. F., Godfrey, D. I., Zhang, L. C., Coultas, L., Puthalakath, H., 
Pellegrini, M., Cory, S., Adams, J. M. and Strasser, A. (2002). "BH3-only Bcl-2 
family member Bim is required for apoptosis of autoreactive thymocytes." Nature 
415(6874): 922-6. 
Brennecke, J., Hipfner, D. R., Stark, A., Russell, R. B. and Cohen, S. M. (2003). 
"bantam encodes a developmentally regulated microRNA that controls cell 
proliferation and regulates the proapoptotic gene hid in Drosophila." Cell 113(1): 
25-36. 
Brennecke, J., Stark, A., Russell, R. B. and Cohen, S. M. (2005). "Principles of 
microRNA-target recognition." PLoS Biol 3(3): e85. 
Chapter 6: Bibliography 
 219 
Cai, X., Hagedorn, C. H. and Cullen, B. R. (2004). "Human microRNAs are 
processed from capped, polyadenylated transcripts that can also function as 
mRNAs." Rna 10(12): 1957-66. 
Calabrese, J. M., Seila, A. C., Yeo, G. W. and Sharp, P. A. (2007). "RNA sequence 
analysis defines Dicer's role in mouse embryonic stem cells." Proc Natl Acad Sci 
U S A 104(46): 18097-102. 
Carmell, M. A., Xuan, Z., Zhang, M. Q. and Hannon, G. J. (2002). "The Argonaute 
family: tentacles that reach into RNAi, developmental control, stem cell 
maintenance, and tumorigenesis." Genes Dev 16(21): 2733-42. 
Carraro, G., El-Hashash, A., Guidolin, D., Tiozzo, C., Turcatel, G., Young, B. M., De 
Langhe, S. P., Bellusci, S., Shi, W., Parnigotto, P. P., et al. (2009). "miR-17 family of 
microRNAs controls FGF10-mediated embryonic lung epithelial branching 
morphogenesis through MAPK14 and STAT3 regulation of E-Cadherin 
distribution." Dev Biol 333(2): 238-50. 
Carthew, R. W. and Sontheimer, E. J. (2009). "Origins and Mechanisms of miRNAs 
and siRNAs." Cell 136(4): 642-55. 
Caudy, A. A., Ketting, R. F., Hammond, S. M., Denli, A. M., Bathoorn, A. M., Tops, 
B. B., Silva, J. M., Myers, M. M., Hannon, G. J. and Plasterk, R. H. (2003). "A 
micrococcal nuclease homologue in RNAi effector complexes." Nature 425(6956): 
411-4. 
Caudy, A. A., Myers, M., Hannon, G. J. and Hammond, S. M. (2002). "Fragile X-
related protein and VIG associate with the RNA interference machinery." Genes 
Dev 16(19): 2491-6. 
Chakravarty, I., Bagchi, M. K., Roy, R., Banerjee, A. C. and Gupta, N. K. (1985). 
"Protein synthesis in rabbit reticulocytes. Purification and properties of an Mr 
80,000 polypeptide (Co-eIF-2A80) with Co-eIF-2A activity." J Biol Chem 260(11): 
6945-9. 
Chan, P. P. and Lowe, T. M. (2009). "GtRNAdb: a database of transfer RNA genes 
detected in genomic sequence." Nucleic Acids Res 37(Database issue): D93-7. 
Chen, C. Y., Zheng, D., Xia, Z. and Shyu, A. B. (2009). "Ago-TNRC6 triggers 
microRNA-mediated decay by promoting two deadenylation steps." Nat Struct Mol 
Biol 16(11): 1160-6. 
Chen, J. F., Mandel, E. M., Thomson, J. M., Wu, Q., Callis, T. E., Hammond, S. M., 
Conlon, F. L. and Wang, D. Z. (2006). "The role of microRNA-1 and microRNA-133 
in skeletal muscle proliferation and differentiation." Nat Genet 38(2): 228-33. 
Chen, J. N. and Fishman, M. C. (2000). "Genetics of heart development." Trends 
Genet 16(9): 383-8. 
Chapter 6: Bibliography 
 220 
Chendrimada, T. P., Finn, K. J., Ji, X., Baillat, D., Gregory, R. I., Liebhaber, S. A., 
Pasquinelli, A. E. and Shiekhattar, R. (2007). "MicroRNA silencing through RISC 
recruitment of eIF6." Nature 447(7146): 823-8. 
Chendrimada, T. P., Gregory, R. I., Kumaraswamy, E., Norman, J., Cooch, N., 
Nishikura, K. and Shiekhattar, R. (2005). "TRBP recruits the Dicer complex to Ago2 
for microRNA processing and gene silencing." Nature 436(7051): 740-4. 
Chi, S. W., Zang, J. B., Mele, A. and Darnell, R. B. (2009). "Argonaute HITS-CLIP 
decodes microRNA-mRNA interaction maps." Nature 460(7254): 479-86. 
Choi, W. Y., Giraldez, A. J. and Schier, A. F. (2007). "Target protectors reveal 
dampening and balancing of Nodal agonist and antagonist by miR-430." Science 
318(5848): 271-4. 
Chu, C. Y. and Rana, T. M. (2006). "Translation repression in human cells by 
microRNA-induced gene silencing requires RCK/p54." PLoS Biol 4(7): e210. 
Chu, C. Y. and Rana, T. M. (2007). "Small RNAs: regulators and guardians of the 
genome." J Cell Physiol 213(2): 412-9. 
Ciaudo, C., Servant, N., Cognat, V., Sarazin, A., Kieffer, E., Viville, S., Colot, V., 
Barillot, E., Heard, E. and Voinnet, O. (2009). "Highly dynamic and sex-specific 
expression of microRNAs during early ES cell differentiation." PLoS Genet 5(8): 
e1000620. 
Costinean, S., Zanesi, N., Pekarsky, Y., Tili, E., Volinia, S., Heerema, N. and Croce, 
C. M. (2006). "Pre-B cell proliferation and lymphoblastic leukemia/high-grade 
lymphoma in E(mu)-miR155 transgenic mice." Proc Natl Acad Sci U S A 103(18): 
7024-9. 
Croce, C. M. and Calin, G. A. (2005). "miRNAs, cancer, and stem cell division." Cell 
122(1): 6-7. 
Davis, B. N., Hilyard, A. C., Lagna, G. and Hata, A. (2008). "SMAD proteins control 
DROSHA-mediated microRNA maturation." Nature 454(7200): 56-61. 
Davis, S., Lollo, B., Freier, S. and Esau, C. (2006). "Improved targeting of miRNA 
with antisense oligonucleotides." Nucleic Acids Res 34(8): 2294-304. 
Davis, S., Propp, S., Freier, S. M., Jones, L. E., Serra, M. J., Kinberger, G., Bhat, B., 
Swayze, E. E., Bennett, C. F. and Esau, C. (2009). "Potent inhibition of microRNA in 
vivo without degradation." Nucleic Acids Res 37(1): 70-7. 
Denli, A. M., Tops, B. B., Plasterk, R. H., Ketting, R. F. and Hannon, G. J. (2004). 
"Processing of primary microRNAs by the Microprocessor complex." Nature 
432(7014): 231-5. 
Dews, M., Homayouni, A., Yu, D., Murphy, D., Sevignani, C., Wentzel, E., Furth, E. 
E., Lee, W. M., Enders, G. H., Mendell, J. T., et al. (2006). "Augmentation of tumor 
angiogenesis by a Myc-activated microRNA cluster." Nat Genet 38(9): 1060-5. 
Chapter 6: Bibliography 
 221 
Didiano, D. and Hobert, O. (2006). "Perfect seed pairing is not a generally reliable 
predictor for miRNA-target interactions." Nat Struct Mol Biol 13(9): 849-51. 
Didiano, D. and Hobert, O. (2008). "Molecular architecture of a miRNA-regulated 3' 
UTR." Rna 14(7): 1297-317. 
Diederichs, S. and Haber, D. A. (2007). "Dual role for argonautes in microRNA 
processing and posttranscriptional regulation of microRNA expression." Cell 
131(6): 1097-108. 
Djuranovic, S., Zinchenko, M. K., Hur, J. K., Nahvi, A., Brunelle, J. L., Rogers, E. J. 
and Green, R. (2010). "Allosteric regulation of Argonaute proteins by miRNAs." 
Nat Struct Mol Biol 17(2): 144-50. 
Doench, J. G., Petersen, C. P. and Sharp, P. A. (2003). "siRNAs can function as 
miRNAs." Genes Dev 17(4): 438-42. 
Doench, J. G. and Sharp, P. A. (2004). "Specificity of microRNA target selection in 
translational repression." Genes Dev 18(5): 504-11. 
Duursma, A. M., Kedde, M., Schrier, M., le Sage, C. and Agami, R. (2008). "miR-148 
targets human DNMT3b protein coding region." Rna 14(5): 872-7. 
Ebert, M. S., Neilson, J. R. and Sharp, P. A. (2007). "MicroRNA sponges: 
competitive inhibitors of small RNAs in mammalian cells." Nat Methods 4(9): 721-
6. 
Edbauer, D., Neilson, J. R., Foster, K. A., Wang, C. F., Seeburg, D. P., Batterton, M. 
N., Tada, T., Dolan, B. M., Sharp, P. A. and Sheng, M. (2010). "Regulation of 
Synaptic Structure and Function by FMRP-Associated MicroRNAs miR-125b and 
miR-132." Neuron 65(3): 373-384. 
Eggan, K., Akutsu, H., Loring, J., Jackson-Grusby, L., Klemm, M., Rideout, W. M., 
3rd, Yanagimachi, R. and Jaenisch, R. (2001). "Hybrid vigor, fetal overgrowth, and 
viability of mice derived by nuclear cloning and tetraploid embryo 
complementation." Proc Natl Acad Sci U S A 98(11): 6209-14. 
Egle, A., Harris, A. W., Bouillet, P. and Cory, S. (2004). "Bim is a suppressor of 
Myc-induced mouse B cell leukemia." Proc Natl Acad Sci U S A 101(16): 6164-9. 
Elbashir, S. M., Lendeckel, W. and Tuschl, T. (2001a). "RNA interference is 
mediated by 21- and 22-nucleotide RNAs." Genes Dev 15(2): 188-200. 
Elbashir, S. M., Martinez, J., Patkaniowska, A., Lendeckel, W. and Tuschl, T. 
(2001b). "Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila 
melanogaster embryo lysate." Embo J 20(23): 6877-88. 
Ender, C., Krek, A., Friedlander, M. R., Beitzinger, M., Weinmann, L., Chen, W., 
Pfeffer, S., Rajewsky, N. and Meister, G. (2008). "A human snoRNA with microRNA-
like functions." Mol Cell 32(4): 519-28. 
Chapter 6: Bibliography 
 222 
Esquela-Kerscher, A. and Slack, F. J. (2006). "Oncomirs - microRNAs with a role in 
cancer." Nat Rev Cancer 6(4): 259-69. 
Eulalio, A., Behm-Ansmant, I., Schweizer, D. and Izaurralde, E. (2007). "P-body 
formation is a consequence, not the cause, of RNA-mediated gene silencing." Mol 
Cell Biol 27(11): 3970-81. 
Eulalio, A., Huntzinger, E. and Izaurralde, E. (2008). "GW182 interaction with 
Argonaute is essential for miRNA-mediated translational repression and mRNA 
decay." Nat Struct Mol Biol 15(4): 346-53. 
Eulalio, A., Huntzinger, E., Nishihara, T., Rehwinkel, J., Fauser, M. and Izaurralde, 
E. (2009). "Deadenylation is a widespread effect of miRNA regulation." Rna 15(1): 
21-32. 
Farh, K. K., Grimson, A., Jan, C., Lewis, B. P., Johnston, W. K., Lim, L. P., Burge, 
C. B. and Bartel, D. P. (2005). "The widespread impact of mammalian MicroRNAs 
on mRNA repression and evolution." Science 310(5755): 1817-21. 
Forstemann, K., Tomari, Y., Du, T., Vagin, V. V., Denli, A. M., Bratu, D. P., 
Klattenhoff, C., Theurkauf, W. E. and Zamore, P. D. (2005). "Normal microRNA 
maturation and germ-line stem cell maintenance requires Loquacious, a double-
stranded RNA-binding domain protein." PLoS Biol 3(7): e236. 
Foshay, K. M. and Gallicano, G. I. (2009). "miR-17 family miRNAs are expressed 
during early mammalian development and regulate stem cell differentiation." Dev 
Biol 326(2): 431-43. 
Friedman, R. C., Farh, K. K., Burge, C. B. and Bartel, D. P. (2009). "Most 
mammalian mRNAs are conserved targets of microRNAs." Genome Res 19(1): 92-
105. 
Gatfield, D., Le Martelot, G., Vejnar, C. E., Gerlach, D., Schaad, O., Fleury-Olela, F., 
Ruskeepaa, A. L., Oresic, M., Esau, C. C., Zdobnov, E. M., et al. (2009). "Integration 
of microRNA miR-122 in hepatic circadian gene expression." Genes Dev 23(11): 
1313-26. 
Giraldez, A. J., Mishima, Y., Rihel, J., Grocock, R. J., Van Dongen, S., Inoue, K., 
Enright, A. J. and Schier, A. F. (2006). "Zebrafish MiR-430 promotes deadenylation 
and clearance of maternal mRNAs." Science 312(5770): 75-9. 
Gregory, R. I., Chendrimada, T. P., Cooch, N. and Shiekhattar, R. (2005). "Human 
RISC couples microRNA biogenesis and posttranscriptional gene silencing." Cell 
123(4): 631-40. 
Gregory, R. I., Yan, K. P., Amuthan, G., Chendrimada, T., Doratotaj, B., Cooch, N. 
and Shiekhattar, R. (2004). "The Microprocessor complex mediates the genesis of 
microRNAs." Nature 432(7014): 235-40. 
Chapter 6: Bibliography 
 223 
Griffiths-Jones, S., Grocock, R. J., van Dongen, S., Bateman, A. and Enright, A. J. 
(2006). "miRBase: microRNA sequences, targets and gene nomenclature." Nucleic 
Acids Res 34(Database issue): D140-4. 
Griffiths-Jones, S., Moxon, S., Marshall, M., Khanna, A., Eddy, S. R. and Bateman, 
A. (2005). "Rfam: annotating non-coding RNAs in complete genomes." Nucleic 
Acids Res 33(Database issue): D121-4. 
Griffiths-Jones, S., Saini, H. K., van Dongen, S. and Enright, A. J. (2008). 
"miRBase: tools for microRNA genomics." Nucleic Acids Res 36(Database issue): 
D154-8. 
Grimson, A., Farh, K. K., Johnston, W. K., Garrett-Engele, P., Lim, L. P. and Bartel, 
D. P. (2007). "MicroRNA targeting specificity in mammals: determinants beyond 
seed pairing." Mol Cell 27(1): 91-105. 
Grishok, A., Pasquinelli, A. E., Conte, D., Li, N., Parrish, S., Ha, I., Baillie, D. L., Fire, 
A., Ruvkun, G. and Mello, C. C. (2001). "Genes and mechanisms related to RNA 
interference regulate expression of the small temporal RNAs that control C. 
elegans developmental timing." Cell 106(1): 23-34. 
Gu, S., Jin, L., Zhang, F., Sarnow, P. and Kay, M. A. (2009). "Biological basis for 
restriction of microRNA targets to the 3' untranslated region in mammalian 
mRNAs." Nat Struct Mol Biol 16(2): 144-50. 
Guil, S. and Caceres, J. F. (2007). "The multifunctional RNA-binding protein 
hnRNP A1 is required for processing of miR-18a." Nat Struct Mol Biol 14(7): 591-6. 
Haase, A. D., Jaskiewicz, L., Zhang, H., Laine, S., Sack, R., Gatignol, A. and 
Filipowicz, W. (2005). "TRBP, a regulator of cellular PKR and HIV-1 virus 
expression, interacts with Dicer and functions in RNA silencing." EMBO Rep 6(10): 
961-7. 
Hafner, M., Landthaler, M., Burger, L., Khorshid, M., Hausser, J., Berninger, P., 
Rothballer, A., Ascano Jr, M., Jungkamp, A.-C., Munschauer, M., et al. (2010). 
"Transcriptome-wide Identification of RNA-Binding Protein and MicroRNA Target 
Sites by PAR-CLIP." Cell 141(1): 129-141. 
Hammond, S. M. (2006). "MicroRNAs as oncogenes." Curr Opin Genet Dev 16(1): 
4-9. 
Hammond, S. M., Boettcher, S., Caudy, A. A., Kobayashi, R. and Hannon, G. J. 
(2001). "Argonaute2, a link between genetic and biochemical analyses of RNAi." 
Science 293(5532): 1146-50. 
Han, J., Lee, Y., Yeom, K. H., Kim, Y. K., Jin, H. and Kim, V. N. (2004). "The Drosha-
DGCR8 complex in primary microRNA processing." Genes Dev 18(24): 3016-27. 
Hardy, R. R., Carmack, C. E., Shinton, S. A., Kemp, J. D. and Hayakawa, K. (1991). 
"Resolution and characterization of pro-B and pre-pro-B cell stages in normal 
mouse bone marrow." J Exp Med 173(5): 1213-25. 
Chapter 6: Bibliography 
 224 
Hardy, R. R. and Hayakawa, K. (2001). "B cell development pathways." Annu Rev 
Immunol 19: 595-621. 
Harfe, B. D., McManus, M. T., Mansfield, J. H., Hornstein, E. and Tabin, C. J. (2005). 
"The RNaseIII enzyme Dicer is required for morphogenesis but not patterning of 
the vertebrate limb." Proc Natl Acad Sci U S A 102(31): 10898-903. 
Hayashita, Y., Osada, H., Tatematsu, Y., Yamada, H., Yanagisawa, K., Tomida, S., 
Yatabe, Y., Kawahara, K., Sekido, Y. and Takahashi, T. (2005). "A polycistronic 
microRNA cluster, miR-17-92, is overexpressed in human lung cancers and 
enhances cell proliferation." Cancer Res 65(21): 9628-32. 
He, L., Thomson, J. M., Hemann, M. T., Hernando-Monge, E., Mu, D., Goodson, S., 
Powers, S., Cordon-Cardo, C., Lowe, S. W., Hannon, G. J., et al. (2005). "A 
microRNA polycistron as a potential human oncogene." Nature 435(7043): 828-33. 
Hemann, M. T., Bric, A., Teruya-Feldstein, J., Herbst, A., Nilsson, J. A., Cordon-
Cardo, C., Cleveland, J. L., Tansey, W. P. and Lowe, S. W. (2005). "Evasion of the 
p53 tumour surveillance network by tumour-derived MYC mutants." Nature 
436(7052): 807-11. 
Hendrickson, D. G., Hogan, D. J., Herschlag, D., Ferrell, J. E. and Brown, P. O. 
(2008). "Systematic identification of mRNAs recruited to argonaute 2 by specific 
microRNAs and corresponding changes in transcript abundance." PLoS One 3(5): 
e2126. 
Heo, I., Joo, C., Cho, J., Ha, M., Han, J. and Kim, V. N. (2008). "Lin28 mediates the 
terminal uridylation of let-7 precursor MicroRNA." Mol Cell 32(2): 276-84. 
Hock, J. and Meister, G. (2008). "The Argonaute protein family." Genome Biol 9(2): 
210. 
Hock, J., Weinmann, L., Ender, C., Rudel, S., Kremmer, E., Raabe, M., Urlaub, H. 
and Meister, G. (2007). "Proteomic and functional analysis of Argonaute-
containing mRNA-protein complexes in human cells." EMBO Rep 8(11): 1052-60. 
Hoffman, J. I., Kaplan, S. and Liberthson, R. R. (2004). "Prevalence of congenital 
heart disease." Am Heart J 147(3): 425-39. 
Hong, X., Hammell, M., Ambros, V. and Cohen, S. M. (2009). "Immunopurification 
of Ago1 miRNPs selects for a distinct class of microRNA targets." Proc Natl Acad 
Sci U S A 106(35): 15085-90. 
Hornstein, E. and Shomron, N. (2006). "Canalization of development by 
microRNAs." Nat Genet 38 Suppl: S20-4. 
Houbaviy, H. B., Murray, M. F. and Sharp, P. A. (2003). "Embryonic stem cell-
specific MicroRNAs." Dev Cell 5(2): 351-8. 
Chapter 6: Bibliography 
 225 
Humphreys, D. T., Westman, B. J., Martin, D. I. and Preiss, T. (2005). "MicroRNAs 
control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and 
poly(A) tail function." Proc Natl Acad Sci U S A 102(47): 16961-6. 
Hutvagner, G., McLachlan, J., Pasquinelli, A. E., Balint, E., Tuschl, T. and Zamore, 
P. D. (2001). "A cellular function for the RNA-interference enzyme Dicer in the 
maturation of the let-7 small temporal RNA." Science 293(5531): 834-8. 
Hutvagner, G., Simard, M. J., Mello, C. C. and Zamore, P. D. (2004). "Sequence-
specific inhibition of small RNA function." PLoS Biol 2(4): E98. 
Hutvagner, G. and Zamore, P. D. (2002). "A microRNA in a multiple-turnover RNAi 
enzyme complex." Science 297(5589): 2056-60. 
Ihaka, R. and Gentleman, R. (1996). "R: A Language for Data Analysis and 
Graphics." Journal of Computation and Graphical Statistics 5(3): 299-314. 
Ikeda, K., Satoh, M., Pauley, K. M., Fritzler, M. J., Reeves, W. H. and Chan, E. K. 
(2006). "Detection of the argonaute protein Ago2 and microRNAs in the RNA 
induced silencing complex (RISC) using a monoclonal antibody." J Immunol 
Methods 317(1-2): 38-44. 
Janowski, B. A., Huffman, K. E., Schwartz, J. C., Ram, R., Nordsell, R., Shames, D. 
S., Minna, J. D. and Corey, D. R. (2006). "Involvement of AGO1 and AGO2 in 
mammalian transcriptional silencing." Nat Struct Mol Biol 13(9): 787-92. 
Janowski, B. A., Younger, S. T., Hardy, D. B., Ram, R., Huffman, K. E. and Corey, D. 
R. (2007). "Activating gene expression in mammalian cells with promoter-targeted 
duplex RNAs." Nat Chem Biol 3(3): 166-73. 
Jiang, F., Ye, X., Liu, X., Fincher, L., McKearin, D. and Liu, Q. (2005). "Dicer-1 and 
R3D1-L catalyze microRNA maturation in Drosophila." Genes Dev 19(14): 1674-9. 
John, B., Enright, A. J., Aravin, A., Tuschl, T., Sander, C. and Marks, D. S. (2004). 
"Human MicroRNA targets." PLoS Biol 2(11): e363. 
Johnson, S. M., Grosshans, H., Shingara, J., Byrom, M., Jarvis, R., Cheng, A., 
Labourier, E., Reinert, K. L., Brown, D. and Slack, F. J. (2005). "RAS is regulated by 
the let-7 microRNA family." Cell 120(5): 635-47. 
Judson, R. L., Babiarz, J. E., Venere, M. and Blelloch, R. (2009). "Embryonic stem 
cell-specific microRNAs promote induced pluripotency." Nat Biotechnol 27(5): 
459-61. 
Kanellopoulou, C., Muljo, S. A., Kung, A. L., Ganesan, S., Drapkin, R., Jenuwein, T., 
Livingston, D. M. and Rajewsky, K. (2005). "Dicer-deficient mouse embryonic stem 
cells are defective in differentiation and centromeric silencing." Genes Dev 19(4): 
489-501. 
Chapter 6: Bibliography 
 226 
Karginov, F. V., Conaco, C., Xuan, Z., Schmidt, B. H., Parker, J. S., Mandel, G. and 
Hannon, G. J. (2007). "A biochemical approach to identifying microRNA targets." 
Proc Natl Acad Sci U S A 104(49): 19291-6. 
Kedde, M., Strasser, M. J., Boldajipour, B., Oude Vrielink, J. A., Slanchev, K., le 
Sage, C., Nagel, R., Voorhoeve, P. M., van Duijse, J., Orom, U. A., et al. (2007). 
"RNA-binding protein Dnd1 inhibits microRNA access to target mRNA." Cell 
131(7): 1273-86. 
Keller, G. (2005). "Embryonic stem cell differentiation: emergence of a new era in 
biology and medicine." Genes Dev 19(10): 1129-55. 
Kent, W. J., Sugnet, C. W., Furey, T. S., Roskin, K. M., Pringle, T. H., Zahler, A. M. 
and Haussler, D. (2002). "The human genome browser at UCSC." Genome Res 
12(6): 996-1006. 
Kertesz, M., Iovino, N., Unnerstall, U., Gaul, U. and Segal, E. (2007). "The role of 
site accessibility in microRNA target recognition." Nat Genet 39(10): 1278-84. 
Khvorova, A., Reynolds, A. and Jayasena, S. D. (2003). "Functional siRNAs and 
miRNAs exhibit strand bias." Cell 115(2): 209-16. 
Kim, K., Lee, Y. S. and Carthew, R. W. (2007a). "Conversion of pre-RISC to holo-
RISC by Ago2 during assembly of RNAi complexes." Rna 13(1): 22-9. 
Kim, V. N., Han, J. and Siomi, M. C. (2009). "Biogenesis of small RNAs in animals." 
Nat Rev Mol Cell Biol 10(2): 126-39. 
Kim, Y. K. and Kim, V. N. (2007b). "Processing of intronic microRNAs." Embo J 
26(3): 775-83. 
Kiriakidou, M., Tan, G. S., Lamprinaki, S., De Planell-Saguer, M., Nelson, P. T. and 
Mourelatos, Z. (2007). "An mRNA m7G cap binding-like motif within human Ago2 
represses translation." Cell 129(6): 1141-51. 
Kloosterman, W. P., Wienholds, E., Ketting, R. F. and Plasterk, R. H. (2004). 
"Substrate requirements for let-7 function in the developing zebrafish embryo." 
Nucleic Acids Res 32(21): 6284-91. 
Koralov, S. B., Muljo, S. A., Galler, G. R., Krek, A., Chakraborty, T., Kanellopoulou, 
C., Jensen, K., Cobb, B. S., Merkenschlager, M., Rajewsky, N., et al. (2008). "Dicer 
ablation affects antibody diversity and cell survival in the B lymphocyte lineage." 
Cell 132(5): 860-74. 
Krek, A., Grun, D., Poy, M. N., Wolf, R., Rosenberg, L., Epstein, E. J., MacMenamin, 
P., da Piedade, I., Gunsalus, K. C., Stoffel, M., et al. (2005). "Combinatorial 
microRNA target predictions." Nat Genet 37(5): 495-500. 
Krutzfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M. 
and Stoffel, M. (2005). "Silencing of microRNAs in vivo with 'antagomirs'." Nature 
438(7068): 685-9. 
Chapter 6: Bibliography 
 227 
Kuhn, R., Schwenk, F., Aguet, M. and Rajewsky, K. (1995). "Inducible gene 
targeting in mice." Science 269(5229): 1427-9. 
Kumar, M. S., Lu, J., Mercer, K. L., Golub, T. R. and Jacks, T. (2007). "Impaired 
microRNA processing enhances cellular transformation and tumorigenesis." Nat 
Genet 39(5): 673-7. 
Lagos-Quintana, M., Rauhut, R., Lendeckel, W. and Tuschl, T. (2001). 
"Identification of novel genes coding for small expressed RNAs." Science 
294(5543): 853-8. 
Lagos-Quintana, M., Rauhut, R., Yalcin, A., Meyer, J., Lendeckel, W. and Tuschl, T. 
(2002). "Identification of tissue-specific microRNAs from mouse." Curr Biol 12(9): 
735-9. 
Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A., Pfeffer, S., 
Rice, A., Kamphorst, A. O., Landthaler, M., et al. (2007). "A mammalian microRNA 
expression atlas based on small RNA library sequencing." Cell 129(7): 1401-14. 
Landthaler, M., Gaidatzis, D., Rothballer, A., Chen, P. Y., Soll, S. J., Dinic, L., Ojo, 
T., Hafner, M., Zavolan, M. and Tuschl, T. (2008). "Molecular characterization of 
human Argonaute-containing ribonucleoprotein complexes and their bound target 
mRNAs." Rna 14(12): 2580-96. 
Landthaler, M., Yalcin, A. and Tuschl, T. (2004). "The human DiGeorge syndrome 
critical region gene 8 and Its D. melanogaster homolog are required for miRNA 
biogenesis." Curr Biol 14(23): 2162-7. 
Langmead, B., Trapnell, C., Pop, M. and Salzberg, S. L. (2009). "Ultrafast and 
memory-efficient alignment of short DNA sequences to the human genome." 
Genome Biol 10(3): R25. 
Lau, N. C., Lim, L. P., Weinstein, E. G. and Bartel, D. P. (2001). "An abundant class 
of tiny RNAs with probable regulatory roles in Caenorhabditis elegans." Science 
294(5543): 858-62. 
Lee, I., Ajay, S. S., Yook, J. I., Kim, H. S., Hong, S. H., Kim, N. H., Dhanasekaran, S. 
M., Chinnaiyan, A. M. and Athey, B. D. (2009). "New class of microRNA targets 
containing simultaneous 5'-UTR and 3'-UTR interaction sites." Genome Res 19(7): 
1175-83. 
Lee, R. C., Feinbaum, R. L. and Ambros, V. (1993). "The C. elegans heterochronic 
gene lin-4 encodes small RNAs with antisense complementarity to lin-14." Cell 
75(5): 843-54. 
Lee, Y., Ahn, C., Han, J., Choi, H., Kim, J., Yim, J., Lee, J., Provost, P., Radmark, O., 
Kim, S., et al. (2003). "The nuclear RNase III Drosha initiates microRNA 
processing." Nature 425(6956): 415-9. 
Lee, Y., Hur, I., Park, S. Y., Kim, Y. K., Suh, M. R. and Kim, V. N. (2006). "The role of 
PACT in the RNA silencing pathway." Embo J 25(3): 522-32. 
Chapter 6: Bibliography 
 228 
Lee, Y., Kim, M., Han, J., Yeom, K. H., Lee, S., Baek, S. H. and Kim, V. N. (2004). 
"MicroRNA genes are transcribed by RNA polymerase II." Embo J 23(20): 4051-60. 
Leung, A. K., Calabrese, J. M. and Sharp, P. A. (2006). "Quantitative analysis of 
Argonaute protein reveals microRNA-dependent localization to stress granules." 
Proc Natl Acad Sci U S A 103(48): 18125-30. 
Leuschner, P. J., Ameres, S. L., Kueng, S. and Martinez, J. (2006). "Cleavage of the 
siRNA passenger strand during RISC assembly in human cells." EMBO Rep 7(3): 
314-20. 
Lewandoski, M., Meyers, E. N. and Martin, G. R. (1997). "Analysis of Fgf8 gene 
function in vertebrate development." Cold Spring Harb Symp Quant Biol 62: 159-
68. 
Lewis, B. P., Burge, C. B. and Bartel, D. P. (2005). "Conserved seed pairing, often 
flanked by adenosines, indicates that thousands of human genes are microRNA 
targets." Cell 120(1): 15-20. 
Lewis, B. P., Shih, I. H., Jones-Rhoades, M. W., Bartel, D. P. and Burge, C. B. 
(2003). "Prediction of mammalian microRNA targets." Cell 115(7): 787-98. 
Li, X., Cassidy, J. J., Reinke, C. A., Fischboeck, S. and Carthew, R. W. (2009). "A 
microRNA imparts robustness against environmental fluctuation during 
development." Cell 137(2): 273-82. 
Licatalosi, D. D., Mele, A., Fak, J. J., Ule, J., Kayikci, M., Chi, S. W., Clark, T. A., 
Schweitzer, A. C., Blume, J. E., Wang, X., et al. (2008). "HITS-CLIP yields genome-
wide insights into brain alternative RNA processing." Nature 456(7221): 464-9. 
Lim, L. P., Glasner, M. E., Yekta, S., Burge, C. B. and Bartel, D. P. (2003). 
"Vertebrate microRNA genes." Science 299(5612): 1540. 
Lim, L. P., Lau, N. C., Garrett-Engele, P., Grimson, A., Schelter, J. M., Castle, J., 
Bartel, D. P., Linsley, P. S. and Johnson, J. M. (2005). "Microarray analysis shows 
that some microRNAs downregulate large numbers of target mRNAs." Nature 
433(7027): 769-73. 
Lingel, A., Simon, B., Izaurralde, E. and Sattler, M. (2004). "Nucleic acid 3'-end 
recognition by the Argonaute2 PAZ domain." Nat Struct Mol Biol 11(6): 576-7. 
Liu, J., Carmell, M. A., Rivas, F. V., Marsden, C. G., Thomson, J. M., Song, J. J., 
Hammond, S. M., Joshua-Tor, L. and Hannon, G. J. (2004). "Argonaute2 is the 
catalytic engine of mammalian RNAi." Science 305(5689): 1437-41. 
Liu, J., Rivas, F. V., Wohlschlegel, J., Yates, J. R., 3rd, Parker, R. and Hannon, G. J. 
(2005a). "A role for the P-body component GW182 in microRNA function." Nat Cell 
Biol 7(12): 1161-6. 
Chapter 6: Bibliography 
 229 
Liu, J., Valencia-Sanchez, M. A., Hannon, G. J. and Parker, R. (2005b). "MicroRNA-
dependent localization of targeted mRNAs to mammalian P-bodies." Nat Cell Biol 
7(7): 719-23. 
Liu, P., Jenkins, N. A. and Copeland, N. G. (2003). "A highly efficient 
recombineering-based method for generating conditional knockout mutations." 
Genome Res 13(3): 476-84. 
Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-
Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005). "MicroRNA 
expression profiles classify human cancers." Nature 435(7043): 834-8. 
Lu, Y., Thomson, J. M., Wong, H. Y., Hammond, S. M. and Hogan, B. L. (2007). 
"Transgenic over-expression of the microRNA miR-17-92 cluster promotes 
proliferation and inhibits differentiation of lung epithelial progenitor cells." Dev 
Biol 310(2): 442-53. 
Lytle, J. R., Yario, T. A. and Steitz, J. A. (2007). "Target mRNAs are repressed as 
efficiently by microRNA-binding sites in the 5' UTR as in the 3' UTR." Proc Natl 
Acad Sci U S A 104(23): 9667-72. 
Ma, J. B., Ye, K. and Patel, D. J. (2004). "Structural basis for overhang-specific 
small interfering RNA recognition by the PAZ domain." Nature 429(6989): 318-22. 
Ma, J. B., Yuan, Y. R., Meister, G., Pei, Y., Tuschl, T. and Patel, D. J. (2005). 
"Structural basis for 5'-end-specific recognition of guide RNA by the A. fulgidus 
Piwi protein." Nature 434(7033): 666-70. 
MacRae, I. J., Zhou, K. and Doudna, J. A. (2007). "Structural determinants of RNA 
recognition and cleavage by Dicer." Nat Struct Mol Biol 14(10): 934-40. 
Maniataki, E. and Mourelatos, Z. (2005). "A human, ATP-independent, RISC 
assembly machine fueled by pre-miRNA." Genes Dev 19(24): 2979-90. 
Maroney, P. A., Yu, Y., Fisher, J. and Nilsen, T. W. (2006). "Evidence that 
microRNAs are associated with translating messenger RNAs in human cells." Nat 
Struct Mol Biol 13(12): 1102-7. 
Marson, A., Levine, S. S., Cole, M. F., Frampton, G. M., Brambrink, T., Johnstone, 
S., Guenther, M. G., Johnston, W. K., Wernig, M., Newman, J., et al. (2008). 
"Connecting microRNA genes to the core transcriptional regulatory circuitry of 
embryonic stem cells." Cell 134(3): 521-33. 
Martensson, I. L., Keenan, R. A. and Licence, S. (2007). "The pre-B-cell receptor." 
Curr Opin Immunol 19(2): 137-42. 
Martinez, J., Patkaniowska, A., Urlaub, H., Luhrmann, R. and Tuschl, T. (2002). 
"Single-stranded antisense siRNAs guide target RNA cleavage in RNAi." Cell 
110(5): 563-74. 
Chapter 6: Bibliography 
 230 
Martinez, J. and Tuschl, T. (2004). "RISC is a 5' phosphomonoester-producing 
RNA endonuclease." Genes Dev 18(9): 975-80. 
Mathonnet, G., Fabian, M. R., Svitkin, Y. V., Parsyan, A., Huck, L., Murata, T., Biffo, 
S., Merrick, W. C., Darzynkiewicz, E., Pillai, R. S., et al. (2007). "MicroRNA 
inhibition of translation initiation in vitro by targeting the cap-binding complex 
eIF4F." Science 317(5845): 1764-7. 
Matranga, C., Tomari, Y., Shin, C., Bartel, D. P. and Zamore, P. D. (2005). 
"Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing 
RNAi enzyme complexes." Cell 123(4): 607-20. 
Matsubara, H., Takeuchi, T., Nishikawa, E., Yanagisawa, K., Hayashita, Y., Ebi, H., 
Yamada, H., Suzuki, M., Nagino, M., Nimura, Y., et al. (2007). "Apoptosis induction 
by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers 
overexpressing miR-17-92." Oncogene 26(41): 6099-105. 
Mayr, C., Hemann, M. T. and Bartel, D. P. (2007). "Disrupting the pairing between 
let-7 and Hmga2 enhances oncogenic transformation." Science 315(5818): 1576-9. 
Meister, G., Landthaler, M., Dorsett, Y. and Tuschl, T. (2004a). "Sequence-specific 
inhibition of microRNA- and siRNA-induced RNA silencing." Rna 10(3): 544-50. 
Meister, G., Landthaler, M., Patkaniowska, A., Dorsett, Y., Teng, G. and Tuschl, T. 
(2004b). "Human Argonaute2 mediates RNA cleavage targeted by miRNAs and 
siRNAs." Mol Cell 15(2): 185-97. 
Meister, G., Landthaler, M., Peters, L., Chen, P. Y., Urlaub, H., Luhrmann, R. and 
Tuschl, T. (2005). "Identification of novel argonaute-associated proteins." Curr 
Biol 15(23): 2149-55. 
Melton, C., Judson, R. L. and Blelloch, R. (2010). "Opposing microRNA families 
regulate self-renewal in mouse embryonic stem cells." Nature 463(7281): 621-6. 
Mesnard, D., Guzman-Ayala, M. and Constam, D. B. (2006). "Nodal specifies 
embryonic visceral endoderm and sustains pluripotent cells in the epiblast before 
overt axial patterning." Development 133(13): 2497-505. 
Metzger, D., Clifford, J., Chiba, H. and Chambon, P. (1995). "Conditional site-
specific recombination in mammalian cells using a ligand-dependent chimeric Cre 
recombinase." Proc Natl Acad Sci U S A 92(15): 6991-5. 
Michlewski, G., Guil, S., Semple, C. A. and Caceres, J. F. (2008). 
"Posttranscriptional regulation of miRNAs harboring conserved terminal loops." 
Mol Cell 32(3): 383-93. 
Mineno, J., Okamoto, S., Ando, T., Sato, M., Chono, H., Izu, H., Takayama, M., 
Asada, K., Mirochnitchenko, O., Inouye, M., et al. (2006). "The expression profile of 
microRNAs in mouse embryos." Nucleic Acids Res 34(6): 1765-71. 
Chapter 6: Bibliography 
 231 
Miranda, K. C., Huynh, T., Tay, Y., Ang, Y. S., Tam, W. L., Thomson, A. M., Lim, B. 
and Rigoutsos, I. (2006). "A pattern-based method for the identification of 
MicroRNA binding sites and their corresponding heteroduplexes." Cell 126(6): 
1203-17. 
Mituyama, T., Yamada, K., Hattori, E., Okida, H., Ono, Y., Terai, G., Yoshizawa, A., 
Komori, T. and Asai, K. (2009). "The Functional RNA Database 3.0: databases to 
support mining and annotation of functional RNAs." Nucleic Acids Res 
37(Database issue): D89-92. 
Miyoshi, K., Tsukumo, H., Nagami, T., Siomi, H. and Siomi, M. C. (2005). "Slicer 
function of Drosophila Argonautes and its involvement in RISC formation." Genes 
Dev 19(23): 2837-48. 
Monteys, A. M., Spengler, R. M., Wan, J., Tecedor, L., Lennox, K. A., Xing, Y. and 
Davidson, B. L. (2010). "Structure and activity of putative intronic miRNA 
promoters." RNA 16(3): 495-505. 
Morita, S., Horii, T., Kimura, M., Goto, Y., Ochiya, T. and Hatada, I. (2007). "One 
Argonaute family member, Eif2c2 (Ago2), is essential for development and 
appears not to be involved in DNA methylation." Genomics 89(6): 687-96. 
Morlando, M., Ballarino, M., Gromak, N., Pagano, F., Bozzoni, I. and Proudfoot, N. 
J. (2008). "Primary microRNA transcripts are processed co-transcriptionally." Nat 
Struct Mol Biol 15(9): 902-9. 
Mourelatos, Z., Dostie, J., Paushkin, S., Sharma, A., Charroux, B., Abel, L., 
Rappsilber, J., Mann, M. and Dreyfuss, G. (2002). "miRNPs: a novel class of 
ribonucleoproteins containing numerous microRNAs." Genes Dev 16(6): 720-8. 
Mu, P., Han, Y. C., Betel, D., Yao, E., Squatrito, M., Ogrodowski, P., de Stanchina, 
E., D'Andrea, A., Sander, C. and Ventura, A. (2009). "Genetic dissection of the miR-
17~92 cluster of microRNAs in Myc-induced B-cell lymphomas." Genes Dev 
23(24): 2806-11. 
Murchison, E. P., Partridge, J. F., Tam, O. H., Cheloufi, S. and Hannon, G. J. (2005). 
"Characterization of Dicer-deficient murine embryonic stem cells." Proc Natl Acad 
Sci U S A 102(34): 12135-40. 
Newman, M. A., Thomson, J. M. and Hammond, S. M. (2008). "Lin-28 interaction 
with the Let-7 precursor loop mediates regulated microRNA processing." Rna 
14(8): 1539-49. 
Nielsen, C. B., Shomron, N., Sandberg, R., Hornstein, E., Kitzman, J. and Burge, C. 
B. (2007). "Determinants of targeting by endogenous and exogenous microRNAs 
and siRNAs." Rna 13(11): 1894-910. 
Niwa, H. (2007). "How is pluripotency determined and maintained?" Development 
134(4): 635-46. 
Chapter 6: Bibliography 
 232 
Nottrott, S., Simard, M. J. and Richter, J. D. (2006). "Human let-7a miRNA blocks 
protein production on actively translating polyribosomes." Nat Struct Mol Biol 
13(12): 1108-14. 
Novotny, G. W., Sonne, S. B., Nielsen, J. E., Jonstrup, S. P., Hansen, M. A., 
Skakkebaek, N. E., Rajpert-De Meyts, E., Kjems, J. and Leffers, H. (2007). 
"Translational repression of E2F1 mRNA in carcinoma in situ and normal testis 
correlates with expression of the miR-17-92 cluster." Cell Death Differ 14(4): 879-
82. 
O'Carroll, D., Mecklenbrauker, I., Das, P. P., Santana, A., Koenig, U., Enright, A. J., 
Miska, E. A. and Tarakhovsky, A. (2007). "A Slicer-independent role for Argonaute 
2 in hematopoiesis and the microRNA pathway." Genes Dev 21(16): 1999-2004. 
O'Connor, L., Strasser, A., O'Reilly, L. A., Hausmann, G., Adams, J. M., Cory, S. 
and Huang, D. C. (1998). "Bim: a novel member of the Bcl-2 family that promotes 
apoptosis." EMBO J 17(2): 384-95. 
O'Donnell, K. A., Wentzel, E. A., Zeller, K. I., Dang, C. V. and Mendell, J. T. (2005). 
"c-Myc-regulated microRNAs modulate E2F1 expression." Nature 435(7043): 839-
43. 
Okamura, K., Hagen, J. W., Duan, H., Tyler, D. M. and Lai, E. C. (2007). "The mirtron 
pathway generates microRNA-class regulatory RNAs in Drosophila." Cell 130(1): 
89-100. 
Olive, V., Bennett, M. J., Walker, J. C., Ma, C., Jiang, I., Cordon-Cardo, C., Li, Q. J., 
Lowe, S. W., Hannon, G. J. and He, L. (2009). "miR-19 is a key oncogenic 
component of mir-17-92." Genes Dev 23(24): 2839-49. 
Olsen, P. H. and Ambros, V. (1999). "The lin-4 regulatory RNA controls 
developmental timing in Caenorhabditis elegans by blocking LIN-14 protein 
synthesis after the initiation of translation." Dev Biol 216(2): 671-80. 
Orom, U. A., Kauppinen, S. and Lund, A. H. (2006). "LNA-modified 
oligonucleotides mediate specific inhibition of microRNA function." Gene 372: 
137-41. 
Orom, U. A. and Lund, A. H. (2007). "Isolation of microRNA targets using 
biotinylated synthetic microRNAs." Methods 43(2): 162-5. 
Orom, U. A., Nielsen, F. C. and Lund, A. H. (2008). "MicroRNA-10a binds the 5'UTR 
of ribosomal protein mRNAs and enhances their translation." Mol Cell 30(4): 460-
71. 
Ota, A., Tagawa, H., Karnan, S., Tsuzuki, S., Karpas, A., Kira, S., Yoshida, Y. and 
Seto, M. (2004). "Identification and characterization of a novel gene, C13orf25, as a 
target for 13q31-q32 amplification in malignant lymphoma." Cancer Res 64(9): 
3087-95. 
Chapter 6: Bibliography 
 233 
Parker, J. S., Parizotto, E. A., Wang, M., Roe, S. M. and Barford, D. (2009). 
"Enhancement of the seed-target recognition step in RNA silencing by a PIWI/MID 
domain protein." Mol Cell 33(2): 204-14. 
Parker, J. S., Roe, S. M. and Barford, D. (2004). "Crystal structure of a PIWI protein 
suggests mechanisms for siRNA recognition and slicer activity." Embo J 23(24): 
4727-37. 
Parker, J. S., Roe, S. M. and Barford, D. (2005). "Structural insights into mRNA 
recognition from a PIWI domain-siRNA guide complex." Nature 434(7033): 663-6. 
Petersen, C. P., Bordeleau, M. E., Pelletier, J. and Sharp, P. A. (2006). "Short RNAs 
repress translation after initiation in mammalian cells." Mol Cell 21(4): 533-42. 
Pfeffer, S., Lagos-Quintana, M. and Tuschl, T. (2005). "Cloning of small RNA 
molecules." Curr Protoc Mol Biol Chapter 26: Unit 26 4. 
Pillai, R. S., Artus, C. G. and Filipowicz, W. (2004). "Tethering of human Ago 
proteins to mRNA mimics the miRNA-mediated repression of protein synthesis." 
Rna 10(10): 1518-25. 
Pillai, R. S., Bhattacharyya, S. N., Artus, C. G., Zoller, T., Cougot, N., Basyuk, E., 
Bertrand, E. and Filipowicz, W. (2005). "Inhibition of translational initiation by Let-7 
MicroRNA in human cells." Science 309(5740): 1573-6. 
Piskounova, E., Viswanathan, S. R., Janas, M., LaPierre, R. J., Daley, G. Q., Sliz, P. 
and Gregory, R. I. (2008). "Determinants of microRNA processing inhibition by the 
developmentally regulated RNA-binding protein Lin28." J Biol Chem 283(31): 
21310-4. 
Ponty, Y., Termier, M. and Denise, A. (2006). "GenRGenS: software for generating 
random genomic sequences and structures." Bioinformatics 22(12): 1534-5. 
Quinlan, A. R. and Hall, I. M. (2010). "BEDTools: a flexible suite of utilities for 
comparing genomic features." Bioinformatics 26(6): 841-2. 
Rand, T. A., Petersen, S., Du, F. and Wang, X. (2005). "Argonaute2 cleaves the anti-
guide strand of siRNA during RISC activation." Cell 123(4): 621-9. 
Rehwinkel, J., Behm-Ansmant, I., Gatfield, D. and Izaurralde, E. (2005). "A crucial 
role for GW182 and the DCP1:DCP2 decapping complex in miRNA-mediated gene 
silencing." Rna 11(11): 1640-7. 
Rivas, F. V., Tolia, N. H., Song, J. J., Aragon, J. P., Liu, J., Hannon, G. J. and 
Joshua-Tor, L. (2005). "Purified Argonaute2 and an siRNA form recombinant 
human RISC." Nat Struct Mol Biol 12(4): 340-9. 
Rodriguez, A., Vigorito, E., Clare, S., Warren, M. V., Couttet, P., Soond, D. R., van 
Dongen, S., Grocock, R. J., Das, P. P., Miska, E. A., et al. (2007). "Requirement of 
bic/microRNA-155 for normal immune function." Science 316(5824): 608-11. 
Chapter 6: Bibliography 
 234 
Rodriguez, C. I., Buchholz, F., Galloway, J., Sequerra, R., Kasper, J., Ayala, R., 
Stewart, A. F. and Dymecki, S. M. (2000). "High-efficiency deleter mice show that 
FLPe is an alternative to Cre-loxP." Nat Genet 25(2): 139-40. 
Rosa, A., Spagnoli, F. M. and Brivanlou, A. H. (2009). "The miR-430/427/302 family 
controls mesendodermal fate specification via species-specific target selection." 
Dev Cell 16(4): 517-27. 
Roy, A. L., Chakrabarti, D., Datta, B., Hileman, R. E. and Gupta, N. K. (1988). 
"Natural mRNA is required for directing Met-tRNA(f) binding to 40S ribosomal 
subunits in animal cells: involvement of Co-eIF-2A in natural mRNA-directed 
initiation complex formation." Biochemistry 27(21): 8203-9. 
Ruby, J. G., Jan, C. H. and Bartel, D. P. (2007). "Intronic microRNA precursors that 
bypass Drosha processing." Nature 448(7149): 83-6. 
Rybak, A., Fuchs, H., Smirnova, L., Brandt, C., Pohl, E. E., Nitsch, R. and Wulczyn, 
F. G. (2008). "A feedback loop comprising lin-28 and let-7 controls pre-let-7 
maturation during neural stem-cell commitment." Nat Cell Biol 10(8): 987-93. 
Saini, H. K., Griffiths-Jones, S. and Enright, A. J. (2007). "Genomic analysis of 
human microRNA transcripts." Proc Natl Acad Sci U S A 104(45): 17719-24. 
Saito, K., Ishizuka, A., Siomi, H. and Siomi, M. C. (2005). "Processing of pre-
microRNAs by the Dicer-1-Loquacious complex in Drosophila cells." PLoS Biol 
3(7): e235. 
Sakata, Y., Kamei, C. N., Nakagami, H., Bronson, R., Liao, J. K. and Chin, M. T. 
(2002). "Ventricular septal defect and cardiomyopathy in mice lacking the 
transcription factor CHF1/Hey2." Proc Natl Acad Sci U S A 99(25): 16197-202. 
Sasaki, T., Shiohama, A., Minoshima, S. and Shimizu, N. (2003). "Identification of 
eight members of the Argonaute family in the human genome small star, filled." 
Genomics 82(3): 323-30. 
Saxena, A. and Tabin, C. J. (2010). "miRNA-processing enzyme Dicer is necessary 
for cardiac outflow tract alignment and chamber septation." Proc Natl Acad Sci U 
S A 107(1): 87-91. 
Schier, A. F. (2003). "Nodal signaling in vertebrate development." Annu Rev Cell 
Dev Biol 19: 589-621. 
Schwartz, J. C., Younger, S. T., Nguyen, N. B., Hardy, D. B., Monia, B. P., Corey, D. 
R. and Janowski, B. A. (2008). "Antisense transcripts are targets for activating 
small RNAs." Nat Struct Mol Biol 15(8): 842-8. 
Schwarz, D. S., Hutvagner, G., Du, T., Xu, Z., Aronin, N. and Zamore, P. D. (2003). 
"Asymmetry in the assembly of the RNAi enzyme complex." Cell 115(2): 199-208. 
Chapter 6: Bibliography 
 235 
Selbach, M., Schwanhausser, B., Thierfelder, N., Fang, Z., Khanin, R. and 
Rajewsky, N. (2008). "Widespread changes in protein synthesis induced by 
microRNAs." Nature 455(7209): 58-63. 
Siepel, A., Bejerano, G., Pedersen, J. S., Hinrichs, A. S., Hou, M., Rosenbloom, K., 
Clawson, H., Spieth, J., Hillier, L. W., Richards, S., et al. (2005). "Evolutionarily 
conserved elements in vertebrate, insect, worm, and yeast genomes." Genome 
Res 15(8): 1034-50. 
Singh, S. K., Pal Bhadra, M., Girschick, H. J. and Bhadra, U. (2008). "MicroRNAs--
micro in size but macro in function." Febs J 275(20): 4929-44. 
Sinha, S. and Tompa, M. (2002). "Discovery of novel transcription factor binding 
sites by statistical overrepresentation." Nucleic Acids Res 30(24): 5549-60. 
Sinkkonen, L., Hugenschmidt, T., Berninger, P., Gaidatzis, D., Mohn, F., Artus-
Revel, C. G., Zavolan, M., Svoboda, P. and Filipowicz, W. (2008). "MicroRNAs 
control de novo DNA methylation through regulation of transcriptional repressors 
in mouse embryonic stem cells." Nat Struct Mol Biol 15(3): 259-67. 
Song, J. J., Liu, J., Tolia, N. H., Schneiderman, J., Smith, S. K., Martienssen, R. A., 
Hannon, G. J. and Joshua-Tor, L. (2003). "The crystal structure of the Argonaute2 
PAZ domain reveals an RNA binding motif in RNAi effector complexes." Nat Struct 
Biol 10(12): 1026-32. 
Song, J. J., Smith, S. K., Hannon, G. J. and Joshua-Tor, L. (2004). "Crystal 
structure of Argonaute and its implications for RISC slicer activity." Science 
305(5689): 1434-7. 
Stark, A., Lin, M. F., Kheradpour, P., Pedersen, J. S., Parts, L., Carlson, J. W., 
Crosby, M. A., Rasmussen, M. D., Roy, S., Deoras, A. N., et al. (2007). "Discovery of 
functional elements in 12 Drosophila genomes using evolutionary signatures." 
Nature 450(7167): 219-32. 
Su, H., Trombly, M. I., Chen, J. and Wang, X. (2009). "Essential and overlapping 
functions for mammalian Argonautes in microRNA silencing." Genes Dev 23(3): 
304-17. 
Sylvestre, Y., De Guire, V., Querido, E., Mukhopadhyay, U. K., Bourdeau, V., Major, 
F., Ferbeyre, G. and Chartrand, P. (2007). "An E2F/miR-20a autoregulatory 
feedback loop." J Biol Chem 282(4): 2135-43. 
Tahbaz, N., Carmichael, J. B. and Hobman, T. C. (2001). "GERp95 belongs to a 
family of signal-transducing proteins and requires Hsp90 activity for stability and 
Golgi localization." J Biol Chem 276(46): 43294-9. 
Tahbaz, N., Kolb, F. A., Zhang, H., Jaronczyk, K., Filipowicz, W. and Hobman, T. C. 
(2004). "Characterization of the interactions between mammalian PAZ PIWI 
domain proteins and Dicer." EMBO Rep 5(2): 189-94. 
Chapter 6: Bibliography 
 236 
Tan, G. S., Garchow, B. G., Liu, X., Yeung, J., Morris, J. P. t., Cuellar, T. L., 
McManus, M. T. and Kiriakidou, M. (2009). "Expanded RNA-binding activities of 
mammalian Argonaute 2." Nucleic Acids Res 37(22): 7533-45. 
Tang, F., Kaneda, M., O'Carroll, D., Hajkova, P., Barton, S. C., Sun, Y. A., Lee, C., 
Tarakhovsky, A., Lao, K. and Surani, M. A. (2007). "Maternal microRNAs are 
essential for mouse zygotic development." Genes Dev 21(6): 644-8. 
Tanzer, A. and Stadler, P. F. (2004). "Molecular evolution of a microRNA cluster." J 
Mol Biol 339(2): 327-35. 
Tay, Y., Zhang, J., Thomson, A. M., Lim, B. and Rigoutsos, I. (2008). "MicroRNAs to 
Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell 
differentiation." Nature 455(7216): 1124-8. 
Thatcher, E. J., Bond, J., Paydar, I. and Patton, J. G. (2008). "Genomic organization 
of zebrafish microRNAs." BMC Genomics 9: 253. 
Thomson, T. and Lin, H. (2009). "The biogenesis and function of PIWI proteins and 
piRNAs: progress and prospect." Annu Rev Cell Dev Biol 25: 355-76. 
Tomari, Y., Matranga, C., Haley, B., Martinez, N. and Zamore, P. D. (2004). "A 
protein sensor for siRNA asymmetry." Science 306(5700): 1377-80. 
Trabucchi, M., Briata, P., Garcia-Mayoral, M., Haase, A. D., Filipowicz, W., Ramos, 
A., Gherzi, R. and Rosenfeld, M. G. (2009). "The RNA-binding protein KSRP 
promotes the biogenesis of a subset of microRNAs." Nature 459(7249): 1010-4. 
Tsang, J., Zhu, J. and van Oudenaarden, A. (2007). "MicroRNA-mediated feedback 
and feedforward loops are recurrent network motifs in mammals." Mol Cell 26(5): 
753-67. 
Ule, J., Jensen, K., Mele, A. and Darnell, R. B. (2005). "CLIP: a method for 
identifying protein-RNA interaction sites in living cells." Methods 37(4): 376-86. 
Ule, J., Jensen, K. B., Ruggiu, M., Mele, A., Ule, A. and Darnell, R. B. (2003). "CLIP 
identifies Nova-regulated RNA networks in the brain." Science 302(5648): 1212-5. 
Valastyan, S., Reinhardt, F., Benaich, N., Calogrias, D., Szasz, A. M., Wang, Z. C., 
Brock, J. E., Richardson, A. L. and Weinberg, R. A. (2009). "A pleiotropically acting 
microRNA, miR-31, inhibits breast cancer metastasis." Cell 137(6): 1032-46. 
van Rooij, E., Sutherland, L. B., Qi, X., Richardson, J. A., Hill, J. and Olson, E. N. 
(2007). "Control of Stress-Dependent Cardiac Growth and Gene Expression by a 
MicroRNA." Science. 
Vasudevan, S. and Steitz, J. A. (2007a). "AU-Rich-Element-Mediated Upregulation 
of Translation by FXR1 and Argonaute 2." Cell 128(6): 1105-1118. 
Vasudevan, S., Tong, Y. and Steitz, J. A. (2007b). "Switching from repression to 
activation: microRNAs can up-regulate translation." Science 318(5858): 1931-4. 
Chapter 6: Bibliography 
 237 
Ventura, A., Kirsch, D. G., McLaughlin, M. E., Tuveson, D. A., Grimm, J., Lintault, 
L., Newman, J., Reczek, E. E., Weissleder, R. and Jacks, T. (2007). "Restoration of 
p53 function leads to tumour regression in vivo." Nature 445(7128): 661-5. 
Ventura, A., Young, A. G., Winslow, M. M., Lintault, L., Meissner, A., Erkeland, S. J., 
Newman, J., Bronson, R. T., Crowley, D., Stone, J. R., et al. (2008). "Targeted 
deletion reveals essential and overlapping functions of the miR-17 through 92 
family of miRNA clusters." Cell 132(5): 875-86. 
Viswanathan, S. R., Daley, G. Q. and Gregory, R. I. (2008). "Selective blockade of 
microRNA processing by Lin28." Science 320(5872): 97-100. 
Voorhoeve, P. M., le Sage, C., Schrier, M., Gillis, A. J., Stoop, H., Nagel, R., Liu, Y. 
P., van Duijse, J., Drost, J., Griekspoor, A., et al. (2006). "A genetic screen 
implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell 
tumors." Cell 124(6): 1169-81. 
Wakiyama, M., Takimoto, K., Ohara, O. and Yokoyama, S. (2007). "Let-7 microRNA-
mediated mRNA deadenylation and translational repression in a mammalian cell-
free system." Genes Dev 21(15): 1857-62. 
Wang, B., Li, S., Qi, H. H., Chowdhury, D., Shi, Y. and Novina, C. D. (2009a). 
"Distinct passenger strand and mRNA cleavage activities of human Argonaute 
proteins." Nat Struct Mol Biol 16(12): 1259-66. 
Wang, B., Love, T. M., Call, M. E., Doench, J. G. and Novina, C. D. (2006). 
"Recapitulation of short RNA-directed translational gene silencing in vitro." Mol 
Cell 22(4): 553-60. 
Wang, B., Yanez, A. and Novina, C. D. (2008a). "MicroRNA-repressed mRNAs 
contain 40S but not 60S components." Proc Natl Acad Sci U S A 105(14): 5343-8. 
Wang, H. W., Noland, C., Siridechadilok, B., Taylor, D. W., Ma, E., Felderer, K., 
Doudna, J. A. and Nogales, E. (2009b). "Structural insights into RNA processing 
by the human RISC-loading complex." Nat Struct Mol Biol 16(11): 1148-53. 
Wang, Y., Baskerville, S., Shenoy, A., Babiarz, J. E., Baehner, L. and Blelloch, R. 
(2008b). "Embryonic stem cell-specific microRNAs regulate the G1-S transition 
and promote rapid proliferation." Nat Genet 40(12): 1478-83. 
Wang, Y., Juranek, S., Li, H., Sheng, G., Tuschl, T. and Patel, D. J. (2008c). 
"Structure of an argonaute silencing complex with a seed-containing guide DNA 
and target RNA duplex." Nature 456(7224): 921-6. 
Wang, Y., Juranek, S., Li, H., Sheng, G., Wardle, G. S., Tuschl, T. and Patel, D. J. 
(2009c). "Nucleation, propagation and cleavage of target RNAs in Ago silencing 
complexes." Nature 461(7265): 754-61. 
Wang, Y., Medvid, R., Melton, C., Jaenisch, R. and Blelloch, R. (2007). "DGCR8 is 
essential for microRNA biogenesis and silencing of embryonic stem cell self-
renewal." Nat Genet 39(3): 380-5. 
Chapter 6: Bibliography 
 238 
Wang, Y., Sheng, G., Juranek, S., Tuschl, T. and Patel, D. J. (2008d). "Structure of 
the guide-strand-containing argonaute silencing complex." Nature 456(7219): 209-
13. 
Webb, S., Brown, N. A. and Anderson, R. H. (1998). "Formation of the 
atrioventricular septal structures in the normal mouse." Circ Res 82(6): 645-56. 
Weinmann, L., Hock, J., Ivacevic, T., Ohrt, T., Mutze, J., Schwille, P., Kremmer, E., 
Benes, V., Urlaub, H. and Meister, G. (2009). "Importin 8 is a gene silencing factor 
that targets argonaute proteins to distinct mRNAs." Cell 136(3): 496-507. 
Wightman, B., Ha, I. and Ruvkun, G. (1993). "Posttranscriptional regulation of the 
heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. 
elegans." Cell 75(5): 855-62. 
Woods, K., Thomson, J. M. and Hammond, S. M. (2007). "Direct regulation of an 
oncogenic micro-RNA cluster by E2F transcription factors." J Biol Chem 282(4): 
2130-4. 
Wu, L. and Belasco, J. G. (2005). "Micro-RNA regulation of the mammalian lin-28 
gene during neuronal differentiation of embryonal carcinoma cells." Mol Cell Biol 
25(21): 9198-208. 
Wu, L., Fan, J. and Belasco, J. G. (2006). "MicroRNAs direct rapid deadenylation of 
mRNA." Proc Natl Acad Sci U S A 103(11): 4034-9. 
Xiao, C., Srinivasan, L., Calado, D. P., Patterson, H. C., Zhang, B., Wang, J., 
Henderson, J. M., Kutok, J. L. and Rajewsky, K. (2008). "Lymphoproliferative 
disease and autoimmunity in mice with increased miR-17-92 expression in 
lymphocytes." Nat Immunol 9(4): 405-14. 
Xie, X., Lu, J., Kulbokas, E. J., Golub, T. R., Mootha, V., Lindblad-Toh, K., Lander, 
E. S. and Kellis, M. (2005). "Systematic discovery of regulatory motifs in human 
promoters and 3' UTRs by comparison of several mammals." Nature 434(7031): 
338-45. 
Yan, K. S., Yan, S., Farooq, A., Han, A., Zeng, L. and Zhou, M. M. (2003). "Structure 
and conserved RNA binding of the PAZ domain." Nature 426(6965): 468-74. 
Yekta, S., Shih, I. H. and Bartel, D. P. (2004). "MicroRNA-directed cleavage of 
HOXB8 mRNA." Science 304(5670): 594-6. 
Yeo, G. W., Coufal, N. G., Liang, T. Y., Peng, G. E., Fu, X. D. and Gage, F. H. (2009). 
"An RNA code for the FOX2 splicing regulator revealed by mapping RNA-protein 
interactions in stem cells." Nat Struct Mol Biol 16(2): 130-7. 
Yi, R., Qin, Y., Macara, I. G. and Cullen, B. R. (2003). "Exportin-5 mediates the 
nuclear export of pre-microRNAs and short hairpin RNAs." Genes Dev 17(24): 
3011-6. 
Chapter 6: Bibliography 
 239 
Yoda, M., Kawamata, T., Paroo, Z., Ye, X., Iwasaki, S., Liu, Q. and Tomari, Y. (2010). 
"ATP-dependent human RISC assembly pathways." Nat Struct Mol Biol 17(1): 17-
23. 
Yuan, Y. R., Pei, Y., Ma, J. B., Kuryavyi, V., Zhadina, M., Meister, G., Chen, H. Y., 
Dauter, Z., Tuschl, T. and Patel, D. J. (2005). "Crystal structure of A. aeolicus 
argonaute, a site-specific DNA-guided endoribonuclease, provides insights into 
RISC-mediated mRNA cleavage." Mol Cell 19(3): 405-19. 
Zekri, L., Huntzinger, E., Heimstadt, S. and Izaurralde, E. (2009). "The silencing 
domain of GW182 interacts with PABPC1 to promote translational repression and 
degradation of microRNA targets and is required for target release." Mol Cell Biol 
29(23): 6220-31. 
Zeng, Y. and Cullen, B. R. (2003). "Sequence requirements for micro RNA 
processing and function in human cells." Rna 9(1): 112-23. 
Zeng, Y. and Cullen, B. R. (2005a). "Efficient processing of primary microRNA 
hairpins by Drosha requires flanking nonstructured RNA sequences." J Biol Chem 
280(30): 27595-603. 
Zeng, Y., Wagner, E. J. and Cullen, B. R. (2002). "Both natural and designed micro 
RNAs can inhibit the expression of cognate mRNAs when expressed in human 
cells." Mol Cell 9(6): 1327-33. 
Zeng, Y., Yi, R. and Cullen, B. R. (2005b). "Recognition and cleavage of primary 
microRNA precursors by the nuclear processing enzyme Drosha." Embo J 24(1): 
138-48. 
Zhang, H., Kolb, F. A., Jaskiewicz, L., Westhof, E. and Filipowicz, W. (2004). 
"Single processing center models for human Dicer and bacterial RNase III." Cell 
118(1): 57-68. 
Zhao, Y., Ransom, J. F., Li, A., Vedantham, V., von Drehle, M., Muth, A. N., 
Tsuchihashi, T., McManus, M. T., Schwartz, R. J. and Srivastava, D. (2007). 
"Dysregulation of Cardiogenesis, Cardiac Conduction, and Cell Cycle in Mice 
Lacking miRNA-1-2." Cell 129(2): 303-317. 
Zisoulis, D. G., Lovci, M. T., Wilbert, M. L., Hutt, K. R., Liang, T. Y., Pasquinelli, A. 
E. and Yeo, G. W. (2010). "Comprehensive discovery of endogenous Argonaute 
binding sites in Caenorhabditis elegans." Nat Struct Mol Biol 17(2): 173-9. 
Zovoilis, A., Smorag, L., Pantazi, A. and Engel, W. (2009). "Members of the miR-290 
cluster modulate in vitro differentiation of mouse embryonic stem cells." 
Differentiation 78(2-3): 69-78. 
 
 
 
Chapter 7: Biographical Note 
 240 
CHAPTER 7: Biographical Note 
Department of Biology and 
Koch Institute for Integrative Cancer Research 
Massachusetts Institute of Technology 
77 Massachusetts Ave E17-531 
Cambridge, MA 02139 
(617) 253-6458 
amandag@mit.edu 
 
EDUCATION 
 
Massachusetts Institute of Technology, Cambridge, MA.                           2003-Present 
Department of Biology PhD program 
Expected graduation date 6/3/2010 
 
Cornell University, Ithaca, NY.                                                                          1999-2003 
Bachelor of Arts in Biology, May 2003.  
Concentration in Genetics and Development 
 
RESEARCH EXPERIENCE 
 
MIT Department of Biology PhD program                                                 2003-Present 
Dr. Phillip Sharp, Advisor, Department of Biology and Koch Institute, Massachusetts 
Institute of Technology, Cambridge, MA. 
• Develop and implement functional assays to identify mRNA targets of miRNAs 
through immunoprecipitation of Argonaute proteins and global RNA detection 
• Understand the function of miRNAs in mouse development and mouse ES cells using 
gene knockout and molecular and cell biological techniques. 
 
Cornell Presidential Research Scholar                                   Academic year 2000-2003 
Mariana Wolfner, Prof., Department of Molecular Biology and Genetics, Cornell 
University, Ithaca, NY. 
• Examined the interactions of the Drosophila nuclear Young Arrest protein (YA) with 
nuclear envelope-associated proteins. 
 
Genzyme Intern Program                  Summer 2002 
Ron Scheule, Gene Therapy Group, Genzyme Corporation, Framingham, MA. 
• Investigated expression of alpha-galactosidase-A in mouse organs delivered by tail-
vein injection of liposome:DNA complexes. 
  
NCI Student Intern Program           1998-1999, Summers 2000-2001 
Stephen O’Brien, Chief, Laboratory of Genomic Diversity, National Cancer Institute, 
National Institutes of Health, Frederick, MD. 
Chapter 7: Biographical Note 
 241 
• Examined the genetic diversity of South American and African felids using 
mitochondrial and microsatellite markers. 
TEACHING EXPERIENCE 
 
Teaching Assistant           Spring 2007 
Course Title: Experimental Biology and Communication 
 
Teaching Assistant                                                                                            Spring 2005 
Course Title: Principles of Human Disease 
 
PUBLICATIONS      
 
A. Ventura, A. Young, M. Winslow, L. Lintault, A. Meissner, S. Erkeland, R. Jaenisch, 
P. Sharp, and T. Jacks. “Targeted deletion reveals unique and overlapping functions of 
the miR-17 through 92 family of miRNA clusters.” Cell. 2008 March 7;132(5):875-86. 
S. Mani, R. Rajagopal, A. Garfinkel, X. Fan and M. Wolfner: “A hydrophilic lamin-
binding domain from the Drosophila YA protein can target proteins to the nuclear 
envelope.” J Cell Sci. 2003 May 15;116(Pt 10):2067-72 
J. Yu, A. Garfinkel, M. Wolfner: Interaction of the essential Drosophila nuclear protein 
YA with P0/AP3 in the cytoplasm and in vitro: implications for developmental 
regulation of YA's subcellular location. Dev Biol. 2002 Apr 15;244(2):429-41. 
 
INVITED LECTURES 
 
“Targeted deletion reveals essential and overlapping functions of the miR-17~92 family 
of miRNA clusters” New England RNA Data Club. Boston, MA. 2008. 
 
CONFERENCE PRESENTATIONS 
 
A.G. Young, A.K. Leung, and P.A. Sharp. “Identification of mRNA Targets of an Early 
Embryonic miRNA Cluster in Murine ES Cells”. Poster. International Congress of 
Genetics. Berlin, Germany. 2008 
A.B. Garfinkel and P.A. Sharp. “Loading of siRNAs into Mammalian Argonaute 
Proteins”. Poster. Keystone Symposia: MicroRNAs and siRNAs: Biological Functions 
and Mechanisms. Keystone, Colorado. 2007. 
A.B. Garfinkel and P.A. Sharp. “Functional Differences Between Human Argonaute 
Proteins”. Poster. Cold Spring Harbor Conference: RNAi.  Cold Spring Harbor, New 
York. 2005. 
 
FELLOWSHIPS AND AWARDS 
 
David H. Koch fellowship recipient. 2007-2008. 
Dupont Fellowship recipient. 2003-2004. 
Magna Cum Laude Honors, Cornell University. 2003. 
Cornell Presidential Research Scholar. 1999-2003. 
 
Chapter 7: Biographical Note 
 242 
OTHER ACTIVITIES  
Lab representative for MIT Environmental Health and Safety, 2004-2009. 
Graduate student representative to MIT Center for Cancer Research Scientific Advisory 
Board, 2007. 
Supervisor of a student in the MIT Undergraduate Research Opportunities Program, 
2007-2009. 
 
 
 
 
 
